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ABSTRACT
Bovine coronavirus (BCV) has been previously detected in the enteric 
and respiratory tracts of cattle and is specifically associated with 
enteritis and diarrhoea in neonatal calves.
Two diagnostic tests, an ELISA and an immunogold EM technique for 
the detection of BCV in faeces, were developed, optimised and compared 
with direct EM, immunosorbent EM and haemadsorption-elution- 
haemagglutination (HEHA). The immunogold EM technique was found to be 
the most sensitive test followed by the ELISA, HEHA, immunosorbent EM 
and direct EM. An IF test for detecting BCV in the respiratory tract 
and a neutralization test for quantifying anti-BCV antibody titres in 
serum and milk were also developed.
Using the immunogold EM technique BCV was demonstrated in 39 of 123 
field samples of bovine diarrheic faeces. From 25 of these samples 2 
isolates were successfully adapted to grow in HRT 18 cells following 
initial isolation in bovine fetal tracheal organ culture. These, and 
three other strains of BCV and a human coronavirus (HCV) strain 
obtained from other laboratories, were compared in immunofluorescence 
(IF), haemagglutination inhibition (HAI) and neutralization tests.
Polyclonal antisera against these 6 viruses were raised in rabbits. 
No significant differences between viruses were detected by IF 
incorporating homologous and heterologous antisera but HCV could be 
distinguished from the bovine coronaviruses in a cross neutralization 
test. In this test all BCV isolates were determined to be of one 
serotype. In the HAI test however, the HCV strain was distinguishable 
from the 5 BCV strains and differences between the BCV strains were 
shown.
Two monoclonal antibodies prepared against one of the BCV strains 
distinguished the HCV from the BCV strains in all three tests. These 
monoclonal antibodies did not distinguish between the 5 BCV strains in 
the IF or HAI test but did so in the neutralization test.
The various strains were also compared at the molecular level using 
the Western blotting technique. This technique showed no significant 
differences between the molecular weights or serological reactivity of 
the structural proteins of these strains.
Experimental infection of a gnotobiotic calf with BCV resulted in 
diarrhoea and fever, but no clinical evidence of disease was seen when 
4 conventionally reared colostrum fed calves and 4 gnotobiotic lambs 
were similarly infected. The oral infection of suckling mice with BCV 
produced diarrhoea in some animals but a full investigation is required 
to optimise this model.
A prospective epidemiological survey on one farm was carried out and 
showed Cryptosporidium and BCV to be associated with diarrhoea. 
Additionally this survey showed that the detection of BCV in the 
respiratory tract was associated significantly with respiratory 
symptoms.
CHAPTER T
INTRODUCTION
1INTRODUCTION
Diarrhoea is an important disease of many young animals and may be 
associated with factors such as environmental conditions, nutrition and 
management, as well as infectious agents. The immunological status and 
genetic predisposition of individual animals on exposure to infectious 
agents are other factors that influence the outcome of the disease.
Several micro-organisms have been shown to cause diarrhoea either 
individually or in conjunction with other agents. These include 
bacteria, e.g. enterotoxigenic Escherichia coli (ETEC) and Salmonella 
species, viruses such as rotavirus and coronavirus, and the parasite 
Cryptosporidium. Dual infections with more than one of these agents are 
common, and the synergistic interaction of ETEC and rotavirus for 
example sometimes leads to death (Runnels et al,1986).
Other agents such as Bredaviruses, small round viruses and
Campylobacter species have been detected in the faeces of young 
diarrheic animals but their importance in the aetiology of neonatal
diarrhoea has not been proven.
It has long been noted that neonatal calf diarrhoea (NCD) is of
economic importance to the farming industry (Mills, 1776) and it is
still considered to be one of the most important diseases of young 
calves. It not only leads to the death of many calves but also entails 
high veterinary bills and a loss through reduced growth (Woode and 
Bridger, 1975).
2Enteric infections account for approximately 40% of all infections 
of calves less then 60 days old. Rotavirus, coronavirus, ETEC and 
Cryptosporidium being responsible for 75% to 95% of these enteric 
infections worldwide (Tzipori, 1985).
3ROTAVIRUS:
The rotavirus genus of the Reoviridae consists of a number of
morphologically identical viruses that cause diarrhoea mainly in young
mammals and some birds (Estes et al, 1983). On electron microscopic
examination, two types of rotavirus particle are seen. The intact,
infectious particles appear as "smooth” double-shelled capsid
structures measuring around 70nm in diameter (Bridger and Woode, 1976).
On losing the outside capsid layer, "rough" single-shelled
non-infectious particles are seen. The rotavirus genome is made up of
11 segments of double-stranded RNA ranging in molecular weight from
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approximately 2.0x10 to 0.2x10 . Electrophoretic analysis on 
polyacrylamide gels (PAGE) has been used to detect rotavirus dsRNA in 
faeces and to study differences between isolates. Major differences in 
the mobility of the genome segments are seen in isolates from different 
host species while only minor differences are detected between 
individual isolates from the same species (Herring et al, 1982). 
Differences in electrophoretype however do not necessarily reflect 
differences in antigenic or biological properties. Strains showing 
identical electrophoretype may not have identical RNA and strains with 
similar serological characteristics may differ in the mobility of their 
RNA segments (DuPont, 1984). Electron microscopy (EM), immunosorbent 
EM, ELISA and latex agglutination tests have been used to detect 
rotavirus in faeces but PAGE has the advantage of being rapid, 
sensitive, and provides more useful information about the type of 
rotavirus present (Herring et al, 1982).
4Serologically, around 9 different serotypes and 2 sub-groups of 
rotavirus have been detected. Segment 6 in a simian rotavirus RNA has 
been found to code for a 41KD protein, the inner capsid VP6 protein 
which is recognised as the common group antigen. Segments 4 and 9 code 
for VP3 and VP7, two other capsid proteins, 88KD and 37KD respectively, 
which bear neutralizing epitopes and are therefore serotyping antigens 
(Estes et al, 1985). Cleavage of VP3 by trypsin, has been shown to 
activate infectivity (Estes et al, 1983).
The mature villous epithelial cells excluding goblet cells and 
immature enterocytes of the small intestine are the main targets for 
the replication of the virus. Infected enterocytes degenerate and are 
replaced by cuboidal cells, stunting the villi (Snodrass et al, 1977). 
In vivo reassortment of rotavirus RNA genomes has been shown to occur 
and may give rise to mixed or novel genetic patterns which play an 
important role in the epidemiology of rotavirus enteritis (DuPont,
1984).
In a recent survey on farms throughout the UK, bovine rotavirus was 
detected in 52% and 42% of diarrheic calves in the north of England and 
Scotland (Snodgrass et al, 1986) and southern Britain (Reynolds et al,
1986) respectively. Rotavirus was also detected in the same regions in 
18% and 13% of healthy calves examined. Affected calves are usually 
less than 4 weeks of age. A bovine rotavirus/ETEC vaccine administered 
to pregnant cows has been shown to provide significant (passively 
acquired) protection against rotavirus challenge to calves born to and 
reared on vaccinated dams (Snodgrass et al, 1982a; Snodgrass, 1986).
ENTEROTOXIGENIC E. COLI:
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E. coli are Gram negative bacilli which occur as normal inhabitants 
of the intestinal tracts of animals and man. Some strains however are
enterotoxigenic and are able to produce adhesive pili and an
enterotoxin. The plasmid controlled adhesive pili enable ETEC to adhere 
to the small intestine and release the enterotoxin at the gut surface 
(Buxton and Fraser, 1977). The enterotoxin causes the secretion of 
fluid from the body into the alimentary tract, causing profuse watery 
diarrhoea and dehydration leading to death in some cases. Strains of 
ETEC tend to fall into particular serogroups. Those that cause 
diarrhoea in humans are distinct from those that cause diarrhoea in 
animals. The fimbrial surface antigen which mediates mucosal adhesion 
and diarrhoea in calves is known as K99 antigen (Tzipori, 1985). ETEC 
usually causes diarrhoea in calves less than 4 days old and is
diagnosed by ELISA (Ellens et al, 1979) or slide agglutination test on 
cultures of E. coli grown on minca-Isovitalex medium to enhance the 
detection of K99 antigen (Guinee et al, 1977). ETEC has been detected 
in 8% of 109 diarrheic calves and in none of 49 healthy calves in a 
recent Scottish survey. Protection of calves against ETEC by
vaccination has been shown to be effective. Calves born to vaccinated 
cows are protected against challenge with K99 positive strains of 
E. coli (Snodgrass et al, 1986).
6CRYPTOSPORIDIUM:
Cryptosporidia are protozoan parasites measuring 3-6um in diameter 
which infect the microvillous surface of intestinal epithelial cells 
(Angus, 1983) of many species of mammals, birds and reptiles, including 
calves. The life cycle resembles that of other enteric coccidia, with 
asexual followed by sexual endogenous stages. Oocysts contain 4 
sporozoites which sporulate endogenously and are therefore infective 
when discharged in the faeces. They are also extremely resistant to 
the action of many disinfectants (Campbell et al, 1982). 
Cryptosporidium has been shown to lack host specificity and therefore 
has zoonotic potential (Tzipori, 1985). Diagnosis is largely based on 
identification of oocysts in faeces. Various staining techniques have 
been used and the modified Ziehl-Nielsen method is often recommended 
(Henriksen and Pohlenz, 1981). This organism has recently been detected 
in 21% of 414 diarrheic calves and in 8% of 379 normal calves (Reynolds 
et al, 1986). Affected calves were under 4 weeks of age. Pathological 
changes which include shortening of the epithelial villi and fusion of 
adjacent villi are found in the ileum and large intestine. No 
effective treatment or vaccine has been found. As more information on 
the biology of the parasite becomes available, the development of 
specific drugs directed against specific targets may prove more 
effective than current treatment.
7OTHER AGENTS ASSOCIATED WITH CALF DIARRHOEA:
Salmonellae:
S. tvphimurium and S. dublin are Gram negative bacteria which infect 
calves 3 to 6 weeks old and older animals. In the United States of 
America 32% of infections affecting diarrheic calves were attributed to 
salmonellosis (Bulgin et al, 1982). In Australia, Salmonella species 
were isolated from 12% of diarrheic calves although on only 2 of 9 
farms examined (Jerret, 1982). In the UK, 2% and 12% of diarrheic 
calves in Scotland and southern Britain respectively excreted 
Salmonellae. The importance of these bacteria in the aetiology of NCD 
is clear.
Campylobacter:
These curved Gram negative rods infect a variety of animals 
including man. Their role as a primary cause of diarrhoea in calves is 
probably insignificant (Snodgrass et al, 1986). C . fetus and 
C . ieuni have both been isolated from enteric lesions of cattle 
(Al-Mashat and Taylor, 1980a) and similar lesions have been induced 
experimentally in calves with both agents (Al-Mashat and Taylor, 1980b; 
Al-Mashat and Taylor, 1983). Campylobacter species have also been 
isolated from normal and diarrheic calves (Snodgrass et al, 1982b). It 
remains to be established whether these are causative agents of 
diarrhoea in young calves.
Small Round Viruses:
The small round viruses include astroviruses, caliciviruses and 
parvoviruses. They are 22-30nm in diameter and spherical shaped. 
Astroviruses contain single-stranded (ss) RNA and exhibit a 5 or 6 
pointed stellate configuration superimposed on a circular outline. They 
have been reported in calves (Woode and Bridger, 1978a) and several 
other species. They are generally required in large numbers to produce 
disease (Flewett, 1978).
Caliciviruses are known pathogens of cats, pigs and probably 
sea-lions (Zwillenberg and Burki, 1966; Madin, 1970; Smith et al, 
1973). They contain ssRNA and have a well defined star shaped 
configuration. Calicivirus-like particles, termed "Newbury Agent", 
have been detected in calves with acute gastroenteritis. No field 
outbreak of NCD has been attributed solely to calicivirus although 
experimental infection of calves caused a mild to severe diarrhoea with 
malabsorption and villous atrophy (Woode and Bridger, 1978a).
Parvovirus, an ssDNA virus, has been isolated from calves but its 
role in NCD is unclear (Storz et al, 1978).
The role of the small round viruses in calf diarrhoea is poorly 
understood and may warrant further investigation.
Breda/Berne viruses:
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A new virus of NCD was reported in 1982 (Woode et al, 1982) and was 
named "Bredavirus11. This virus caused diarrhoea when fed to 
gnotobiotic calves. It morphologically resembled bovine coronavirus 
but was antigenically different. Another similar and antigenically 
related virus, "Berne" virus, was isolated from a diarrheic horse 
(Horzinek et al, 1983; Weiss et al, 1983) in 1983. These virus 
particles are pleomorphic (they can be spherical, oval, elongated and 
often kidney-shaped) measuring 100-140nm with a fringe of closely 
applied peplomers 7-9nm in length with occasional larger peplomers 20nm 
long. Antigenically related and morphologically similar particles have 
been detected in children and adults with gastroenteritis (Beards et 
al, 1984). A new family, Toroviridae (from latin torus= a doughnut 
shaped ring), has been proposed for these positive stranded RNA viruses 
which demonstrate unique features. In the USA 89% of cattle sera were 
reported positive in an ELISA using Bredavirus as antigen (Weiss and 
Horzinek, 1987). In France, faeces from 16 of 21 diarrheic calves 
examined contained particles morphologically similar to Bredavirus 
(Lamouliatte et al, 1987). Further characterisation is required to 
confirm these viruses as members of a new family and to determine their 
clinical and epidemiological significance.
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CORONAVIRIDAE 
Inter-Relationships in the Coronaviridae Family:
The family Coronaviridae comprises a monogeneric group of viruses 
that infect vertebrates. They were originally recognised on the basis 
of a characteristic virion morphology (Tyrrell et al, 1968) but can now 
be defined by biological and molecular criteria. They possess a large 
6-8 megadalton single-stranded polyadenylated RNA genome, have a lipid 
envelope and distinctive morphology characterised by pleomorphic 
particles (80-200nm in diameter) depending on species, bearing 
club-shaped surface projections (about 20nm long) (McIntosh, 1974), 
called peplomers. On this basis the International Committee on the 
Taxonomy of Viruses approved the creation of a new family Coronaviridae 
in 1975 (Tyrrell et al, 1975). Members of this family are distributed 
worldwide and naturally infect man (Bradburne et al, 1967), calves 
(Stair et al, 1972; Mebus et al, 1973), mice (Gledhill and Andrewes, 
1951), pigs (Lee, 1956; Mengeling et al, 1972), rats (Parker et al, 
1970), cats (Tupper et al, 1987), dogs (Binn et al, 1974), chickens 
(Beaudette and Hudson, 1937), turkeys (Deshmukh and Pomeroy, 1974) and 
possibly foals (Bass and Sharpee, 1975; Huang et al, 1983), causing a 
wide variety of disorders involving a number of different organs 
summarised in table 1 (Wege et al, 1982; McIntosh, 1974).
A tentative coronavirus family tree illustrates the serological 
relationships diagramatically (figure 1) (Pensaert et al, 1981; Patel 
et al, 1982; Wege et al, 1982; Brian et al, 1983; Huang et al, 1983; 
Gerna et al, 1985). This was compiled on serological evidence from 
neutralization tests, haemagglutination inhibition tests,
immunofluorescence tests and immuno EM.
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Table 1:
Coronaviruses and the diseases they cause.
CORONAVIRUS SPECIES DESIGNATION ANIMAL HOST DISEASE
Infectious Bronchitis 
Virus
Mouse Hepatitis Virus
Human Coronavirus
Transmissible 
Gastroenteritis Virus
Haemagglutinating 
encephalomyelitis Virus
Porcine Epidemic 
Diarrhoea Virus
Feline Infectious 
Peritonitis Virus
Bovine Coronavirus
Canine Coronavirus
Turkey Coronavirus
Rat Coronavirus
Rat Sialodacryoadenitis 
Virus
IBV
MHV-JHM
MHV-A59
HCV-0C43
HCV-229E
TGEV
HEV
CV777
FIPV
BCV
CCV
TCV
RCV
SDAV
chicken respiratory
mouse encephalomyelitis/
hepatitis/diarrhoea
man respiratory
pig diarrhoea
pig vomiting and wasting/
encephalomyelitis
pig diarrhoea
cat peritonitis
calf enteritis/respiratory
dog diarrhoea
turkey diarrhoea
rat pneumonitis
rat adenitis
Other Possible Coronaviruses
Foal Enteritis 
Coronavirus
Human Enteric 
Coronavirus
FECV
HECV
horse
man
diarrhoea
diarrhoea
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Figure 1:.
Tentative coronavirus family tree.
Solid lines indicate evidence for cross 
neutralizing activity.
Dashed lines indicate immunological evidence 
(other than neutralization) for cross reactivity. 
Dotted lines indicate possible relatedness.
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The relatedness of different coronaviruses has been confirmed at the 
molecular level using copy (c) DNA probes of around 10% of the BCV and 
TGEV genomes in dot blot hybridisation assays. The BCV cDNA probe 
reacted with BCV, HCV-0C43, HEV and to a lesser extent with MHV. The 
TGEV probe reacted with TGEV, FIPV and CCV. Neither of the probes 
reacted with HCV-229E (Shockley et al, 1987).
Within a viral species, serological and molecular data do not always 
correlate. Many serotypes of MHV can be detected serologically (Wege et 
al, 1982) but extensive sequence homology has been described among MHV 
strains in molecular hybridisation studies using cDNA of the majority 
of the MHV genome. In contrast, IBV has many serotypes and 
T^ resistant oligonucleotide fingerprinting of the genome of 13 
isolates produced 11 quite distinct fingerprints (Siddell et al, 1983).
The Zoonotic Potential of Coronaviruses:
Most coronaviruses cause clinical disease only in the host species, 
and replicate predominantly in cell lines derived from that host. 
However, transmission to other species can be acheived either 
experimentally or by a natural route of infection. TGEV has been shown 
to be capable of infecting cats and dogs while CCV can infect pigs 
(Patel et al, 1982). Further evidence of a case of diarrhoea 
transmitted from cattle to man (Storz and Rott, 1981) and from man to 
cattle (Patel et al, 1982) may indicate a wider host range for enteric 
coronaviruses and a possible zoonotic potential (Brian et al, 1983). In 
contrast to other positive strand RNA viruses, coronaviruses readily 
establish persistent infections in the host, a phenomenon which may 
lead to subacute or chronic disorders (Ter Meulen et al, 1981).
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Research on Coronaviruses:
The most economically important coronavirus infections are IBV 
(Cavanagh and Davis, 1986), TGEV (Lucas et al, 1974) and BCV (Tzipori,
1985). TGEV, IBV and MHV could readily be adapted to grow in cell 
culture and have therefore been well studied and fully characterised. 
To take IBV as an example, the complete genome has been sequenced and 
found to be 27.6Kb long, the largest stable viral RNA species known 
and considerably larger than previously estimated (Boursnell et al,
1987). Eighteen Kb of this RNA is a single gene at the 5' end that 
probably encodes the RNA-dependent RNA polymerase and has the capacity 
to code for 2 proteins of 440KD and 300KD.
Virion Structural Proteins:
Sodium-dodecyl-sulphate (SDS) PAGE reveals that coronavirus virions 
contain up to 7 structural proteins which fall into 3 main classes. 
The molecular weight of the reported proteins varies depending on 
species and sometimes strains within a species. The nucleocapsid (N) 
protein is a 50-60KD phosphorylated protein that is closely associated 
with the viral genome. Protein kinase activity has been linked with 
this protein.
The second species of structural protein is the 20-35KD matrix (M or 
El) glycoprotein, O-glycosidically linked and often appearing as 
several bands around the 25KD region on SDS-PAGE. The different bands 
generally reflect differing degrees of glycosilation. The M protein 
appears to possess three domains: a glycosilated hydrophilic region 
which projects outside the viral envelope; a hydrophobic portion which 
extends across the membrane; and a domain which is probably associated 
with viral RNA on the inner side of the viral envelope.
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The third species of structural protein is a large 170-200KD 
glycoprotein (P or E2) which makes up the peplomer of the virion. On 
treatment with 2-mercaptoethanol, this glycoprotein is cleaved into 2 
smaller glycopeptides of 80 to 120KD which may either comigrate or 
separate on SDS-PAGE. The peplomer glycoprotein is made up of 2 
non-identical disulphide linked subunits. The proteolytic cleavage of 
the P protein enhances the in vitro infectivity of these viruses by 
activating cell fusion. Neutralizing epitopes are associated with the 
P protein which is also involved in the attachment of virus particles 
to target cells. The oligosaccharide side chain of the P protein is 
N-glycosidically linked.
Some coronaviruses including BCV, HEV and HCV-0C43 possess another 
100-140KD glycoprotein (H or E3) on the surface of the envelope which 
is associated with haemagglutination. This haemagglutinin is a dimer 
that dissociates in the presence of 2-mercaptoethanol to 65KD 
glycopeptides held together by disulphide bonds. The H glycoprotein has 
also been found to elicit neutralizing antibodies (Siddell et al, 1982; 
Brian et al, 1983; Deregt et al, 1983; Siddell et al, 1983; Sturman and 
Holmes, 1983; Sardinia, 1985; Deregt and Babiuk, 1987; Deregt et al, 
1987; Keck et al, 1987).
Replication Pathway of Coronaviruses:
Coronaviruses have a unique replication strategy. Replication occurs 
exclusively in the cytoplasm (McIntosh, 1974). Virions initially 
attach over the whole surface but are then rapidly redistributed away 
from the cell periphery by an energy requiring process. Virion 
nucleocapsids subsequently penetrate the cell. Both viropexis and 
envelope-membrane fusion have been described as mechanisms of
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penetration. The mechanism by which nucleocapsids are uncoated after 
entering the cell is unknown (Siddell et al, 1982). Viral RNA attaches 
to ribosomes and is used as messenger for an RNA-dependent RNA 
polymerase which transcribes the genomic RNA. This negative stranded 
RNA then serves as the template for the synthesis of 6 or 7 subgenomic 
mRNAs and new genomic RNA. The structure of the subgenomic sequences 
is such that they each start from the 3' end of the genomic RNA and 
extend for various distances toward the 5' end. The sequence of each 
subgenomic mRNA is completely contained within the 3' portion of the 
next larger mRNA. This is termed a nested-set structure with the 5' 
portion of each mRNA containing a unique sequence which does not 
overlap with the smaller mRNAs. Only this unique portion is translated 
into a protein. Thus each mRNA is functionally monocistronic but 
physically polycistronic. Each mRNA is used for the synthesis of 
either a viral structural or non-structural protein. The 
non-structural proteins are probably used to regulate virus replication 
and transcription, and include the RNA-dependent RNA polymerase. The 
structural proteins, together with the genomic RNA, are used to 
assemble the virions which bud into the endoplasmic reticulum instead 
of directly into the plasma membrane. They are then transported 
through and accumulate in the Golgi complex and smooth-walled vesicles. 
No budding from the cell membrane is observed and cell lysis only 
occasionally occurs. The mechanism of virus release has not yet been 
elucidated but the smooth-walled vesicles may fuse with the plasma 
membrane and release the virions (Siddell et al, 1982; Siddell et al, 
1983; Tektoff et al, 1983; Sturman and Holmes, 1985; Lai, 1987; Ter 
Meulen, 1987; Ebner et al, 1988; Keck et al, 1988).
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BOVINE CORONAVIRUS
Bovine coronavirus possess a few distinct characteristics. 
Morphologically, BCV is comparatively less pleomorphic with most 
particles being spherical and ranging between 80 and 130nm with widely 
spaced petal-shaped peplomers 15-20nm long (Doughri et al, 1976; 
Tektoff et al, 1983). Two layers of projections have been observed by 
negative staining (Caul and Egglestone, 1977) but only one type of 
peplomer is seen by a freeze-drying technique (Roseto et al, 1982). BCV 
belongs to the small group of coronaviruses that possess the extra H 
structural protein. There has been some disagreement as to the exact 
number and character of the structural proteins of BCV (table 2). Minor 
differences in the reported molecular weight of the same proteins may 
be due to different experimental conditions. Larger discrepancies 
however may indicate differences between the strains and warrant 
further investigation. Monoclonal antibodies against the peplomer and 
haemagglutinin proteins of the PQ strain have been found to efficiently 
neutralize virus infectivity while monoclonal antibodies to the matrix 
glycoprotein had no neutralizing ability (Deregt and Babiuk, 1987). The 
P protein is responsible for cell membrane fusion and cellular 
attachment. The H protein may have an important function in BCV 
infectivity but the exact nature of this role remains to be determined.
Diagnosis:
Since 1972, BCV has been a confirmed causative agent of NCD since it 
can readily be passaged in gnotobiotic calves (Stair et al, 1972; Mebus 
et al, 1973; Sharpee et al, 1976; Woode and Bridger, 1978b). It has 
been identified in Belgium (Zygraich et al, 1975), New Zealand (Durham
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Table 2:
The structural proteins of different BCV 
strains.
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et al, 1979), USA (Stair et al, 1972), Canada (Deregt et al, 1987), 
Switzerland (Battaglia et al, 1986), UK (Snodgrass et al, 1986), 
France and Denmark (Tektoff et al, 1983). The relative importance of 
the virus in NCD has not been fully determined, largely due to 
diagnostic problems (Woode and Bridger, 1978b). Several methods have 
been used to detect BCV in faeces. With direct electron microscopy
(Reynolds et al, 1984) it is often difficult to differentiate 
coronavirus particles from membranous material or other fringed bodies. 
The characteristic morphology of the core virion surrounded by a fringe 
of peplomers is not always apparent (Dea et al, 1981; Crouch and Acres,
1984) because these peplomers are fragile and easily sheared. An 
alternative method, the haemadsorption-elution-haemagglutination assay 
(HEHA) (Van Balken et al, 1978/9) relies on the virus' selective 
adsorption to and elution from rat red blood cells at different 
temperatures. The HEHA however occasionally suffers from non-specific 
reactions due to the complex nature of faeces (Viscidi et al, 1984). 
Additionally, several ELISAs have been reported for detecting BCV 
(Crouch et al, 1984; Reynolds et al, 1984) but require highly specific 
antisera. The detection of coronavirus antigen in cells of the infected 
gut using an immunofluorescent antibody technique has been described 
(Woode and Bridger, 1978b) but is dependent on tissue being removed 
very shortly after death and most antigen is present early in the 
course of disease. Isolation of the virus in tissue culture is 
difficult and unsuitable as a routine diagnostic method since BCV is 
notoriously difficult to grow in vitro. (Mebus et al, 1973; Bridger et 
al, 1978a; Bridger et al, 1978b; Storz et al, 1981; Tektoff et al, 
1983) .
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BCV in Culture:
Many strains of coronavirus either cannot be grown in cell culture 
or can only be propagated in organ cultures and show stringent species 
and tissue specificity during primary isolation (McIntosh, 1974; 
Doughri et al, 1976; Bridger et al, 1978b; Storz et al, 1981; Hirano et 
al, 1985).
Several attempts have been made to grow BCV in vitro with varying 
degrees of success. BCV was first characterised by animal passage after 
purification from faeces (Stair et al, 1972). It was later grown in 
cell culture on fetal bovine kidney cells but only low virus titres 
were obtained after many passages (Mebus et al, 1973). This isolate was 
called the Mebus (M) strain of BCV. No cytopathic effect (CPE) could be 
observed and the presence of the virus was determined by the method of 
microscopically examining cell cultures for syncytia after staining 
with Hemotoxylin Eosin, or immunofluorescent staining after 
centrifugation of cells in cell culture fluid (Mebus et al, 1973; Sato 
et al, 1984). BCV has also been grown in intestinal organ culture 
(Bridger et al, 1978b) but was found to grow more readily on bovine 
fetal tracheal organ culture (TOC). Attempts to grow two British 
strains and a Danish strain in primary calf kidney cells were mostly 
unsuccessful (Bridger et al, 1978a). Bovine fetal thyroid and bovine 
fetal brain cells were used to grow BCV strain M successfully but their 
isolation and cultivation from clinical samples still remained 
difficult (Storz et al, 1981).
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The replication of BCV and the production of marked CPE was reported 
in BEK-1 cell cultures (Inaba et al, 1976), a continuous cell line 
derived from bovine embryo kidney having undergone 103 passages over a 
four year period. However demonstration of the virus by this procedure 
was still elaborate and time consuming (Sato et al, 1984). The PQ 
strain has been adapted to grow in Vero and Madin-Darby bovine kidney 
(MDBK) cells (Dea et al, 1980). HRT 18 cells, a cell line established 
from a human rectal adenocarcinoma, were found to be susceptible to 
infection by BCV. HRT 18 cells possess some properties of the
differentiated brush border cells of the intestinal epithelium (De 
Leeuw and Guinee, 1981; Laporte and Bobulesco, 1981). Titres of 5x10^ 
TCID^Qml ^ of virus were obtained with the F15 strain of BCV but other 
strains could not be propagated in this cell line. Few BCV strains can 
be adapted to culture and their propagation still presents difficulties 
since an enterocyte line does not exist and BCV presents a marked 
tropism (Tektoff et al, 1983).
The presence of lOugml ^ of trypsin in the medium has been shown to 
enhance CPE, haemagglutination titre, viral infectivity yields and 
plaque formation (Storz et al, 1981). The sensitivity of BCV to 
trypsin however seems to differ from one isolate to another (Dea et al, 
1980). Under EM, trypsin treated virions present shorter surface 
projections (Storz et al, 1981) confirming the activation of 
infectivity by protease cleavage of the peplomer protein.
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Physico-Chemical Properties:
Replication of BCV is inhibited by 5-iodo-2'-deoxyuridine, 
indicating an RNA genome. Sensitivity to ether and chloroform indicates 
that the virus is enveloped, and this is confirmed by EM observation. 
This virus is readily inactivated by sodium deoxycholate, is labile at 
50°C in undiluted medium but is readily stabilised in the presence of 
MgC^. It is stable at pH5 and 7, with only a slight loss of 
infectivity at pH3. The virus is readily filtered through membrane
filters of 200 and lOOnm but not 50nm. The buoyant density of the
-1 -1 virion is estimated to be 1.25gml in CsCl and 1.18gml in sucrose.
Formalin treatment destroys viral infectivity but the haemagglutinin
remains unaltered. Haemagglutination is observed with chicken, mouse,
rat and hamster erythrocytes but not with those from human (0), cattle,
horse, sheep, guinea pig, geese, ducks, pigeons and 1-day-old chicks
(Sharpee et al, 1976; Sato et al, 1977a; Sato et al, 1977b).
Pathogenesis:
Gnotobiotic calf experiments have shown that following oral 
inoculation with BCV, clinical signs of profuse watery diarrhoea appear 
within 24 to 30 hours and are accompanied occasionally by fever, loss 
of appetite and dullness. Diarrhoea and virus excretion usually last
4-5 days. Diarrheic animals present lesions in the small intestine 
similar to those reported for TGE. Small intestinal villi are 
shortened, some adjacent villi are fused, and villous epithelium is 
composed of low cuboidal to squamous cells. In the ansa spiralis coli, 
there is atrophy of the colonic ridges and marked differences in length 
and spacing of the microvilli on individual epithelial cells (Mebus et 
al, 1975). The destruction of the intestinal absorptive epithelium 
leads rapidly to pathophysiological changes followed by extensive loss
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of water, sodium, chloride, bicarbonate and potassium. Metabolism of 
glucose and lactate becomes severely disturbed and hypoglycemia, 
lactic acidosis and an elevated efflux of potassium to the hypovolemic 
plasma consequently lead to acute shock, heart failure, and death 
(Woode and Bridger, 1975; Wege et al, 1982).
Maternal antibodies (IgA and IgM) present in the gut lumen and 
transmitted to the calves via colostrum reduce the severity of the 
disease. Colostral antibody circulating in the blood of the calves is 
not protective. The levels of antibodies in milk rapidly decline after 
parturition and consequently the level of protection also declines 
after the first few days of life (Crouch and Raybould, 1983; Crouch, 
1985). This is reflected in the observation that calves are usually 
affected at 5 to 7 days of age. Calves fed colostrum 4 hours prior to 
challenge with BCV do not develop disease. However, virus is excreted 
asymptomatically at high levels for several days. This probably 
constitutes an important source of infection within the herd (Woode and 
Bridger, 1975).
BCV in the Respiratory Tract:
BCV has also been recently detected in the respiratory tract of
calves with respiratory disorders (Singh et al, 1985; Wellemans et al,
1985). This has prompted experiments which have shown BCV to infect and
multiply in the upper respiratory tract of gnotobiotic calves and
induce mild respiratory symptoms. This virus has been isolated on TOC 
from the lungs and trachea of affected calves and has been shown to be 
morphologically and antigenically indistinguishable from enteric BCV
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(Thomas et al, 1982; McNulty et al, 1984). The same virus is now 
recognised to infect the distal small intestine, large intestine and 
epithelia of the nasal cavity and trachea giving rise to diarrhoea and 
occasionally to mild respiratory symptoms (Reynolds et al, 1985).
The presence of BCV in the respiratory tract may have important 
implications for the epidemiology of the virus. Current diagnostic 
tests do not detect BCV in the respiratory tract. As only mild 
respiratory symptoms occur, this important reservoir of the virus has 
been largely overlooked.
Prevalence:
The incidence of BCV in the faeces of diarrheic calves (4 days to 2 
weeks old) has been reported to vary between 15 and 76% (Durham et al, 
1979; Crouch et al, 1984; Crouch, 1985; De Visser et al, 1987). In a 
recent study, BCV was detected in 13% of 128 diarrheic calves and in 4% 
of 49 healthy calves in Scotland and the north of England (Snodgrass 
et al, 1986). This difference was not statistically significant. In a 
similar survey carried out at the same time in southern Britain, BCV 
was detected in 14% of 439 diarrheic calves and in none of 385 healthy 
calves (Reynolds et al, 1986). In this case, a very strong association 
of BCV with diarrhoea was shown. BCV has been reported to be more 
common in beef calves than dairy calves with diarrhoea (42% and 13% 
respectively). In terms of mortality rotavirus with 5% mortality has 
been considered less economically important than BCV which although of 
lower incidence, has been reported to have a mortality rate around 30% 
(Tzipori, 1985). Antibody to BCV is widespread in the adult bovine 
population and has been detected in over 90% of adult cattle
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(Zygraich et al, 1975; Rodak et al, 1982; Battaglia et al, 1986). More 
surveys utilising improved diagnostic tests are required to assess the 
real prevalence of BCV in the field.
Winter Dysentery:
Winter dysentery is an acute gastrointestinal disorder of adult 
cattle, particularly dairy cows. The disease occurs in epidemic 
proportions in the winter months and is highly contagious within a 
farm. It is characterised by acute onset of diarrhoea with profuse 
dark-coloured faeces, severe decrease in milk production, variable 
depression and anorexia, and sometimes a mild cough. For a long period 
of time no causative agent could be identified (Van Kruiningen et al,
1985). Recently, coronavirus-like particles have been detected in 
cattle with winter dysentery (Takahashi et al, 1980; Espinasse et al, 
1982) and in normal adult cows (Collins et al, 1987). BCV and 
BCV-immunoglobulin complexes have been detected in 75% of 121 
clinically normal adult cows by ELISA. Five cows were surveyed for a 
period of 12 weeks and all 5 cows were found to be chronically shedding 
virus (Crouch and Acres, 1984; Crouch et al, 1985).
In a winter dysentery outbreak in Japan, 59% of affected animals 
showed an increase in antibody titre to BCV (Takahashi et al, 1980) and 
BCV was detected using EM in 1 faecal sample. This "Kakegawa" strain 
has been adapted to BEK-1 cell culture and found to be morphologically 
and serologically similar to BCV-M strain, with the same 
physico-chemical characteristics (Takahashi et al, 1983). Other 
workers however have been unsuccessful at attempts to isolate the virus
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(Van Kruiningen et al, 1987). Histological features in animals with 
winter dysentery, are similar to those in calfhood coronavirus 
enterocolitis.
Current data therefore suggests that BCV is the cause of winter 
dysentery, but this remains to be confirmed. Clinical and subclinical 
infection of adults may in addition provide a source for infection of 
the neonate.
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AIMS OF THIS STUDY
This investigation is aimed at studying the following aspects of 
infections caused by BCV:
1-Strain Variation:
The few strains of BCV so far isolated have been serologically 
similar. The adaptation of more field strains to cell culture and 
improved cell culture techniques will enable the comparison of a larger 
number of strains by serological (using polyclonal and monoclonal 
antibodies) and molecular techniques (SDS-PAGE and Western blotting).
2-Diagnostic Tests:
Six to 27% of cases of diarrhoea in calves cannot be attributed to 
an aetiological agent (Tzipori, 1985). Improved diagnostic tests will 
allow more accurate investigation of the prevalence of BCV in faeces 
and in the respiratory tract and may well reduce the above figures.
3-Animal Model:
Animal experiments will provide important data on the biology and 
immunology of BCV in the host. A small-animal model will also be of 
great value in studying immunity to BCV and pathogenicity of different 
strains.
28
4-Molecular Biology of BCV:
Differences in the structural proteins of different BCV strains may
reflect biological or serological differences.
5-Field Survey:
A prospective survey of the infections of neonatal calves will 
provide valuable information about the epidemiology of BCV and
interactions with other enteric pathogens.
Only when such knowledge is available will the development of
vaccines or other control strategies be feasible.
CHAPTER TT
IN  VITRO CULTURE 
OF BCV
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INTRODUCTION
Many workers have found it difficult to adapt BCV to in vitro 
culture. This difficulty is compounded by the observation that many 
strains of BCV could not be adapted to cell culture or could only be 
grown in bovine fetal tracheal organ culture (TOC) (McIntosh, 1974; 
Doughri et al, 1976; Storz et al, 1981). Bovine foetuses however are 
often difficult to obtain and several "blind" passages are often 
required before virus can be detected in infected cultures (Mebus et 
al, 1973). The choice of cells for primary isolation is also crucial 
for successful adaptation of field strains of BCV (McIntosh, 1974). 
Trypsin can be used to enhance viral infectivity of some BCV strains 
(Storz et al, 1981) but not others (Dea et al, 1980).
In an attempt to isolate and culture field strains for comparison 
with reference strains, faecal samples containing BCV were inoculated 
onto fetal TOCs from different species and then onto various cell 
lines. Several media with a variety of supplements including trypsin 
were tested. One of the cell lines was found to be mycoplasma 
contaminated. This cell line was treated with anti-mycoplasma 
antibiotic until no mycoplasma could be detected before being used to 
isolate BCV. The growth conditions and kinetics of a reference strain 
of BCV were studied in order to optimise the production of infectious 
virus.
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MATERIALS AND METHODS
Media and supplements:
All media and supplements were purchased from either Flow 
Laboratories or Sigma and prepared as required on a weekly basis. The 
choice of medium was made from Eagle's minimum essential medium (MEM), 
Earle's 199 medium and RPMI 1640 medium depending on which facilitated 
optimum growth of the particular cell line.
-1 -1 All cell culture media contained: lOOIUml penicillin, lOOugml
streptomycin, lugml ^ fungizone, 0.12% sodium bicarbonate buffer, 0.1%
yeast extract, 0.5% lactalbumin hydrolysate and 0.025M HEPES.
Cell growth media contained 20% fetal bovine serum (FBS) and virus 
maintenance media contained 2% FBS. In addition, several media 
supplements were tested: 0.1% glucose, 0.1% galactose, 0.1% glutamate, 
10% tryptose phosphate broth (TPB), and 1, 5 and lOugml trypsin. The 
effect of rolling the cultures was also studied.
All TOC media contained: Earle's 199 medium, 10% bovine serum
-1 -1 
albumin (BSA) or 10% FBS, 200IUml penicillin, 200ugml streptomycin,
-1
2ugml fungizone, 8% sodium bicarbonate buffer, 0.1% yeast extract 
and 0.5% lactalbumin hydrolysate.
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Tracheal Organ Culture:
Fresh bovine and ovine foetuses of varying ages were obtained from
local abattoirs. Nineteen day old embryonated chicken eggs were
supplied by the Poultry Research Station, Roslin. The tracheas of these
animals were aseptically removed and trimmed. Five small cubes 
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(approximately 3mm ) were placed on scratched ventilated 6cm diameter 
petri dishes with the inner side, containing the cilia, uppermost 
(Stott et al, 1976). A volume of 2ml of TOC medium containing 10% FBS 
was added to each of the petri dishes which were then incubated at 37°C 
in a gas chamber containing 5% CO2 , 5% O 2  and 90% N 2 .
TOCs were only used for virus propagation if the cilia were seen to 
be beating 24 hours after setting up the cultures. This provided 
evidence of the viability of the epithelial cells. For inoculation, the 
medium was removed and the TOCs were washed twice in phosphate buffered 
saline (PBS) at 37°C. A volume of 50ul of the inoculum was placed 
directly on each TOC cube and 2ml of TOC medium containing 10% BSA was 
added to each petri dish. At least 4 petri dishes were inoculated with 
each sample. The medium bathing the TOC was harvested every 3 or 4 
days, pooled, and stored on ice. The harvests were tested for BCV by 
haemagglutination and confirmed by haemagglutination inhibition. The 
TOCs were harvested up to 7 times and on each occasion fresh BSA-TOC 
medium was used to replace the harvested medium.
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Cell Cultures:
The following cells were supplied by the Moredun Research Institute 
(MRI) Cell Culture Unit: the primary bovine embryonic kidney (BEK) and 
bovine turbinate (BT) cells; the semi-continuous embryonic bovine
trachea (EBTr), bovine embryonic muscle (BE muscle) and bovine
embryonic skin (BE skin) cells; and the continuous baby hamster kidney 
(BHK), fibroblastic monkey kidney (Vero), and epithelial monkey kidney 
(MA104) cells. The human rectal tumour (HRT 18) continuous
differentiated epithelial cell line was supplied initially by Dr E. 
Davies, PHLS, Bristol.
One ml of each of the cell types was seeded at 2x10^ cells per ml in
1x10cm test tubes containing coverslips measuring 21x7mm. These were
used for virus propagation when a confluent monolayer developed over 
the coverslip, usually 24 hours later.
Passaging HRT 18 Cells:
All the cell cultures except HRT 18 cells were maintained and
passaged by the Cell Culture Unit. The HRT 18 cells were passaged in 
Falcon 250ml flasks by removing the medium and washing the monolayer 
twice with PBS at 37°C. One ml of 0.25% trypsin and 0.08% EDTA in PBS 
was added and the flasks left at 37°C until the monolayers sloughed off 
after approximately 5 minutes (min). The cells were pipetted into
freshly prepared RPMI 1640 growth medium containing 20% FBS.
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Aggregates of cells were disrupted by repeated pipetting. The 
concentration of living cells (as determined by acridine orange 
staining) was then counted in a Fuchs Rosenthal counter and the 
appropriate dilutions made to obtain the required concentration of 
cells. Normally, the cultures were split 1 in 4 weekly and the growth 
medium was replaced by 2% FBS maintenance medium after 3 days.
Cell Culture Inoculation:
Test tube cultures were inoculated, usually in triplicate, by 
removing the growth medium, washing the cells twice with warm PBS and 
adding 0. 1ml of inoculum per tube. The inoculum was allowed to adsorb 
for lh at 37°C before adding 1ml of maintenance medium and incubating 
at 37°C. Infected cultures were screened for virus multiplication by 
immunofluorescence (IF), haemagglutination (HA), and cytopathic effect 
(CPE). Control cultures received a sham inoculum.
Trvpsinisation:
In some cases, the inoculum was treated with lOugml ^ trypsin for lh
o 1
at 37 C and the virus maintenance medium contained lugml trypsin.
Testing Cell Lines for Mycoplasma:
Mycoplasma contamination was assessed by a DNA staining procedure 
using bisbenzamide fluorochrome stain (Hoechst). Mycoplasma-free Vero 
cells were used as indicator cells. These Vero cells were seeded out on 
day 1 at 2x10^ cells ml ^ in Eagle's 59 medium containing 10% FBS. Cell 
cultures under test were passaged twice in antibiotic-free medium
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before testing. Two dilutions were made for each test sample and each
dilution required three test tubes of Vero cells containing coverslips.
Uninfected controls were always included. On day 2, the medium was
removed from the Vero cells and 0.2ml of each test sample at 2x10^ and 
5 -10.2x10 cells ml was inoculated onto the coverslips and incubated at
37°C for lh. One ml of medium containing 2% FBS was then added to each
tube followed by incubation for three days at 37°C. On day 5, the
maintenance medium in the tubes was replaced with fresh medium and some
tubes were removed for staining. This was repeated on days 10 and 12.
Staining was performed at room temperature (RT). Coverslips were fixed
in glacial acetic acid : methanol (1:3) for 5 min. Fixation was
repeated with fresh fixative for 10 min. Fluorochrome stain at a
-1
concentration of 0.05ugml in Hank's balanced salts solution was added 
for 30 min. The coverslips were washed 3 times in distilled water and 
mounted in mounting buffer (0.1M citric acid-0.2M disodium phosphate- 
50% glycerol, pH 5.5). Specimens were examined for cytoplasmic 
fluorescence in a Leitz UV microscope.
Mycoplasma Decontamination:
Mycoplasma infected cells were treated with an anti-mycoplasma 
antibiotic: BM-Cycline (Boehringer Mannheim).
The affected cell line was passaged 6 times in the alternating 
presence of BM-Cyline 1 and BM-Cycline 2 at the recommended 
concentrations. No BM-Cycline was used in subsequent passages.
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Cell Culture Virus:
Three reference BCV strains already adapted to cell culture were 
obtained from other laboratories. The American M strain of BCV was 
kindly supplied by Dr S. McNulty, Veterinary Research Laboratory, 
Belfast (Mebus et al, 1973); the Canadian PQ strain by Dr L. Babiuk, 
University of Saskatchewan, Canada (Dea et al, 1980); and the British 
CK strain by Dr Janice Bridger at the Institute for Animal Health, 
Compton (Reynolds et al, 1985).
Faecal Virus:
Several faecal samples from diarrheic calves in Scotland and 
gnotobiotic calf faeces containing BCV and no other virus as detected 
by EM, were used as a source of faecal virus. A 10% suspension of each 
sample in PBS containing lOOugml ^ gentamicin was homogenised and 
incubated at 37°C for lh. The suspension was clarified by 
centrifugation at 2,000g for 15 min at 4°C and the supernatant fluid 
used as an inoculum for TOCs. The antibiotic treatment was performed on 
all samples except the gnotobiotic calf faeces.
Haemagglutination Test:
Rat red blood cells (RBC) were collected and washed 3 times in 
Alsever's solution and the packed cell volume determined using a micro- 
haematocrit reader. The viral test samples were double diluted in 
V-bottomed microtitre plates (Flow Laboratories) in 50ul volumes in 
horizontal rows using PBS containing 0.5% BSA (PBS/BSA) as diluent. The 
RBC were diluted to a concentration of 0.5% in PBS/BSA and 50ul added 
to each well. The plate was shaken lightly to mix the sample and the
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RBC, and left at RT for lh (Sato et al, 1977b). If BCV was present, 
the RBC were agglutinated and remained in suspension. If no virus was 
present, the RBC accumulated at the bottom of the well to form a red 
pellet. This pellet smeared into a "tear-drop" shape when the plate was 
tilted slightly. The HA titre was recorded as the highest dilution to 
cause complete haemagglutination. A positive coronavirus control and a 
RBC control were always included.
Positive HA samples were confirmed to be BCV positive by an 
haemagglutination inhibition (HAI) test utilising a specific anti-BCV 
serum.
Haemagglutination Inhibition Test:
A hyperimmune gnotobiotic calf anti-BCV serum and a hyperimmune 
gnotobiotic calf anti-rotavirus serum were used as positive and 
negative control sera respectively. Both sera were supplied by 
Dr D R Snodgrass at the MRI. Prior to performing the HAI test, these 
sera were treated for 30 min at RT with 25% acid-washed kaolin in PBS 
to remove non-specific inhibitors of agglutination. This stage also 
diluted the sera by 1/10. The kaolin was pelleted at 2,000g for 10 min 
and the supernatant sera treated at 4°C for lh with 40% rat RBC in 
PBS/BSA in order to remove non-specific agglutinins (Sharpee et al, 
1976; Gerna et al, 1981). The RBC were then pelleted as above and 
complement in the sera was inactivated at 56°C for 30 min. The HA 
positive samples were diluted to 8HA units for the HAI test. Using 
duplicate V-bottomed wells, 50ul of each serum at 1/10 dilution was 
mixed with 50ul of each diluted viral sample and left at 37°C for lh.
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Then 50ul of 0.5% RBC in PBS/BSA was added to each well and left at RT 
for lh. Haemagglutination was read as before. The following controls 
were incorporated in the test: a red blood cell control (omitting
sample and sera), a serum control for each serum (omitting the 
sample), an antigen control (to confirm 8HA units), and a. positive BCV 
control. Control volumes were made up to 150ul with PBS/BSA.
Immunofluorescence Test:
An indirect IF test was performed on coverslips of infected
cultures. The coverslips were washed twice in PBS, fixed in cold 
acetone for 5 min and air dried. The detecting antibody was a 
hyperimmune gnotobiotic calf anti-BCV serum which was used at an
optimal dilution of 1/50 in PBS for 30 min at 37°C. Excess unbound 
serum was removed by washing the coverslips twice in PBS. A pig 
anti-sheep immunoglobulins IgG was conjugated to fluorescein- 
isothiocyanate (FITC) by Mr A McL Dawson at the MRI. Since sheep
immunoglobulins cross reacted with bovine immunoglobulins, this serum 
was appropriate for use here. An optimal dilution of 1/160 of this 
conjugate in PBS was allowed to react with the antigen for 30 min at 
37°C and then washed twice in PBS. The coverslips were examined for 
infected fluorescing cells under a Leitz UV microscope. A negative 
serum control was included by replacing the calf anti-BCV detecting 
serum with a calf anti-rotavirus serum.
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RESULTS
Tracheal Organ Cultures:
The growth of BCV from gnotobiotic calf faeces was examined in TOC.
The source of the inoculum was the same throughout but was used at 2
dilutions to give an initial HA titre of 1/128 and 1/2 respectively. 
Using bovine foetuses of an estimated gestational age of 7-8 months (as 
estimated by the crown to rump length -Nichols, 1944), the virus
multiplied and was released into the surrounding medium (figure 2a). 
The medium bathing the TOCs was harvested every 3 or 4 days. TOC 1 
received the high titre inoculum while TOC 2 was inoculated with the 
low titre sample. High titre harvests were collected for over 14 days 
irrespective of the initial titre of the inoculum. BCV multiplied in 
TOCs 3 and 4 from foetuses estimated to be of 3-4 months' gestation but 
lower titres of virus were obtained and the duration of virus release
was reduced (figure 2b). These results were also not linked to the
titre of the inoculum.
Approximately 4 month old ovine foetuses were also tested for their 
ability to grow BCV from faeces. TOCs 5 and 6 were inoculated with a 
low and high titre inoculum respectively (figure 2c). There was 
evidence of virus multiplication in both cases but this was minimal and 
HA activity lasted only a short time.
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Figure 2a:
BCV replication in 7-8 months old bovine fetal 
tracheal organ cultures.
Harvest
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Figure 2b:
BCV replication in 3-4 months old bovine fetal 
TOC.
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Figure 2c:
BCV replication in 4 months old ovine fetal 
TOC.
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Figure 2d:
The attempted growth of BCV in 19 day old chick 
embryo TOC.
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Nineteen day old chick embryo TOCs, which had been successfully used 
to grow another coronavirus, IBV (Cunningham, 1973) were also tested 
for their ability to allow BCV multiplication, but no replication could 
be detected (figure 2d).
Control cultures of fetal tracheas did not produce any 
haemagglutinating activity while the HA titres of infected cultures 
could always be inhibited by the specific anti-BCV serum in the HAI 
test.
Isolation of Field Strains of BCV on Bovine TOC:
Bovine fetal tracheas between 7 and 8 months old appeared to provide 
maximum sensitivity for the growth of faecal BCV, consequently it was 
decided to use these TOCs as a first step for isolating and culturing 
additional strains of BCV. The supply of TOCs was very limited, so only 
faecal samples that produced relatively high HA titres were passaged 
more than twice in organ culture. A total of 25 faecal samples 
containing BCV were inoculated. The first harvest of each passage, 
taken 4 days after inoculation, was in each case passaged onto fresh 
TOCs. When microbial (usually fungal) contamination was encountered, 
the organ cultures were discarded. The HA titres obtained with each 
harvest of each passage are shown in table 3. Sample 1 was from a 
gnotobiotic calf experimentally inoculated with BCV. All other samples 
were from field cases of BCV enteritis in Scotland. Samples 1, 2 and 3 
out of 25 samples tested seemed to have been successfully adapted to 
organ culture. The presence of BCV in TOC fluid was confirmed by HAI 
and electron microscopy.
44
Table 3:
The attempted adaptation of 25 bovine faecal 
samples to passage in TOC.
Sample Number First Passage Second Passage Third Passage
harvest no. harvest no. harvest no.
1 2 3 4  1 2 3 4  1 2 3 4
1 64 128 64 32 32 32 16 16 64 64 32 8
2 32 8 16 8 2 32 8 4 32 128 2 4
3 16 16 8 4 16 32 16 4 32 64 16 8
4 <2 <2 <2 <2
5 8 <2 <2 <2 <2 <2 <2 <2
6 8 2 <2 <2 <2 <2 <2 <2
7 4 <2 <2 <2 <2 <2 <2 <2
8 2 4 8 4 <2 2 4 2
9 <2 <2 <2 <2
10 <2 <2 <2 <2 <2 <2 <2 <2
11 <2 <2 <2 <2 <2 <2 <2 <2
12 8 4 <2 <2 <2 <2 <2 <2
13 2 2 2 <2 <2 2 <2 <2
14 <2 <2 <2 <2 <2 2 <2 <2
15 2 <2 <2 <2 <2 <2 <2 <2
16 8 4 *
17 8 16 64 32 128 256 16 16 <2 <2 <2 <2
18 2 64 32 16 128 256 16 8 8 <2 4 <2
19 8 4 4 8 128 64 8 8 4 2 2 <2
20 2 2 <2 <2 2 2 *
21 32 16 *
22 64 16 2 <2 32 32 4 2 <2 <2 <2 <2
23 16 4 <2 <2
24 32 *
25 8 <2 <2 <2
*:fungal contamination
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Field Strains of BCV in Cell Culture:
The TOC fluid of the third passage of sample 1 was used to test the 
susceptibility of different cell lines to BCV infection. Various 
combinations of media supplements and different treatments were tested 
with each cell line, some of which are listed in table 4. However the 
result was that no cytopathic changes were observed, no haemagglutinin 
was produced and no fluorescing cells were detected in any of the 
cultures. The HA test was performed on both the cell culture supernate 
and frozen-thawed cell cultures.
Mycoplasma Testing:
The HRT 18 cells were expected to facilitate the growth of this 
virus. However since this was not the case, it was decided to test the 
above mentioned cell lines for mycoplasma contamination. Only the 
HRT 18 cells were found to be mycoplasma positive (figure 3). This 
contamination was markedly reduced after 4 passages in the presence of 
anti-mycoplasma antibiotic (figure 4) and seemed to be completely 
removed by the sixth passage (figure 5).
Behaviour of Field Strains of BCV in HRT 18 Cells:
The mycoplasma free HRT 18 cells were inoculated with trypsin 
treated TOC fluid from samples 1, 2 and 3 (SI, S2 and S3) and in this
case HA activity was detected (table 5) and fluorescing cells were seen 
(figure 6) but no CPE was observed with any of the strains (figure 7). 
Strains SI and S2 seemed to adapt well to HRT 18 cells but S3 gradually 
lost its infectivity.
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Table 4:
The susceptibility of different cell lines to 
BCV infection.
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Figure 3:
Bisbenzamide DNA staining of VERO cells 
inoculated with HRT 18 cells. In addition to the 
fluorescing nuclei (large arrow), the DNA of 
mycoplasma can also be seen fluorescing in the 
cytoplasm (small arrow).(2000X magnification).
Figure 4:
HRT 18 inoculum having been passaged 4 times in 
anti-mycoplasma antibiotic. The amount of
cytoplasmic fluorescence is markedly reduced 
(small arrow). (2000X magnification).
Figure 5:
After six passages in the presence of the 
antibiotic BM cycline, no cytoplasmic fluorescence 
can be seen indicating the reduction or 
elimination of mycoplasma. (2000X magnification).
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Table 5:
The adaptation of 3 BCV strains to HRT 18 cell 
culture.
Passage Haemagglutination titre of BCV Strain
SI S2 S3
1 32 32 8
2 32 32 2
3 64 128 4
4 128 256 8
5 64 128 <2
6 128 256 <2
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Figure 6:
Specific cytoplasmic fluorescence detected in 
HRT 18 cells infected with BCV/S1.
(250X magnification).
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Figures 7A. 7B:
A) HRT 18 cells 48 hours post inoculum with 
BCV/S1. No CPE can be seen when compared to:
B) sham inoculated HRT 18 cells.
(200X magnification).
• . ; : . • ’ ■ '
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Optimisation of Conditions:
Conditions for M strain virus propagation in HRT 18 cells were
optimised, with infectivity titres calculated by the Karber formula
-1
(Grist et al, 1980). The pre-treatment of virus inoculum with lOugml 
trypsin in conjunction with the use of lugml trypsin in the culture 
maintenance medium, while rolling the cultures at 37°C provided maximum 
infectious virus yields (table 6). The use of media supplements such 
as TPB, glutamate, glucose, and galactose did not greatly enhance the 
virus yields. The HA titre could not be directly compared with the 
infectivity titre since these two properties of the virus are not 
linked (Sato et al, 1977b). Freezing and thawing the cultures three 
times was not necessary since once seemed sufficient to release 
cell-bound virus. The freeze-thaw cycle could even be dispensed with 
completely since only a slight increase in titre was detected.
Growth Kinetics:
Single cycle growth kinetics for the M strain in HRT 18 cells were 
examined. After the use of a multiplicity of infection of 0.1 TCID^q 
per cell, samples were removed at appropriate intervals and titrated 
for infectivity and haemagglutination (figure 8). Infectious virus was 
obtained, after a short latent phase, with exponential growth for up 
to 24 hours followed by a slower production of infectious particles up 
to a maximum at 72 hours. The HA activity showed a more gradual 
increase in titre which did not reach a plateau until 4 days. In 
subsequent experiments virus was harvested at 72 hours post infection 
to yield maximum infective doses.
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Table 6:
Optimal conditions for the growth of BCV/M in 
HRT 18 cells 48 hours post infection.
-1Condition Log TCID,-Qnil Pooled
(mean of 5) HA titre
1) Presence of lOugml ^ trypsjn at 37°C 4.2
for lh in inoculum and lugml in medium
128
2) Absence of trypsin 3.4 64
3) As 1) with rolling cultures 4.8 128
4) As 1) but incubated at 34°C 4.0 64
5) As 1) with the medium supplemented with 4.4 128
10% TPB, 0.1% galactose, 0.1% glutamate
6) As 1) with freezing and thawing 4.4 256
cultures once before assay
7) As 1) with freezing and thawing 4.4 256
cultures 3 times before assay
TPB: tryptose phosphate broth
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Figure 8a:
The infectivity growth curve for BCV/M in HRT18 
cells.
Figure 8b:
The haemagglutination growth curve for BCV/M in 
HRT 18 cells.
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Sequential Passaging:
The three reference strains M, PQ and CK as well as the two field 
strains SI and S2 were biologically cloned by 3 terminal dilutions in 
HRT 18 cells and passaged several times in this cell line at a 
multiplicity of infection ranging between 0.1 and 0.01 TCID^q per cell 
(figure 9). The infectivity titres obtained varied quite significantly
in successive passages. Occasionally, very high or very low titres
3 8 -1
were obtained ranging between 10 and 10 TCID^Qml
\
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Figure 9:
The infectivity titres of sequential passages 
of BCV strains in HRT 18 cells.
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DISCUSSION
A definition of the current strains of BCV and their serological 
relationship is required in order to obtain a better insight into the 
epidemiology of these infections. The probability of detecting 
differences between strains is likely to be enhanced by culturing and 
examining as many field isolates as possible. The technique most likely 
to succeed in growing these faecal BCVs in cell culture is an initial 
adaptation to growth in bovine TOC followed by adaptation to a 
permissive cell line (Stott et al, 1976; Hirano et al, 1985). The 
bovine foetuses had to be 7-8 months old for maximum virus propagation 
since 3-4 month old foetuses were shown to provide significantly lower 
virus yields. This was probably due to the ciliated epithelial cells 
of the trachea not having differentiated sufficiently. The supply of 
bovine foetuses from local abattoirs was seasonal and very limited, 
with no control over their age.
Attempts were therefore made at employing TOCs from alternative 
species. Ovine foetuses were readily available in larger numbers 
although with marked seasonality of supply. However these foetuses only 
permitted minimal virus replication and were deemed unsuitable for BCV 
isolation. Nineteen day old chick embryos were very readily available 
in relatively unlimited supply at all seasons. Tracheas from these 
embryos have been successfully used to grow IBV (Cunningham, 1973) but 
they unfortunately failed to grow BCV.
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Thus in order to isolate more field strains of BCV, bovine fetal 
TOCs were used. Sufficient TOCs were available to attempt isolation of 
25 BCV strains, and most samples were only passaged twice. The seven 
samples that yielded high HA titres were passaged a third time and 
three of these maintained their high HA titres (SI, S2 and S3).
The sample SI was chosen for initial comparison of different cell
lines and media supplements. None of the cell lines used or the
conditions tested allowed the replication of this strain. The HRT 18 
cells which have been reported to be permissive for BCV (De Leeuw and 
Guinee, 1981; Laporte and Bobulesco, 1981) were found to be mycoplasma 
contaminated. Upon decontamination with antibiotic these cells did
eventually allow the replication of the SI and S2 strains. The S3 
strain however gradually lost its infectivity and was excluded from the 
study. Out of 25 faecal samples, 2 were finally successfully adapted 
to HRT 18 cell culture. Three other reference strains of BCV (PQ, M 
and CK) were obtained from other laboratories and were also grown in
HRT 18 cells. No CPE was detected with any of these strains.
The optimum growth conditions were assessed using the M strain. The
pre-treatment of virus with lOugml ^ trypsin followed by rolling the 
cultures in the presence of lugml  ^trypsin provided high virus yields. 
The use of several media supplements and 3 freeze-thaw cycles did not 
significantly alter the amount of virus produced. The growth curve of 
the M strain showed that maximum infectious virus was produced 3 days 
post infection whereas the HA titre showed a steady increase until 4 
days post infection. The continual rise in HA activity may reflect a 
continued production of non-infectious particles or the production of
haemagglutinin-containing cellular membrane components. The HA titres 
therefore do not correspond directly to infectivity titres.
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Sequential passaging of the different strains of BCV gave rise to
3 8 -1very varied infectivity titres ranging between 10 and 10 TCID^qIiiI
Such variation may be due to the production of defective interfering
particles (DIP) instead of infectious virions. The production of DIP is
encouraged at high multiplicity of infection, but in this case,
relatively low multiplicities were used in order to avoid DIP
production (Holland, 1986). The state and condition of the HRT 18 cells
at the time of infection may have played a role in the final titres
obtained. Alternatively, the mycoplasma contamination may not have been
totally eliminated and may have affected virus growth. On regular
retesting of the HRT 18 cells for mycoplasma, the results have always
been negative. If mycoplasmas were still present, the level of
contamination was below the sensitivity of the test used.
Even with the drawback of occasional low titre virus, the BCV 
strains could now be grown in cell culture as and when required and
could therefore be used to raise polyclonal and monoclonal antisera, 
and as antigens in the setting up and optimisation of diagnostic tests. 
This was the first step towards serological and molecular comparison of 
the different strains.
CHAPTER TTT
D/A GNOSTIC TESTS
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INTRODUCTION
The detection of BCV in faeces has long been associated with 
difficulties. If direct electron microscopy (DEM) is used, virus 
particles are often indistinguishable from the many fringed particles 
that occur in faeces. BCV peplomers are also noted for being very 
fragile and easily lost, leaving behind a much less distinctive 
particle (Dea et al, 1981; Crouch and Acres, 1984). An alternative 
technique, the HEHA test suffers from non-specific reactions due to the 
complex nature of faeces (Viscidi et al, 1984) and lacks sensitivity. 
Several ELISA tests for the detection of BCV have been reported 
(Reynolds et al, 1984; Crouch et al, 1984; Crouch and Acres, 1984; 
Crouch et al, 1985). The ELISA tests however have also suffered from 
non-specific reactions (Beards, 1988). Attempts were therefore made to 
improve EM diagnosis by incorporating an immunogold probe for accurate 
and sensitive identification of BCV particles. This was then used as a 
benchmark technique against which to evaluate the subsequent 
development of polyclonal ELISAs.
The detection of antibody to BCV provides important epidemiological 
information. The level of antibody is also a reflection of the immune 
status of individual animals and can be used to assess the efficacy of 
vaccines or immunisation schedules. A micro-neutralization test was 
therefore developed and optimised in order to quantify anti-BCV 
antibody levels in sera and in milk or colostrum samples.
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MATERIALS AND METHODS
Virus Propagation:
Faeces from gnotobiotic calves experimentally and separately 
infected with BCV or rotavirus were used as positive and negative 
control samples respectively. For EM studies, faecal samples were 
diluted 1 in 4 in phosphate buffer, pH 7.2, mixed and ground with 
carborundum powder, centrifuged at 10,000g for 3 min at 4°C and the 
clarified supernatant fluid was examined for the presence of BCV. For 
the ELISA, the positive and negative control faecal samples were 
diluted 1/10 in PBS containing 0.05% Tween 20 (PBS/T2 q) and 
homogenised.
BCV was also grown in vitro on fetal TOC and in HRT 18 cells. For 
EM, culture fluid was clarified by centrifugation at 10,000g for 1 min 
at 4°C and the supernatant fluid examined.
Antisera:
An antiserum was produced in a gnotobiotic lamb which had been 
inoculated orally and intranasally with BCV strain CK at 2 and 16 days 
of age and given intramuscular injections of BCV strain SI in Freund's 
incomplete adjuvant (FIA) at 4 and 7 weeks of age. A control serum was 
raised by Dr D R Snodgrass (MRI) in a similar way in a gnotobiotic lamb 
inoculated with rotavirus. Serum was collected 1 week after the last 
injection and IgG extracted by affinity chromatography by Mr A McL 
Dawson (MRI) .
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Another serum was raised in a rabbit inoculated intramuscularly with 
a BCV (strain PQ) pellet emulsified in FIA. These injections were 
repeated 4 and 6 weeks later. The serum was collected 1 week after the 
third injection and the IgG extracted.
In addition, immunoglobulins (Ig) from an anti-BCV serum (strain CK) 
produced in a gnotobiotic piglet by Dr Janice Bridger (I.A.H., Compton) 
were extracted by ion exchange chromatography.
Ion Exchange Chromatography:
A 10cm column was packed with diethylaminoethyl (DEAE-52) cellulose
anion exchanger in 0.01M phosphate buffer pH 7.6. One ml of serum was
dialysed against the phosphate buffer overnight at 4°C and loaded onto
the column. The outflow was connected to an absorbance monitor which
was set at 254nm to measure protein level, while 2ml fractions were
-1
collected at a flow rate of 12mlh . The fractions containing the 2 
peaks of immunoglobulins were pooled and concentrated back down to 1ml 
using a Sartorius Collodion dialysis bag. The purity of the extracted 
serum was assayed by an immunoelectrophoresis test (Hudson and Hay, 
1980). The porcine serum components were separated by electrophoresis 
for lh in 1% agarose at 45V. A trough was cut in the agar into which 
goat anti-whole-pig-serum was placed. The 2 components diffused 
towards each other and precipitin bands formed.
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Pierce Protein Estimation:
A 0.2ml volume of Pierce Reagent B was added to 10ml of Pierce 
Reagent A and mixed. A 0.1ml volume of each test sample was added to 
2ml of the mixed reagents and incubated at 37°C for 30 min before the 
absorbance at 562nm was read. The spectrophotometer was blanked on the 
mixed reagents containing PBS instead of sample. A standard curve was 
drawn using BSA diluted in PBS at concentrations of 1.2mgml ^ to 
0.2mgml ^.
Haemadsorption-Elution-Haemagglutination (HEHA) :
The HEHA test utilises the ability of BCV to adsorb to rat RBC at
4°C and elute from them at 37°C (Van Balken et al, 1978/79). Faecal
samples were diluted 1/4 in PBS and clarified at 2,000g for 10 min.
Equal volumes (usually 0.5ml) of faecal supernate and 40% rat RBC were
mixed and left at 4°C for lh. Shaking every 15 min prevented the RBC
from settling. The mixture was then centrifuged at l,000g for 5 min at
4°C and the supernatant fluid discarded. The RBC were washed 3 times 
with 5ml of cold PBS (4°C). After the third wash the RBC were
centrifuged at l,000g for 5 min and 1ml of PBS at 37°C added and the
mixture incubated at 37°C for lh. The RBC were removed by 
centrifugation at RT and the supernatant fluid tested for HA activity. 
Positive HA samples were confirmed to be BCV positive by an HAI test.
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Direct Electron Microscopy (DEM):
Formvar carbon-coated 400 mesh copper EM grids were used throughout. 
A 3.5ul drop of poly L-lysine was added to each grid and excess fluid 
was blotted with filter paper. A 3.5ul drop of fluid to be examined was 
placed on each grid as appropriate and the excess removed with filter 
paper. The grids were negatively stained using phosphotungstic acid and 
ammonium molybdate (2:1). A set pattern of examining EM grids was 
adhered to in order to standardise the counting of virus particles and 
facilitate comparison between different preparations. Virus particles 
were counted around the 4 edges of a grid square and across one 
diagonal. A total of ten grid squares from different areas of 2 
duplicate grids was examined. The grids were coded and examined at a 
magnification of 20,000 on a Siemens Elmiskop 1A electron microscope.
Immunosorbent Electron Microscopy (ISEM):
Copper EM grids were floated on a lOul drop of ovine anti-BCV IgG on 
a block of dental wax and incubated. The grids were then washed twice 
in phosphate buffer and refloated on a lOul drop of antigen. After a 
second incubation the grids were negatively stained as previously 
described for DEM. All incubations were performed in a moist chamber at 
37°C for lh.
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Immunogold Electron Microscopy (IGEM):
A copper EM grid was coated with the porcine antibody by floating 
the grid on a drop of the pig anti-BCV Ig and was incubated for lh. The 
grid was washed twice with phosphate buffer and reacted with a drop of 
antigen. After incubation for lh the grid was washed as described 
earlier and then floated on a drop of ovine anti-BCV IgG, reincubated 
for a further 30 min and washed. The grid was then placed on a drop of 
pig anti-ovine IgG which was conjugated to 5nm colloidal gold. The 
conjugation was performed by Mr J D Menzies (MRI) (De Mey, 1984). This 
conjugate was stored at 4°C and was diluted in phosphate buffer 
immediately before use. Any aggregates which may have formed on 
storage were removed by centrifugation of the diluted conjugate at 
10,000g for 2 min at 4°C. After incubation with the gold conjugate for 
lh, excess fluid on the grid was removed by blotting the side with 
filter paper and the grid negatively stained as described. All 
incubations were performed in a moist chamber at 37°C and a standard 
drop of lOul was used throughout.
During examination, only virus particles with more than 20 gold 
particles attached to them were counted as positive in order to reduce 
the possibility of confusing light background staining with specific 
labelling.
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Sucrose Gradient Fractionation of BCV:
A volume of 60ml of BCV/S1 grown in HRT 18 cells was clarified by 
centrifugation at 3,000g for 20 min to remove gross debris. Virus in 
the supernatant fluid was pelleted through a 10% (w/w) sucrose cushion 
by ultracentrifugation at 100,000g for 45 min at 4°C in a Beckman L5 
Ultracentrifuge using the SW28 rotor. The pellet was resuspended in 
0.3ml TNE buffer (0.01M tris-hydrochloride (pH 7.5) - 0.1M NaCl - l.OmM 
EDTA). This pellet was either used as a crude virus pellet for animal 
immunisation or further purified by layering onto a 20-55% (w/w) 
sucrose gradient and centrifugation at 52,OOOg in an SW40Ti rotor 
overnight at 4°C. The gradients were fractionated on an ISCO Density 
Gradient Fractionator and 0.5ml fractions collected. Each fraction was 
examined by IGEM and the HA titre measured. Fractions containing the 
virus peak were pooled, diluted in TNE buffer and pelleted again to 
provide a purified virus pellet.
ELISA:
An indirect antibody sandwich blocking ELISA test, based on the 
technique developed by Engvall and Perlmann (1972) was developed and 
optimised. Dynatech M129A micro ELISA plates containing lOOul per well 
were used throughout. PBS/^ q was used as diluent, each incubation step 
was for lh at 37°C (except where otherwise stated) and the plates were 
washed 3 times in PBS/^ q between each step. The plates were coated 
with ovine anti-BCV IgG in carbonate/bicarbonate buffer (pH 9.6) and 
incubated at 4°C overnight. Antigen was added to each of 6 wells and 
incubated for 3h at 37°C. An ovine anti-BCV serum and an ovine anti­
rotavirus serum were then used at a dilution of 1/20 in duplicate wells 
for the blocking step. The other 2 wells per sample received only
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PBS/T^q . The next step was adding rabbit anti-BCV IgG to all wells. 
A goat anti-rabbit serum conjugated to horseradish peroxidase was 
purchased from Wellcome and used at the optimum dilution of 1/6,000. 
The substrate o-phenylenediamine (OPD) in 0.1M citric acid - 0.2M 
disodium phosphate buffer was added and left at RT in the dark for 10 
min. The colour reaction was stopped by the addition of 50ul per well
of 2M sulphuric acid. The absorbance of each well at 492nm was read in
a Titertek Multiskan spectrophotometer. The blank wells only received 
the substrate and sulphuric acid. Samples which gave optical density 
(OD) readings above 0.2 and were blocked specifically only by the 
anti-BCV serum, with >50% reduction in OD, were considered positive.
The lower limit of the sensitivity of this test was fixed at 0.2 by the
mean OD of 18 negative faecal samples plus 2 standard deviations.
Neutralization Test:
The optimum conditions for performing the virus neutralization test
were found to be as follows: Nunc tissue culture grade 96-well flat
5
bottomed microtitre plates were seeded out with lOOul/well of 2x10 
cells ml ^ HRT 18 cells in RPMI medium containing 20% FBS, and 
incubated at 37°C for 2 days or until confluent. The medium was 
replaced by 200ul/well of 2% FBS RPMI medium. Complement was 
inactivated in serum samples by placing them at 56°C for 30 min. The 
whey was extracted from decreamed milk or colostrum samples using 
essence of rennet before complement inactivation as above. Antibody 
samples were double diluted in duplicate in 25ul volumes in microtitre 
transfer plates (Flow Laboratories) using 2% FBS RPMI medium containing 
lOugml ^ trypsin as diluent. Cell culture grown virus was then added 
(25ul/well) to the antibody samples at a previously determined dilution 
which provided 20 to 200 fluorescing cells per field in the UV
microscope at a magnification of xl25. The BCV/M strain was used as a 
reference strain in the neutralization test unless otherwise indicated. 
Virus and antibody were allowed to interact at 37°C for lh. This 50ul 
mixture was then inoculated onto the HRT 18 cells, using the transfer 
plate as a template which simultaneously transferred 50ul to each of 
the 96 wells of the microtitre plate. The microtitre plates were sealed 
and incubated at 37°C for 2 days after which the cells were washed, 
fixed and the infected cells visualised as for the IF test using a 
gnotobiotic calf anti-BCV serum and a pig anti-sheep FITC conjugate. 
The recorded titre of serum and whey samples was the highest dilution 
to cause 90% neutralization of the virus, i.e. a 90% reduction in the 
number of fluorescing cells compared to the mean of the virus control 
wells. At least 8 wells of virus control were included in each test and 
the same positive control serum was titrated in all the tests. The 
results of a neutralization assay were only accepted if the mean of the 
number of fluorescing cells in the virus control wells was between 20 
and 200 per field of view and the neutralization titre of the positive 
control serum was within a 2 fold dilution when compared to previous 
tests.
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RESULTS
Ion Exchange Chromatography:
At the pH used, most of the porcine serum proteins were bound to the 
column allowing the immunoglobulins to elute. Two peaks were detected 
by the absorbance monitor (figure 10). These peaks were pooled and 
immunoelectrophoresis showed them to contain only IgG and IgA (figure 
11). Total protein concentration was 2.02mgml This pool was used in 
later experiments as a source of anti-BCV immunoglobulins.
Direct Electron Microscopy:
It was often difficult to visualise intact virions and differentiate 
these from other fringed bodies by DEM. The low numbers of virus 
particles in addition to the presence of faecal debris compounded these 
difficulties and made unequivocal diagnosis of the presence of 
coronavirus difficult. Figure 12A illustrates a coronavirus particle in 
a bovine faecal sample and highlights the problem of differentiating 
coronavirus-like paricles (CVLP).
Immunosorbent Electron Microscopy:
Using whole pig or lamb anti-BCV sera in the ISEM test on faeces 
from the gnotobiotic calf provided no substantial concentration of the 
BCV particles onto the grids (figure 13). However, when extracted 
immunoglobulins were used, a concentration effect was observed. At a 
dilution of 1/100, a greater than 500 fold increase in the number of
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Figure 10:
The absorbance of ion-exchange chromatography 
fractions. The contents of fractions 3-13 and 
20-23 were pooled.
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Figure 11:
Immunoelectrophoresis of porcine serum.
The top well contained whole pig serum.
The middle well contained the pooled fractions of 
ion- exchange chromatography.
The bottom well contained other fractions off the 
column.
The 2 troughs contained a goat anti-pig serum.
Ion-exchange chromatography therefore purified 
the IgG (small arrow) and IgA (large arrow) from 
other components.
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virus particles in 10 grid squares was detected. Using anti-rotavirus 
serum gave no such increase in virus numbers. It was therefore decided 
to use the extracted sera at a dilution of 1/100 in future ISEM tests. 
The number of virus particles detected in TOC fluid by ISEM using the 
ovine anti-BCV IgG increased with increasing HA titre (figure 14). When 
faecal samples were examined, the background debris was markedly 
reduced, and diagnosis was facilitated. The concentration effect of 
ISEM is illustrated in figure 12B. However, fringed bodies and 
virus-like particles were still detected in around 30% of samples, 
sometimes making interpretation difficult.
Immunogold Electron Microscopy:
The ovine and porcine extracted sera were used at a dilution of 
1/100 in this test. The gold conjugate was found to give optimum 
results at a dilution of 1/5 (figure 15) . An incubation temperature of 
37°C for all the stages was found to give best results (figure 16). The 
optimum incubation times for all the different stages were lh for the 
coating pig anti-BCV stage, lh for the antigen stage, 30 min for the 
ovine anti-BCV stage and lh for the gold conjugate stage (figure 17).
Using the IGEM technique, BCV particles were both concentrated and 
specifically labelled. As illustrated by figure 12C, most of the gold 
particles were closely associated with the virus particles, with 
minimal background staining. Figure 12D illustrates a negative sample 
in which relatively low background staining was observed and debris or 
other particles which may have been mistaken for coronavirus were not 
labelled. Compared to DEM the background debris was also substantially 
reduced.
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Figure 12:
A) A particle considered to be BCV (large 
arrow) and a coronavirus-like particle (small 
arrow) observed by DEM. The potential for 
misdiagnosis is clear.
B) BCV particles detected by ISEM. The 
pleomorphic coronavirus particles (large arrow) 
are concentrated onto the antibody coated grid. In 
addition, many intact peplomers (small arrow) are 
obvious.
C) An IGEM preparation of a bovine faecal 
sample containing BCV. The 5nm colloidal gold 
particles are mainly bound to the coronavirus 
particles (arrowed).
D) A bovine faecal sample, negative for BCV, as 
observed by IGEM. Fringed coronavirus-like 
particles are not labelled.
Bars represent lOOnm.

73
Figure 13:
The number of virus particles in 10 grid 
squares at various serum dilutions as detected by 
ISEM.
PaBCV: pig anti-BCV 
OaBCV: ovine anti-BCV 
Igs: immunoglobulins
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Figure 14:
Variation of HA titre with the number of virus 
paticles in 10 grid squares as detected by ISEM on 
different samples of TOC fluid containing BCV.
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Figure 15:
The effect of diluting the gold conjugate on 
the number of labelled virus particles in 10 grid 
squares in the IGEM test.
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Figure 16:
The effect of performing the IGEM test at 
different temperatures on the number of labelled 
virus particles in 10 grid squares.
Temperature (Celcius)
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Figure 17:
The optimal incubation times for the different 
stages of the IGEM test - all other stages being 
held at 1 hour.
P: pig 
0: ovine
Virus numbers represent the number of labelled 
virus particles in 10 grid squares.
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Control experiments utilised culture and faecal BCV, and a faecal 
rotavirus preparation (table 7). These control experiments showed that 
all the virus particles (table 7, column 1) were specifically 
labelled. In the coating antibody control, the results were similar to 
DEM examination, with no concentration of particles (column 2). Where 
the second antibody was omitted (column 3), results similar to ISEM 
were obtained, with concentration of the sample but no specific 
labelling. Finally by omitting both antisera (column 4) no 
concentration and no specific labelling were observed. These results 
demonstrate the specificity of the IGEM test.
/
Sucrose Gradient:
The number of labelled virus particles in sequential fractions of a 
sucrose gradient and the HA activity of each fraction are given in 
figure 18. The fractions containing the highest numbers of virus 
particles coincided with the peak of HA activity. The density of this 
region was 1.18gml ^ which corresponds with that of BCV in sucrose 
(Siddell et al, 1983).
ELISA:
The coating ovine anti-BCV IgG and the detecting rabbit anti-BCV IgG
-1
contained 10 and 24mgml protein respectively. Checkerboard titrations 
of the coating and detecting antibodies were performed on plates 
bearing positive and negative antigens of both cell culture and faecal 
origin. Optimum differences between the positive and negative controls 
were obtained at a coating antibody dilution of 1/51,200 and a 
detecting antibody dilution of 1/12,800. These dilutions were chosen 
for subsequent tests. On dilution of the cell culture and faecal
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Table 7:
The number of coronavirus and coronavirus-like 
particles in 10 grid squares observed in IGEM and 
control preparations.
Sample technique
IGEM __________ IGEM performed without
1st Ab 2nd Ab 1st and 2nd Ab
Cultured BCV 3,556/0 0/1 0/2,943 nt
Faecal BCV 6,225/0 6/3 0/1,344 0/0
Faecal rotavirus 0/0 0/4 0/1 0/4
Ab: antibody, nt: not tested,
no. of labelled particles/ no. of unlabelled particles
r
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Figure 18:
HA and IGEM results on a 20-55% (w/w) sucrose 
gradient BCV preparation.
RECIPROCAL HA TITRE
NUMBER/10 GRID SQUARE
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antigens (figure 19), maximum differences between positive and negative 
controls were obtained while using the cell culture antigen neat and 
the faecal antigen at 1/10. In the presence of the blocking step, the 
OD of positive controls was always reduced by more than 50% (table 8).
Comparison of Diagnostic Tests:
The 5 available diagnostic tests were then compared using a panel of 
37 bovine faeces samples (table 9). IGEM was found to detect the 
largest number of positive samples (9 out of 37). The ELISA, HEHA, ISEM 
and DEM detected 6, 5, 4, and 2 of these positives respectively. No 
false positive results were detected by any technique.
A further 94 faecal samples were compared by DEM and IGEM only 
(table 10) . In this comparison, 68 samples were found to be negative 
for BCV by both DEM and IGEM. Only 14 samples (15% of total) were
positive when examined by DEM, whereas all 26 (28% of total) were found
to be positive in the IGEM test.
Another 123 bovine faecal samples were compared by ELISA and IGEM 
(table 11). IGEM detected 39 BCV samples (32%) while ELISA only 
detected 24 positive samples (20%). No false positive samples were 
detected by this ELISA.
Once this IGEM technique had been proven, this test was taken over
by the Moredun EM Unit who have used it as a routine diagnostic test.
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Figure 19:
The effect of antigen dilution on the mean 
optical density (n=6) in the BCV ELISA.
The starting material for the cell culture 
antigen was neat cell culture supernatant fluid. 
The starting material for the faecal antigen was 
1/10 faecal homogenate in PBS/^ q .
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Table 8:
The specific blocking of BCV samples in the 
ELISA.
Antigen mean OP (^=2) using__________  Designation
anti-RV block anti-BCV block
Control HRT cells 0.11 0.12 -
Cell culture BCV/M 1.185 0.19 +
Gnotobiotic RV faeces 0.10 0.10 -
Gnotobiotic BCV faeces 0.705 0.105 +
Other faeces: A 0.235 0.11 +
B 0.175 0.08 -
C 0.68 0.155 +
D 1.235 0.19 +
E 0.24 0.23 -
OD: optical density, RV: rotavirus, BCV: bovine coronavirus 
negative, +: positive
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Table 9:
Comparison of 5 tests for the diagnosis of BCV 
in faeces.
Faecal Sample ________________ Detection of BCV by_______________
DEM IS EM HEHA ELISA IGEM
1 + + + + +
2 + + + + +
3 - + + + +
4 - - + - +
5 - - + + +
6 - - - - +
7 - + - + +
8 - - - + +
9 - - - - +
10-37 - - - - -
Total positive 2 4 5 6 9
negative, +: positive
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Table 10:
Comparison between DEM and IGEM in the 
diagnosis of BCV in 94 faecal samples.
Table 11:
Comparison between ELISA and IGEM in the 
diagnosis of BCV in 123 faecal samples.
Results Number of Samples
DEM+IGEM+ 14
DEM+IGEM- 0
DEM-IGEM+ 12
DEM-IGEM- 68
negative, +: positive
Results Number of Samples
ELISA+IGEM+ 24
ELISA+IGEM- 0
ELISA-IGEM+ 15
ELISA-IGEM- 84
negative, +: positive
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For the calender year 30/3/87 to 29/3/88, the EM Unit examined 296 
bovine faecal samples by this technique and reported 32 of them (11%) 
to be BCV positive. In the previous year 30/3/86 to 29/3/87, the EM 
Unit examined 236 bovine faecal samples by DEM and reported only 5 (2%) 
as BCV positive.
Neutralization Test:
During the optimisation procedures, it became evident that the use 
-1
of lugml trypsin in the maintenance medium or centrifugation of the 
microtitre plates for lh at RT after inoculation did not significantly
5
alter the results. The use of HRT 18 cells at 2x10 cells per ml and 
incubation for 2 days were found to give optimum results.
This neutralization test was used to assess the humoral immune 
response to a coronavirus vaccine (provided by an animal health 
company) which was administered to pregnant cows one month prior to 
calving in the hope of increasing specific antibody levels in colostrum 
and milk, thus imparting passively acquired immunity to the calves. In 
some cases, a secondary booster injection was given to cows on the day 
of calving. The serum antibody levels were assayed 4 weeks prior to 
calving, at calving and 4-6 weeks after calving. Additionally, the 
antibody titres in colostrum and milk was also assayed on the day of 
calving and on days 3, 7, 14 and 28 after calving (table 12). The 
geometric mean of the titres was used, i.e. Loge values of titres of 
each sample in each group were used to calculate the mean titres in 
order to take the doubling dilutions into consideration. For 
calculation purposes, neutralization titres below 10 were taken as 5.
The "Minitab" statistical computer programme was used to perform these 
calculations. Serum antibody levels only increased slightly in 
vaccinates compared to controls. The antibody levels in the colostrum 
and milk, however, did not alter significantly.
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Table 12:
The effects of vaccination on antibody levels 
to BCV in serum and milk.
Group (no.) The Geometric Mean of the reciprocal neutralization titre
Serum Samples_____   Milk Samples on Days
4w pre 
calving
on
calving
4-6w post 
calving 0 3 7 14 28
Control (9) 217 86 92 1,098 80 16 10 <10
A (6) 131 254 139 1,810 143 18 23 <10
B (6) 215 320 254 2,032 90 20 11 11
C (6) 262 403 190 2,280 113 22 14 <10
D (6) 177 180 63 2,032 90 16 11 <10
w: weeks
A: received 2 intramuscular injections 
B: received 1 intramuscular injection 
C: received 2 subcutaneous injections 
D: received 1 subcutaneous injection
89
DISCUSSION
It has been noted that BCV peplomers are fragile and easily sheared 
from the outer envelope leaving a much less distinctive particle (Stair 
et al, 1972). Our results confirmed that when faecal samples containing 
BCV were examined by DEM coronavirus particles were usually observed to 
be widely spaced and the background heavily contaminated with debris. 
Equivocal results were compounded by the presence in faeces of other 
fringed particles which could be mistaken for coronavirus (Dea et al, 
1981).
In this study, a higher sensitivity and specificity were observed in 
ISEM preparations. However around 30% of faecal samples still contained 
virus-like particles which could not be unequivocally determined to be 
BCV. It was noted that the use of whole sera in the ISEM provided no 
significant increase in the number of captured virus paricles. 
Extracted immunoglobulins had to be used in order to obtain a 
substantial concentration of the antigen. It may be that the other 
proteins in the whole serum competed with the immunoglobulins in 
adsorbing to vacant sites on the EM grids, allowing much fewer specific 
Ig molecules to attach unless pure preparations were used.
An attempt was made to further increase the sensitivity and 
specificity of BCV diagnosis by combining the concentration effect of 
ISEM with the specific labelling of antibody conjugated to colloidal 
gold in an IGEM test. This was successfully achieved with the IGEM 
allowing coronavirus-like particles to be diagnosed accurately as BCV 
or debris. The results of the coronavirus purification on a sucrose 
gradient gave further confirmation of specificity. The peplomers of 
coronavirus particles were obscured by antibody and rarely seen in IGEM
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preparations. IGEM detected all the different strains of BCV examined 
whether in faeces, TOC fluid or cell culture fluid. The main 
disadvantages of IGEM are the expense of reagents and equipment and the 
limited throughput of samples.
In order to alleviate this problem, an ELISA was developed and 
optimised. The ELISA was cheaper and many more samples could be 
examined routinely than by the IGEM technique. The ELISA, however, 
required highly specific antisera and non-specific reactions often 
occurred when faeces was used in such a test (Viscidi et al, 1984). 
Several attempts were made using a variety of gnotobiotic calf, lamb, 
pig and rabbit sera and alkaline phosphatase as the conjugated enzyme. 
All these attempts failed however due to non-specific alkaline 
phosphatase activity in some faecal samples. This observation was 
recently confirmed when many faecal samples were found to contain 
endogenous alkaline phosphatase activity (Beards, 1988). It was 
therefore decided to use horseradish peroxidase as an enzyme label in 
later attempts. This eventually led to the successful setting up of 
the current ELISA test which was shown to be specific, and more 
sensitive than the DEM, ISEM and the HEHA tests. The IGEM test however, 
remained the most sensitive of the 5 tests. This ELISA therefore can 
be performed on a large scale but one must be aware that the IGEM test 
would detect around 30 to 40% more positive samples. This figure is 
reduced substantially when results are examined on a herd basis.
Ideally the IGEM should be performed for maximum sensitivity and 
specificity. Visual confirmation rules out the possibility of 
non-specific results. Using this techique the rate of diagnosis of BCV 
in faecal samples by the EM Unit at the MRI increased 5 fold from 2% to 
11% positive samples over a period of 1 year. The incidence of BCV in
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the field is not likely to have increased to this extent over that 
year. The observed figures therefore related to the increased 
sensitivity of the diagnostic test used.
The principle of this iiranunogold detection technique can be applied 
to other antigens which are not morphologically distinct and need to be 
labelled or localised. The technique therefore has widespread 
applications (Horisberger, 1981; Ducatelle et al, 1984; Bruce Birrell 
et al, 1987; Hodges et al, 1987; Patterson and'Verduin, 1987) and has 
been used to label rotaviruses and adenoviruses in human faeces by an 
indirect labelling test (Kjeldsberg, 1985) where the viruses were 
directly adsorbed onto EM grids. Caliciviruses in human faeces have 
been labelled in suspension and the complexes adsorbed onto EM grids 
(Kjeldsberg 1986).
This novel technique should prove useful as a standard against which 
to evaluate the development of other diagnostic techniques, such as the 
new dot-blot hybridisation assay to detect viral RNA using a cDNA probe 
(Shockley et al, 1987) and in the epidemiological study of disease 
associated with BCV infection.
In order to achieve a wider understanding of BCV infection, the 
immune response of animals to the virus needs to be evaluated. The 
humoral immune response to BCV has been shown to play a major role in 
controlling this disease. The presence of specific IgG and IgA in the 
lumen of the gut of young calves protects them from infection (Crouch 
1985). The specific antibody level in serum and milk can be assayed in 
a neutralization test. It is more usual to calculate the 
neutralization endpoint on the basis of 50% reduction in infectious 
foci. For this test it was decided to use 90% reduction since the
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number of fluorescing cells in positive control wells occasionally 
varied between 20 and 200 cells per field - individual cells were 
counted. This strict endpoint ensured that the neutralization titres 
were not affected by fluctuations in the number of virus infected 
cells. The source of this variation was investigated by changing the 
cell concentration and the incubation times but no reason for this 
fluctuation was evident. This effect may have been due to the quality 
of the monolayer or may have been related to the inexplicable variation 
detected in virus titres of sequential passages.
The efficacy of a commercial vaccine designed to provide passive 
immunity was tested. The serum and milk BCV antibody levels in control 
and vaccinated cows were examined. Only a 4 fold or greater alteration 
in titre was considered significant. The serum antibody level in 
control cows showed a slight decline from the period 4 weeks before 
calving to 6 weeks after calving. Vaccinated cows showed a slight 
increase in serum antibody titre from 4 weeks prior to calving until 
calving, but this antibody level declined after calving . This 
increase was greater than 4 fold only in cows belonging to group C 
which received 2 subcutaneous injections of the vaccine.
The serum antibody level in the cow however is not important in 
imparting immunity to the calf. The specific antibody levels in milk 
and colostrum play the major role in calf protection. The BCV antibody 
level in the colostrum in all groups was significantly higher than any 
other samples. This level rapidly declined to low levels over a few 
days, confirming other workers' findings (Crouch and Raybould, 1983). 
The same pattern was observed in control and vaccinated groups, with
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no significant differences between the titres. The overall conclusion 
regarding this vaccine had to be that no significant protection 
would be imparted to the calves of vaccinated dams in their colostrum 
or milk, regardless of the route of administration of the vaccine.
CHAPTER TV
IN  VIVO CULTURE 
OF BCV
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INTRODUCTION
Neonatal calf diarrhoea is a syndrome of complex aetiology in which 
several infectious agents interact with environmental and immunological 
influences to determine the health of the young calf. Field outbreaks 
of NCD are unsuitable for studying the biology of BCV due to the 
complex interactions and unknown factors that occur. Animal experiments 
therefore in a controlled environment need to be performed in order to 
gain this knowledge.
To this aim, gnotobiotic animals were invaluable since they provided 
germ free hosts with a virgin immune system. However these animals were 
very expensive to produce and maintain and care needed to be taken in 
interpreting the information gained from these experiments in the 
absence of a natural flora, which plays a role in non-specific defence 
mechanisms.
In order to gain information about the pathogenicity of BCV and to 
relate the findings to animals on the farm, experiments on normal 
colostrum fed animals were performed. Attempts were made to exclude 
other enteric pathogens from the area where these animals were housed 
in order to study the effects of BCV individually. A small-animal model 
which would be of great value was also attempted. These studies on BCV 
in various in vivo systems were undertaken while taking into 
consideration this virus' tropism for the upper respiratory tract as 
well as the enteric tract.
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MATERIALS AND METHODS 
Detection of BCV in the Respiratory Tract:
Although BCV is now recognised to infect the upper respiratory tract 
(URT) as well as the enteric tract, little attention has been paid to 
methods for detecting BCV in the URT (Thomas et al, 1982; Singh et al, 
1985; Wellemans et al, 1985)
We used an immunofluorescence test to identify BCV in epithelial 
cells of the URT. Nasal swabs were collected using standard swabs (long 
nasopharyngeal swabs were found to give the same results), placed in 
virus transport medium and stored on ice for up to 24 hours. The
epithelial cells from the nasal swabs were centrifuged onto glass
slides in Cytospin apparatus (Shandon Southern), and fixed in cold 
acetone for 5 min. A standard indirect IF test was then performed using 
a rabbit anti-BCV serum at 1/320 and a goat anti-rabbit FITC conjugate 
(Wellcome) at 1/60 in PBS. To confirm the specificity of the IF test, 
an ovine anti-BCV serum was used in a blocking assay. This serum was 
added to the fixed cells at a dilution of 1/20 in PBS for 30 min at 
37°C before the rabbit anti-BCV serum.
A mouse monoclonal antibody against BCV was also used in an attempt
to increase specificity and perhaps sensitivity. It was used at a
dilution of 1/1,000 and probed with a swine anti-mouse FITC conjugate 
(Wellcome) at 1/40 in PBS. The appropriate anti-rotavirus polyclonal 
and monoclonal antibodies (raised by Miss Iris Campbell at the MRI) 
were used as negative control sera in this test.
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Detection of Enteric Pathogens in Faeces:
Faecal samples from experimental animals were examined for 
rotavirus, ETEC, Cryptosporidium and coronavirus. The IGEM technique 
was used for detecting BCV in faeces. Rotavirus was diagnosed by PAGE 
of double stranded RNA (Herring et al, 1982) by Mrs Tracey Fitzgerald 
at the MRI. Some samples were examined for ETEC by the slide 
agglutination test (Guinee et al, 1977). The diagnosis of 
Cryptosporidium was performed by Dr D Blewett and Mr S Wright (MRI) 
using the modified Ziehl-Nielsen method (Henriksen and Pohlenz, 1981).
Gnotobiotic Calf:
A male Limousin cross calf (numbered L965) was derived by caesarean 
into a gnotobiotic isolator by the Clinical Department at the MRI. The 
calf was maintained in a positive pressure isolator (figure 20) and was 
fed ultra-heat-treated milk.
The inoculum for this calf was a field strain of BCV passaged once 
in a gnotobiotic calf (calf F690) by Dr D Snodgrass. Faeces from calf 
F690, which contained BCV and the bacterium Staphylococcus aureus, were 
diluted 1/10 in PBS, homogenised and filtered through a series of two 
pre-filters, two 5um, two 1.2um, one 0.8um and two 0.45um filters. This 
bacteriologically sterile filtrate was inoculated to calf L965 orally 
(0, 10ml) and intranasally (IN, 5ml in each nostril) at 2 days of age. 
A harness was fitted on this calf in order to collect faeces. The same 
inoculum was given again to this calf by 0/IN route at 26 days of age.
97
Figure 20:
Positive pressure gnotobiotic calf isolator. 
The entry ports were used for removing samples and 
for placing milk inside the isolator.
)
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Faeces from calf L965 were designated SI strain, diluted 1/10 in 
PBS, homogenised and clarified. Virus was then pelleted by 
ultracentrifugation and sucrose gradient purified as described earlier. 
The purified virus was treated with 0.5% Nonidet-P40 (Sigma), a 
non-ionic detergent, for 25 min at 4°C to solubilize the viral envelope 
and release the membrane-bound proteins. The virus was layered onto 15 
to 70% (w/w) sucrose gradient and centrifuged at 100,000g in the SW40Ti 
rotor for 16h at 4°C and fractionated. The peplomer protein was 
expected to be found in fractions around the 1.12gml ^ density (Sturman 
et al, 1980). These fractions were pooled and dialysed overnight in PBS 
at 4°C. The peplomer preparation was concentrated down to 1ml in a 
Sartorius Collodion bag, emulsified with FIA and inoculated 
intramuscularly (IM) in the hind leg of calf L965 at 38 days of age. A 
large volume of blood was taken from the calf at 51 days of age in 
order to provide a stock of hyperimmune monospecific bovine antiserum 
to BCV before releasing the calf from the isolator.
Colostrum Fed Calves:
Four healthy conventionally reared 1 day old colostrum fed male 
calves were purchased from the Hannah Research Institute. They were 
housed in individual pens with 2 pens to each enclosed room. Separate 
sets of complete protective clothing were disinfected and kept in each 
room. Only 3 people were allowed into each room, and no individual was 
permitted to go into both rooms.
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Calves 1 and 2 were inoculated 0 (90ml) and IN (5ml per nostril)
when 4 and 5 days old respectively with a 10% suspension of faeces from
calf L965 containing BCV/S1. Calves 3 and 4 received a silmilar 0/IN
inoculum of 100ml of BCV/CK cell culture fluid containing 
5.2 -1
10 * TCID^Qml when 4 and 5 days old respectively. Harnesses were 
fitted to collect faecal samples. Rectal temperatures and nasal swabs 
were also taken daily while serum samples were collected twice a week.
Gnotobiotic Lambs:
Gnotobiotic lambs were hysterectomy-derived and maintained in
positive pressure isolators either singly or in pairs. They were
inoculated 0/IN with 100ml of inoculum when 2 days of age unless
otherwise stated. Male lambs were fitted with a harness to collect
faeces. Lambs 1 and 2 (a female and a male respectively) were
5 2 -1
inoculated with BCV/CK cell culture fluid at 10 ' TCID^Qml . The 
female lamb 3 was inoculated with 1/5 suspension of the S2 strain of 
BCV in faeces while lambs 4 and 5 (2 males) received a 1/10 suspension 
of the SI faecal strain. A further 3 gnotobiotic lambs were used to 
passage virus containing faeces from the above lambs. Faecal samples, 
nasal swabs and rectal temperatures were taken daily and serum samples 
collected twice a week.
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Suckling Mice:
Swiss White mice were bred from MHV-free stocks at the MRI. Litters 
containing around 10 mice and a dam were used with each mouse in the 
litter receiving the same inoculum. Three to six day old mice were 
inoculated orally with lOOul of faecal or cell culture virus. The mice 
were examined daily by holding them upside down between the thumb and 
forefinger and pressing gently on their abdomen. Diarrhoea was recorded 
when very loose yellow faeces were released.
Control litters received a sham inoculum of faeces containing no 
enteropathogens, or negative cell culture fluid or the diluent PBS 
containing 200IUml-l penicillin and 200ugml-l streptomycin.
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RESULTS
Gnotobiotic Calf Experiment-Respiratory Tract:
Epithelial cells from the nasopharyngeal swabs from L965 were shown 
to contain BCV (figure 21). Coronavirus was detected in the respiratory 
tract of the calf from 2 to 5 days post inoculation and sporadically 
thereafter until 26 days of age. When this calf was given a second 
inoculum, every sample for a period of 11 days post inoculation was 
found to be positive (table 13). Sampling stopped at that stage. The 
specificity of the rabbit polyclonal serum was confirmed by the 
monoclonal antibody to BCV, but the monoclonal antibody detected a 
larger number of positive samples, probably due to its higher 
specificity and affinity. The immunofluorescence reactions were further 
confirmed by a blocking assay. The use of an ovine anti-BCV serum 
blocked the fluorescence of 7 out of 9 positive samples and no
difference was observed in 4 negative samples . The two positive
samples that were not blocked may have contained a higher proportion of 
antigen. The presence of BCV in the respiratory tract was also 
confirmed by virus isolation from nasal swabs onto TOC. The first ten 
samples were inoculated onto TOC cubes and virus was grown from 5 
samples 2 to 6 days post inoculation (dpi). Isolation of virus onto TOC
seemed to be a more sensitive technique for the detection of BCV than
IF on epithelial cells but required bovine TOC. No fluorescence was 
obtained with any sample when the anti-rotavirus control sera were 
used. The infection of the respiratory tract was subclinical in this 
case since no respiratory symptoms of any kind were detected.
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Figure 21:
Specific immunofluorescence of nasal epithelial 
cells with a monoclonal anti-BCV antibody. 
Fluorescing (large arrow) and non-fluorescing 
(small arrow) cells can be seen. Some of the 
fluorescing cells contained 2 or more nuclei. 
(600X magnification).
*
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Table 13:
Detection of BCV in the respiratory tract of 
gnotobiotic calf L965.
Age (days) IF on nasal swabs utilising Growth of virus
Rabbit polyclonal Monoclonal Ab from nasal swabs
serum to BCV onto TOC
1
2* - -
3 -
4 + +
5 +
6 + +
. 7 -
8
9 - +
10 -
11 - -
12 -
13 •- +
14 - -
15 - -
16 + +
17 + +
18 - -
19 + +
20 + +
21 - +
22 - +
23
24
25 +
26* + -
27 + +
28 + +
29 + +
30 + +
31 + +
32 + +
33 + +
34 + +
35 + +
36 - +
37 +
*: oral/intranasal inoculum given, +: specific fluorescence observed, 
no specific fluorescence observed, blank: no sample,
IF: immunofluorescence
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Gnotobiotic Calf Experiment-Enteric Tract:
Faecal samples containing BCV as detected by IGEM were found between 
3 and 10dpi (figure 22). The detection of BCV coincided with profuse 
watery diarrhoea as indicated by the sudden high output of watery 
faeces. When the calf was inoculated a second time, no coronavirus was 
detected and no diarrhoea was present. The BCV containing faecal 
samples were pooled to provide a positive BCV control faeces for use in
setting up diagnostic tests, inoculating other animals and virus
isolation in cell culture ( virus SI). This pool was also tested for 
the presence of rotavirus, ETEC and Cryptosporidium and was found to be
negative for these enteric pathogens.
Gnotobiotic Calf Experiment-Serology:
Serum samples were collected from the calf twice a week and were 
assayed for neutralizing and HAI antibody titres. Both these titres 
followed the same pattern (figure 23), with maximum titres around 16 
days of age and the titre remained approximately constant after the 
second oral inoculum. The intramuscular boost with the peplomer 
preparation did not appreciably alter the antibody titres.
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Figure 22:
BCV infection of the enteric tract of 
gnotobiotic calf L965. BCV was detected in the 
faeces of days 5, 6, 7, 8, 11 and 12 by IGEM.
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Figure 23:
Anti-BCV antibody levels in the serum of calf 
L965.
HAI: haemagglutination inhibition 
Neut.: neutralization
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Figure 24:
Rectal temperature of calf L965.
The shaded area represents a temperature over 
39.5°C or fever.
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Gnotobiotic Calf Experiment-Clinical:
The rectal temperature of the calf was measured daily and a fever 
(>39.5°C) was detected coinciding with virus excretion in faeces and 
diarrhoea (figure 24). No fever was detected after the second oral 
inoculum. The appetite of the calf was reduced during the period of 
diarrhoea when it was also dull and relatively inactive. No coughing 
or nasal discharge was detected at any time during the experiment.
Colostrum Fed Calves:
All four calves had a high initial serum neutralizing antibody to 
BCV. After inoculation, none of them developed diarrhoea or respiratory 
symptoms. No fever was detected and none of the nasal swabs were
positive by IF. BCV was detected in the faeces of calves 1 and 2 which
received the faecal inoculum (table 14). Rotavirus was also detected in
the faeces of all four calves. Cryptosporidium was not detected in 
these calves. No seroconversion (a greater than a 4 fold increase in 
antibody titre within a 2 week period) was detected in any calf.
Gnotobiotic Lambs:
No fever or respiratory symptoms were observed in any of the lambs 
and no coronavirus could be detected in any nasal swab. Lambs 2, 3 , 4  
and 5 (table 15) did not excrete BCV in their faeces and did not 
develop diarrhoea. Loose faeces was produced by lamb 1 which did
excrete BCV in its faeces 3 to 5dpi. This was also the only lamb to 
produce a serological response markedly stronger than those produced by 
the other lambs. It was decided to produce hyperimmune serum in this 
lamb. A second 0/IN inoculum was therefore given at 16 days of age
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Table 14:
Virological and serological response of 
colostrum fed calves to BCV inoculation.
Age  Faecal SI_strain______ Cell culture CK strain
(days) calf 1 calf 2 calf 3 calf 4
HAI SNT CV RV HAI SNT CV RV HAI SNT CV RV HAI SNT CV RV
2 - - - - - - - -
3 - - - - -  +
4* 80 640 - - - - 160 320 - - - +
5" - + 40 320 - - - 160 640 -
6 - + + +  - -  +
7 80 320 - + + + 80 320 - - - -
8 - + 40 160 - + - + 320 640 - -
9 + +  - +  - +  -
10 160 320 - + - - 160 640 - + - -
11 - + 80 320 - + - - 640 640 -
12 - - - + - - - -
13 . . . . . _ . .
14 160 320 - - - - 160 640 - - -
15 - - 40 320 - - - 320 640
16 - - -
17 160 160 - 160 320
18 80 80 - 320 640
19
20
21 160 320 160 640
22 80 160 320 320
23
24 160 160 160 640
25 40 160 640 1,280
*: calves 1 and 3 received O/IN inoculum at the age of 4 days
": calves 2 and 4 received 0/IN inoculum at the age of 5 days
HAI: serum antibody titre by haemagglutination inhibition
SNT: serum virus neutralizing titre
CV: coronavirus detection in faeces by IGEM
RV: rotavirus detection in faeces by PAGE
-: negative, +: positive, blank: no sample
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Table 15:
Virological and serological response of 
gnotobiotic lambs to BCV inoculation.
Age Cell culture CK strain Faecal S2 strain Faecal Si strain
(days)  lamb 1____ lamb 2 lamb 3 lamb 4 lamb 5
HAI SNT CV HAI SNT CV HAI SNT CV HAI SNT CV HAI SNT CV
1 -
2*
O
<10 <10 - <10 <10 - <10 <10 - <10 <10 - <10 <10 -
J
4 _ _ _ _
5 <10 <10 + <10 <10 - <10 <10 - 10 <10 - 20 <10 -
6 + - - - -
7
Q
+ - - - -
O
9 40 640 _ <10 <10 - <10 <10 - 10 <10 - 20 <10 -
10 - - - - -
11 - - - - -
12 40 1,280 - 40 80 - <10 <10 - 80 <10 - 20 <10 -
16* 40 640 _
19 80 640 -
23 80 640 -
26'* 80 640
30 80 1,280
34 2,560 2,560
36 5,120 2,560
41 5,120 2,560
44 10,240 2,560
48*' 1,280
54 5,120
*: O/IN inoculum given 
": intramuscular inoculum given
HAI: serum antibody titre by haemagglutination inhibition 
SNT: serum virus neutralizing titre 
CV: coronavirus detection in faeces by IGEM 
-: negative, +: positive, blank: no sample
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followed by two intramuscular inoculations with BCV pellet in FIA at 26 
and 48 days of age. The serum was collected one week after the last 
boost. In hyperimmunizing this lamb, the cell culture SI strain was 
used in order to obtain a serum with a wider strain specificity.
In order to attempt to adapt the CK strain to gnotobiotic lambs, it 
was decided to passage virus from lamb 1 in further gnotobiotic lambs. 
Lamb 6 was therefore inoculated with a 10% suspension of BCV positive 
faeces from lamb 1. Lamb 6 produced a large volume of loose faeces 3dpi 
and was found dead on day 5 post inoculation. BCV was not detected in 
its faeces at any stage but coronavirus-like particles (CVLP) were 
detected in the loose faeces of day 3 and were slightly smaller in size 
than BCV and had a fringe of closely packed peplomers approximately 
half the size of BCV peplomers (figure 25). These particles did not 
react with anti-BCV serum in the ISEM or the IGEM tests. A post-mortem 
carried out by Dr K Angus (MRI) revealed that the lungs were filled
with fluid and the abomasum was enlarged and very gaseous but no
obvious cause of death could be established. No virus could be isolated 
on bovine TOC or HRT 18 cells from the lungs, trachea or faeces of 
this lamb. No bacteria, other than E. coli were detected. The 
E. coli was probably a contaminant at the post-mortem. These faecal 
CVLP were passaged into another 5 day old gnotobiotic lamb (lamb 7) by 
0/IN inoculation of faeces from lamb 6. No diarrhoea or other symptoms
were detected in this lamb although CVLP were detected in its faeces
from 1 to 7dpi (figure 26). These particles were not detected prior to 
inoculation or after day 7.
A third passage of CVLP was performed from lamb 7 into lamb 8 and
again CVLP were detected on day 1 and 3 post inoculation. However no 
symptoms of any kind were detected.
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Figure 25:
Comparison of BCV (A) and CVLP (B) by EM. Note 
the different peplomer size and spacing. The CVLP 
also has a slightly smaller diameter. Bars 
represent lOOnm.
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Figure 26:
The number of CVLPs per grid square shed in 
the faeces of lamb 7.
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BCV was not detected at any time up to 10dpi in the faeces or nasal 
swabs of lambs 6, 7 or 8. Since BCV could not be adapted to passage in 
gnotobiotic lambs, and since these interesting CVLP could not be 
adapted to tissue culture, no further studies were carried out.
Suckling Mice:
The SI and S2 faecal strains of BCV caused diarrhoea in 4 out of 9 
and 1 out of 33 mice respectively. No diarrhoea was observed in 89 
control mice which received either negative faeces, the diluent or no 
inoculum (table 16). Diarrhoea was clearly recognisable as very loose 
yellow faeces (figure 27). Control mice only occasionally released 
faeces when their abdomen was pressed, but when they did , their faeces 
tended to be firm and dark brown in colour.
Inoculating newborn mice with the HRT 18 grown cell culture strains 
of BCV also gave rise to diarrhoea (table 17). Using an inoculum
c r _ -|
containing 10 -10 TCID^Qml , 2 out of 22, 6 out of 24 and 4 out of 33
mice were diarrheic when inoculated with the SI, S2 and M strains
respectively. These figures were 4 out 16, 1 out of 12 and 1 out of 24
4 5 -1respectively when the inoculum contained 10 -10 TCID^Qml . Control HRT 
18 cells and the diluent did not give rise to diarrhoea in 26 and 42 
mice respectively.
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Table 16:
Clinical signs detected after oral inoculation 
of faecal BCV to newborn mice.
Table 17:
Clinical signs detected after oral inoculation 
of cell culture BCV to newborn mice.
BCV strain in Faeces 
diluted 1/10
Number with 
diarrhoea
Total
number
SI 4 9
S2 1 33
negative faeces 0 23
diluent 0 42
no inoculum 0 24
105-106TCIDcnml-1 104-105TCIDcnml-1
5U 50
Number with Total Number with Total
diarrhoea number diarrhoea number
SI 2 22 4 16
S2 6 24 1 12
M 4 33 1 24
M pellet 7 10
cell pellet 5 10
HRT cells 0 26
diluent 0 42
Cell Culture 
inoculum
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Figure 27:
A 7 day old mouse showing diarrheic symptoms 48 
hours after inoculation with BCV.

117
5 8 -1When an M virus pellet with a titre of 10 ’ TCID^Qml was used, 7 
out of 10 mice were diarrheic. However, 5 out of 10 control mice 
which received a pellet of negative cell culture fluid also developed 
diarrhoea. It seemed therefore that in this case the pelleting 
procedure gave rise to non-specific toxic reactions which led to 
diarrhoea.
These preliminary results suggested that it may be possible to adapt 
BCV to the enteric tract of newborn mice, but lack of time has 
precluded further investigation in this area.
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DISCUSSION
Animal experiments have to be performed in order to study the 
biology of an infectious agent and especially if control strategies or 
vaccines need to be evaluated. The use of a model is also a valuable 
testing ground in investigating the feasibility or the likely success 
of different control strategies before they are evaluated on a large 
scale in the natural host.
An IF diagnostic test for the detection of BCV in the respiratory
tract was developed using a rabbit anti-BCV serum. The specificity of
this test was confirmed by a blocking assay and by the use of a 
monoclonal anti-BCV antibody. Further confirmation was obtained by 
virus isolation on TOC from nasal swabs. This rapid and simple
diagnostic test is a very useful addition to the techniques designed to
identify BCV infections and has recently been used for detecting BCV in 
the respiratory tract but is not widely used as a diagnostic tool 
(McNulty and Allan, 1984; Reynolds et al, 1985).
The gnotobiotic calf experiment confirmed the pathogenicity of BCV 
and showed it to infect both the enteric and respiratory tracts. A high 
fever accompanied profuse diarrhoea and virus excretion in faeces and 
nasal swabs. A serological response to this virus was also detected. 
This calf was given a second O/IN inoculum at the age of 26 days. The 
high serum antibody titre seemed to protect this calf against the 
challenge dose and no diarrhoea or other symptoms were seen. No virus 
was excreted in the faeces but virus was detected in nasal swabs for 
11 days subsequently. This persistent asymptomatic shedding of the 
virus from the respiratory tract may prove important 
epidemiologically.
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When this calf was hyper immunised intramuscularly with a peplomer 
protein preparation, no increase in neutralizing or haemagglutination 
inhibiting antibody titre was detected. This may have been an
indication that extracted peplomer protein was not immunogenic. 
Alternatively, the extraction procedure may have been unsuccessful and 
failed to provide pure peplomer protein and therefore no boost in
antibody titre was detected.
The pathogenicity of this virus to colostrum fed calves was 
investigated. These calves were shown to have a high colostrum-derived 
serum antibody titre to BCV before O/IN inoculation. None of the calves 
developed any enteric or respiratory clinical signs. No fever and no 
virus excretion in the respiratory tracts were detected, although BCV 
was excreted in the faeces of calves inoculated with the faecal SI 
strain. Alhtough many measures were taken to exclude other enteric 
pathogens from the rooms where these calves were housed, rotavirus was 
excreted by all 4 calves. This virus may have been present in the 
calves when they were bought.
The two faecal strains SI and S2 did not cause any significant 
changes in the gnotobiotic lambs. One of 2 lambs inoculated with the
cell culture CK strain did excrete virus in the faeces 3 to 5dpi but
showed only mild diarrheic symptoms and no respiratory symptoms nor 
virus in nasal swabs. On passage into another gnotobiotic lamb, BCV 
was no longer detected but CVLP were seen. This lamb died after a mild 
diarrheic episode. No definite cause of death could be identified but 
the CVLP were successfully but asymptomatically passaged two more times 
in gnotobiotic lambs. The CVLP could not be grown in TOC or HRT 18 cell 
culture and were shown to be serologically distinct from BCV as they
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did not react with anti-BCV sera in the ISEM or the IGEM tests. BCV 
were not successfully serially passaged in gnotobiotic lambs but the 
CVLP which suddenly appeared could be successfully passaged. The source 
of these particles could not be identified. They may have been present 
in the lambs before they were inoculated. This is unlikely, however, 
since these particles could not be seen in any samples taken prior to 
inoculation or in samples taken more than 7dpi. It is also unlikely 
that these particles were present in the original cell culture inoculum 
since these particles could not be adapted to grow in cell culture 
again. Due to the constraints of time and expense, it was decided to 
abandon the lamb model and the study of CVLP.
Effort was then concentrated on the development of a mouse model. 
Coronaviruses, including BCV, have been grown in the brains of newborn 
mice by intracerebral inoculation (Akashi et al, 1981). If BCV could 
be adapted to infect the enteric tract of newborn mice, a very valuable 
model would be available for studying various aspects of the immunology 
of this virus. The use of such a model for studying rotavirus 
infections has proved a valuable asset (Offit et al, 1984) and may well 
prove to be so for BCV. Using faecal or cell culture BCV caused 
diarrhoea in some newborn mice. Control negative faeces and cell 
culture fluid did not give rise to any symptoms. A non-specific 
effect, presumably toxic, gave rise to diarrhoea when
ultracentrifugation of control cell cultures was used. This virus model 
however is still in the early stages of development. BCV has only been 
detected in the faeces of 3 diarrheic mice. In order to prove that BCV 
infected the mouse gut, virus should be isolated back from the mice and 
viral replication demonstrated, for example by immunofluorescence
staining and sequential passaging. Histopathological and serological 
evidence would also be required before one could be confident in using 
this model.
CHAPTER V
SEROLOGICAL COMPARISON 
OF BCV STRAINS
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INTRODUCTION
Some members of the Coronaviridae are serologically assignable to a 
small number of groups. The coronaviruses TGEV, FIPV, CCV and HCV-229E 
form one group (here named group A) . The MHV, RCV and SDAV 
coronaviruses form another group (Bl) which is related to the group 
containing HCV-0C43, HEV and BCV (group B2). The IBV, FECV, CV777 
and TCV coronaviruses were found to be unrelated to any of the above 
groups and to each other (Pensaert et al, 1981; Patel et al, 1982; 
Wege et al, 1982; Brian et al, 1983; Huang et al, 1983; Gerna et al, 
1985).
There has been no extensive serological comparison of different 
strains of BCV or investigations into the extent of their relationship 
with other members of group B2. There have been a few limited 
comparisons between selected isolates. The M strain and the PQ strain 
were found to possess similar physicochemical and biological properties 
(Dea et al, 1980), but differed antigenically by counterimmuno- 
electrophoresis and immunodiffusion techniques (Dea et al, 1982). Four 
British isolates (1 from the enteric tract and 3 from the respiratory 
tracts) were compared by a neutralization test using antisera to three 
of these isolates raised in pigs. There was complete virus 
neutralization in tests with homologous sera and significant 
cross-reactions with the other isolates (Reynolds et al, 1985) 
indicating one serotype. At the molecular level, slight variation in 
the molecular weights of the structural proteins of different BCV 
strains has been reported (Hajer and Storz, 1979; Laporte and 
Bobulesco, 1981; Deregt et al, 1983; Deregt et al, 1987).
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A more comprehensive serological comparison of different BCV strains 
is required in order to investigate possible variation. This knowledge 
is essential if an effective immunological control strategy is to be 
implemented.
Comparison of BCV strains with related members of group B2, e.g. 
HCV-0C43, would also yield useful information.
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MATERIALS AND METHODS
Viruses:
The M, PQ, CK, SI and S2 strains of BCV were biologically cloned and 
grown in HRT 18 cells as described earlier.
The human coronavirus 0C43 was kindly supplied by Mr G Winters of 
the City Hospital, Edinburgh. This virus had been passaged in newborn 
mice by intracerebral inoculation. A 1/100 mouse brain homogenate in 
PBS was treated with lOugml ^ trypsin and inoculated onto HRT 18 cells.
This virus was adapted to this cell line by 5 passages; and was
detected in cells by IF using ovine anti-BCV/Sl serum.
Rabbit Polyclonal Antisera:
Each of the six virus strains was pelleted by ultracentrifugation. 
Antiserum to each was raised in a rabbit by intramuscular inoculation 
of virus pellet emulsified in Freunds Complete Adjuvant (FCA). After 4 
weeks, each rabbit received an intramuscular boost of the same virus
pellet in FIA, and was bled out under anaesthesia 2 weeks later.
Mouse Monoclonal Antibodies:
On day 0, two groups of 10 female 6 week old balb/c mice received
lOOul intraperitoneally (IP) of the BCV/M and S2 pellets in FCA. On
days 30 and 152 the mice received a booster injection of lOOul IP of
the respective BCV pellets in FIA. At fortnightly intervals from
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day 206, one mouse on each occasion received an intravenous (IV) 
inoculum of BCV pellet without any adjuvant. Three days after the IV 
boost, the mouse was killed and the spleen aseptically removed for 
fusion.
Cells were removed by grinding the spleen between sterile glass 
slides. These cells were washed twice in PBS at 37°C and the live cells 
counted. The mouse myeloma NSO cells, in the log phase of growth, were 
also harvested, washed twice in PBS at 37°C and the live cells counted. 
Cells were mixed together in the ratio of 2 spleen cells to 1 NSO cell 
and cells of each type were also kept back to be used as controls for 
the hypoxanthine-amniopterin- thymidine (HAT) medium which only allowed 
the growth of hybrid cells. The mixture was centrifuged at 1,200rpm for 
5 min on a bench centrifuge. Polyethylene glycol (PEG) solution was 
made up as 50% PEG 4000 in RPMI 1040 (no serum) and adjusted to pH 9.0 
by 2M Tris. One ml of PEG solution at 37°C was allowed to drain down 
the side of the vessel onto the cell mixture pellet over 2 min. The 
cells were resuspended by gentle swirling and a stop-watch was started. 
At 2 min the cells were centrifuged at 700rpm for 5 min. At 8 min, 5ml 
of RPMI medium (no serum) was added very gently over 2 min without 
disturbing the pellet. This pellet was gradually resuspended by gentle 
swirling over 4 min. The cells were then centrifuged at l,000rpm for 5 
min and the supernatant fluid removed. Five ml of HAT-RPMI medium 
containing 15% FBS was added slowly without disturbing the pellet. The 
pellet was left for 7 min and then resuspended by gentle swirling.
HAT-RPMI medium (with 15% FBS) was then added to a final cell
6 -1 concentration of 2x10 cells ml
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The centre 60 wells of 96-well microtitre plates were primed with
lOOul per well of mixed thymocyte medium (MTM) in HAT-RPMI medium
containing 15% FBS (l:3v/v). This acted as a feeder layer for the
fused cells. The fused cells were then seeded out into the centre 60
wells of the primed plates (lOOul per well). Spleen and NSO cell
controls were also included. Four to six plates were usually obtained
from each fusion. The plates were incubated at 37°C in a CO^ incubator
and not moved for one week, and were then examined for the presence of
hybridomas. Care was taken to ensure the survival of hybrid cells by
regular maintenance and medium replacement when acidity was detected.
When hybridoma cells covered a large proportion of a well, the
supernatant fluid was screened by IF, HAI and neutralization test (NT)
for anti-BCV activity using the homologous strain. Positive hybridomas
were cloned by three terminal dilutions and expanded by passage from a
2
96-well plate to a 12-well plate (Costar) and then to a 25cm tissue 
culture flask (Costar). A proportion of the cells was frozen down in 
liquid nitrogen in order to provide a back-up. Ascites was produced by 
injecting 10 cloned hybridoma cells per mouse IP into 8 week old male 
balb/c mice which had been primed 2 weeks earlier with 0.5ml pristane 
(2,6,10,14-tetramethylpentadecane) IP. Ascitic fluid was collected from 
10 days later by puncturing the peritoneal cavity with a 20-guage 
needle. The fluid was collected into sterile glass bijoux bottles each 
containing lOOul of heparin sodium l,000units ml ^ (Evans Medical Ltd) 
and clarified by light centrifugation (500g for 10 min at 4°C) and 
stored in aliquots at -20°C.
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Cross Immunofluorescence Test:
Microtitre plates containing confluent monolayers of HRT 18 cells
3
were inoculated with 10 TCID50 per well of each virus strain, incubated
at 37°C for 2 days, washed twice with PBS and fixed in acetone.
Doubling dilutions of each serum sample were added in duplicate to the 
fixed cells. After a half hour incubation at 37°C, the plates were 
washed twice in PBS and the appropriate FITC conjugate added. IF titres 
were recorded as the highest dilutions to provide clear fluorescing 
cells when compared to uninoculated controls.
Cross Haemagglutination Inhibition Test:
The HAI test was performed as described in Chapter II. Each serum
sample was kaolin extracted, treated with rat erythrocytes and
complement inactivated. Each virus was used at a standard dilution of 8 
HA units. Serum samples were double diluted in duplicate and reacted 
with the virus. The highest titres to completely inhibit the HA 
activity of 8 HA units of virus were recorded.
Cross Neutralization Test:
Each serum sample was titrated in duplicate against each of the 5 
BCV strains and the HCV-OC43 as described in Chapter III. This test was 
repeated using all the sera and all the virus strains in order to 
provide a replicate set of results.
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RESULTS
Adaptation of HCV-0C43 to HRT 18 Cells:
After 3 blind passages in HRT 18 cells the HCV-0C43 was adapted to
further passage in this cell line (table 18). Two further passages were
5 -1performed and a titre of around 10 TCID^Qml was obtained. No CPE was 
detected at any stage and the use of trypsin was essential for virus 
replication.
Rabbit Antisera:
Polyclonal rabbit sera against each of the six strains was raised 
(table 19). The initial HA titre in the inoculum did not directly 
relate to the antibody titres produced.
Monoclonal Antibodies Against BCV:
Six fusions were performed with mice which had received the M strain 
of BCV. Four of these fusions failed to provide hybrid cells. One 
successful fusion was lost due to a CO2  incubator failure over a 
weekend, and another fusion provided hybridomas but none of the 
supernates possessed HAI, IF or virus neutralizing activity against the 
homologous strain.
A further five fusions were performed by Miss Iris Campbell (MRI). 
Four fusions with the M strain were negative for anti-BCV activity but 
the fifth with an S2-immunised mouse was successful. Around 150 wells 
were found to contain hybridomas, and 19 of these were positive by at
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Table 18:
Adaptation of HCV-0C43 to HRT 18 cells.
Table 19:
Raising polyclonal rabbit antisera to 
coronavirus strains.
the
OC43 passage HA titre Log TCID^qIhI ^
1 4 <1.,8
2 <1 <1.•8
3 <1 2.,8
4 16 5..1
5 32 4.,8
Virus HA titre of the 
pellet inoculum
Homologous Neutralization titre 
initial titre final titre
M 10,240 <10 5,120
PQ 40,960 <10 5,120
CK 10,240 <10 20,480
SI 10,240 <10 640
S2 20,480 <10 5,120
0C43 1,600 <20 2,560
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Table 20:
Characteristics of early hybridomas to BCV/S2.
Table 21:
The ability of MAB/S2/1 and MAB/S2/2 to capture 
the different coronavirus strains in an ISEM test.
Number of hybridomas Status
3 NT+,IF+,HAI+
6 NT+,IF+,HAI-
1 NT+,IF-,HAI-
9 NT-,IF+,HAI-
NT: neutralization, IF: immunofluorescence, HAI: haemagglutination- 
inhibition, +: positive, -: negative
Monoclonal Antibody Number of Virus Particles in 10 grid squares
M PQ CK SI S2 0C43
MAB/S2/1 30,310 4,240 25,410 7,840 18,730 12
MAB/S2/2 1,580 301 470 590 219 4
Anti-rotavirus 143 82 57 103 124 25
mleast one of these three screening tests (table 20). Due to time
limitations, it was decided to concentrate on two hybridomas in this
study. One had the characteristics NT+, IF+, HAI+ and another was from
the NT+, IF+, HAI- group. These hybridomas were cloned, expanded and
ascites produced by Miss Iris Campbell and were named MAB/S2/1 and
MAB/S2/2 respectively. The other positive hybridomas were stored in
liquid nitrogen for future use. Ascitic fluid of MAB/S2/1 and MAB/S2/2
-1
contained 11.4 and 15.3mgml protein respectively.
ISEM was performed using ascitic fluid containing MAB/S2/1, MAB/S2/2 
and an anti-rotavirus monoclonal antibody as a control at dilutions of 
1/100 using the 5 BCV strains and the HCV-0C43 (table 21). MAB/S2/1 was 
found to have a higher affinity for all the BCV strains than MAB/S2/2. 
Neither of the S2 monoclonal antibodies reacted with the HCV-0C43 in 
ISEM but captured all the BCV strains approximately equally. The 
control monoclonal antibody did not react with any of the viruses 
confirming the specificity of reaction.
Comparison of Strains:
In the comparison studies replicate results were obtained in each 
case. Most of these replicate titres fell consistently within four-fold 
values. The geometric mean of 2 replicate results was calculated in 
each case and quoted in the results below. Strains were assumed to be 
serologically different on the basis of a 20 fold or greater 
difference between homologous and heterologous titres. The antigenic 
relationship (R) between the strains was calculated by a slight 
modification of the method of Archetti and Horsfall (1950), using the
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formula:
R - 100 rl x r2 %
\
where rl = heterologous titre (strain 2) / homologous titre (strain 1)
and r2 = heterologous titre (strain 1) / homologous titre (strain 2)
A high R value indicated a close degree of relatedness. A value of 
R<5% was assumed to show antigenic distinction between two strains, as 
this R value corresponded to a 20 fold reciprocal difference between 
homologous and heterologous titres. This value (5%) was severe in the 
light of 10-32% used in differentiating between types and subtypes of 
foot-and-mouth disease virus (Forman, 1975).
Immunofluorescence Test:
Using the IF test, the 5 BCV strains and the HCV-0C43 strain could 
not be significantly distinguished by the polyclonal antisera (tables 
22 and 23). None of the R values fell below or equalled 5%.
Using the monoclonal antibodies against BCV/S2 in this test however
enabled the HCV-0C43 to be clearly distinguished (table 22). Both 
monoclonal antibodies had >20-fold lower IF titres with M and SI than 
with homologous strain S2, and MAB/S2/2 in addition had a 32-fold lower 
IF titre with strain CK.
Haemagglutination Inhibition Test:
The results of the HAI test are shown in tables 24 and 25. Using the 
polyclonal antisera, the HCV-0C43 was assigned to a different serotype 
(R<5%) to BCV/PQ, CK and S2. The R values of the HCV with the BCV/M and
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Table 22:
Mean IF titres with coronavirus isolates.
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Table 23:
Mean IF titres with coronavirus isolates + R% 
using polyclonal antisera.
Coronavirus _____________ Antiserum to Coronavirus_______
M PQ CK SI S2 0C43
M 100
PQ 35 100
CK 21 100 100
SI 50 118 71 100
S2 21 100 59 59 100
OC43 15 84 30 30 50 100
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Table 24:
Mean HAI titres with coronavirus isolates.
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Table 25:
Mean HAI titres with coronavirus isolates + R% 
using polyclonal antisera.
Coronavirus _____________ Antiserum to Coronavirus_______
M PQ CK SI S2 OC43
M 100
PQ 70 100
CK 21 18 100
SI 15 5 5 100
S2 18 30 84 21 100
OC43 9 5 4 6 4 100
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SI strains were 9 and 6% respectively. These low R values indicated a 
considerable serological difference between HCV-0C43 and all BCV 
isolates. Within the BCV strains, distinct serological differences 
were detectable by the HAI test between the SI and the PQ and CK 
strains.
Using the HAI positive monoclonal antibody to the S2 strain, very 
marked differences were detected between the human and bovine viruses. 
Within the BCV strains, MAB/S2/1 reacted with all the strains. Its 
reaction with the BCV/S1 however was 16 fold lower than with the 
homologous strain (table 24).
Neutralization Test:
The neutralization results are shown in tables 26 and 27. Using the 
polyclonal antisera to the BCV strains, the human coronavirus was 
easily distinguished from the BCV/M, PQ and CK strains. The R values 
of HCV-OC43 with the SI and S2 strains were 7 and 11% respectively, 
which reflected considerable antigenic differences. Within the 5 
bovine strains, no significant or serotypic differences could be 
detected using the polyclonal antisera.
Using the monoclonal antibodies however, differences were detected. 
The MAB/S2/1 could clearly distinguish between M/PQ/S2 on the one hand 
and CK/S1 on the other, while MAB/S2/2 neutralized all 5 strains of BCV 
to a similar extent. Additionally, both monoclonal antibodies clearly 
differentiated the HCV-0C43.
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Table 26:
Mean neutralization titres with coronavirus 
isolates.
Vi
ru
s 
An
ti
bo
dy
 
to 
St
ra
in
CMCO
CQ
o
CMm
oIX)
CM
CM
O
O
vO
O
Ovo
om
0
01
o
o
i— i
V
o
orH
CO 
i— I
o
o
CMr^
o
o
i— i
V
o
o
1— I
V
o
o
CM
r-*
o
o
CO
o
o
o
CM
oi—i
V
vo
CM
CM
O
VO
o
T—I 
CO
CMCO
o
00
CM
o
I— I 
00
o
CM
vo
o
VO
o
CM
VO
CMm
<!■
o
VO
o
VO
CMml
<n
CMm
<r
o
CM
O
o o o O o O
00 »—1 vo
CM CM 00 in
* •V •0
r^- O
r—1
o
CM
!—1 CM
O'P4
O O o o o VO
i—1 CM CM 00 00 m
00 i—1 VO CM CM
tH in co i—1
o
VOin
in
oo\
o
rH
00
CMm
< 1-
o
VO
O'P-i
CM
CO
CO
o
o
139
Table 27:
Mean neutralization titres with coronavirus 
isolates + R% using polyclonal antisera.
Coronavirus _____________ Antiserum to Coronavirus_______
M PQ CK SI S2 0C43
M 100
PQ 35 100
CK 50 59 100
SI 42 59 35 100
S2 30 35 35 42
OC43 0.8 0.5 0.2 7 100
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DISCUSSION
Polyclonal antibodies are directed against many different epitopes 
on the virus proteins. Differences may be masked as only a proportion 
of the virus epitopes need remain constant for the antiserum to react 
with the virus. This can be highlighted in the case of BCV by the 
haemagglutinin and peplomer proteins, both of which elicit
neutralizing activity (Deregt and Babiuk, 1987). In a neutralization 
test, any differences in the haemagglutinin would not be detected using 
polyclonal antiserum, if the peplomer protein remained unchanged. This 
also applies in the case of different epitopes on one protein.
Monoclonal antibodies however can often be too specific. Very slight 
differences may be detected by these antibodies but may have no 
biological significance. Alternatively, the monoclonal antibodies may 
be directed against a common antigen and may not detect important 
differences between strains.
For these reasons both monoclonal and polyclonal antibodies were 
used in a variety of serological tests to determine the extent of
differences detween isolates.
The five strains of BCV and a closely related human coronavirus were 
compared by an immunofluorescence test, a haemagglutination inhibition 
test and a neutralization test using polyclonal rabbit antisera to each 
of the viruses and 2 monoclonal antibodies to the S2 strain. One of 
the monoclonal antibodies was probably directed against the
haemagglutinin protein while the other may have been directed against
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the peplomer protein (since it had no HAI activity but was NT 
positive), but this has yet to be confirmed. Both of these proteins 
are located on the outer surface of the virion and would be expected to 
react in the IF test.
One-way interactions occurred in these comparative tests but were 
difficult to explain. Variation between the individual animals used to 
produce the antisera may have played a role in determining the extent 
of such one-way reactions. The use of R values for antigenic 
relationships helped in the interpretation of results while taking into 
account such interactions.
The immunofluorescence test using the polyclonal antisera could not 
distinguish between any of the bovine or human strains indicating that 
all these viruses possess at least one common or similar epitope 
recognisable by these polyclonal antibodies. Using the monoclonal 
antibodies in the IF test, the HCV-0C43 was easily distinguishable. The 
MAB/S2/1 and MAB/S2/2 also detected some differences between M/CK/S1 
and PQ/S2 in this test. The significance of these differences was 
unclear since no other monoclonal antibodies were available to perform 
reciprocal tests.
The HAI test provided information regarding the haemagglutinin of 
the different strains although stearic hinderance may have also played 
a role. The polyclonal antisera showed that the haemagglutinin of 
HCV-OC43 differed considerably from that of the bovine strains. This 
was confirmed by MAB/S2/1. The HAI test showed that the PQ and CK 
strains belonged to a different serotype to the SI strain.
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The neutralization test yielded more information regarding the 
grouping of these coronaviruses. With the aid of polyclonal antibodies 
the HCV-0C43 could be considered a different serotype to M, PQ and CK. 
The SI and S2 strains were found to be more closely related to the 
HCV-OC43 although the SI and S2 antisera clearly distinguished the 
human strain. No major serotypic differences could be detected between 
the 5 BCV strains while using polyclonal antisera. When MAB/S2/1 and 
MAB/S2/2 were used, the BCV/S2 strain could be clearly differentiated 
from 0C43 confirming the results obtained with the S2 polyclonal 
antiserum. The anti-S2 monoclonal antibody MAB/S2/2 could not 
differentiate between the 5 BCV strains indicating that they shared 
this epitope. The anti-S2 haemagglutinin monoclonal antibody MAB/S2/1 
could not distinguish between the haemagglutinin proteins of M,PQ or S2 
but marked differences were detected in the haemagglutinin of the CK 
and SI strains. This result confirmed the serotypic difference obtained 
with the PQ and SI strains in the HAI test using polyclonal antisera.
Using the IF and neutralization tests therefore, the five BCV 
strains were closely related and belonged to one serotype since very 
few differences could be detected between them using polyclonal 
antisera. Using the HAI test however the SI strain was found to belong 
to a different serotype to the PQ or CK strains. The highly specific 
monoclonal antibodies could not differentiate between the 
haemagglutinin of the M, PQ and S2 strains, but the CK and SI
haemagglutinin was different to that of the others. No difference in
the five BCV strains was detectable with the MAB/S2/2 monoclonal 
antibody other than by the IF test when the CK, SI and M strains
reacted more than 20 fold less effectively than with the S2 strain.
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These monoclonal antibodies also differentiated the HCV-0C43 strain by 
all three tests while the polyclonal antisera could not differentiate 
0C43 by the IF test but could generally do so by HAI and NT. Some cross 
reaction occurred with the anti-0C43 antiserum and the SI and S2 BCV 
strains in the NT probably due to the polyclonal nature of the serum. 
The HCV-0C43 was confirmed to belong to a different serotype from M, PQ 
and CK but showed some similarities with the SI and S2 strains.
CHAPTF.R VT
MOLECULAR BIOLOGY 
OF BCV
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INTRODUCTION
All coronaviruses possess at least 3 structural proteins : the
nucleocapsid (N: 50-60KD) protein; the matrix (M: 20-35KD)
glycoprotein; and the peplomer (P: 170-200KD) glycoprotein. In addition 
some coronaviruses including BCV and HCV-0C43 possess an additional 
haemagglutinating (H: 100-140KD) glycoprotein (Sturman and Holmes,
1983). The P and H proteins may be reduced in the presence of 
2-mercaptoethanol to subunits of molecular weight ranging between 
100-125 and 60-70KD respectively.
There has been some disagreement over the exact number and molecular 
weight of the structural proteins of BCV (Hajer and Storz, 1979; 
Laporte and Bobulesco, 1981; Deregt et al, 1983; Hogue et al, 1984; 
Deregt et al, 1987). These differences may reflect amino acid sequence 
differences between the strains or may be due to different reducing 
conditions being used in each experiment. Since some antigenic 
differences between BCV strains have been detected, a closer 
investigation is required of the molecular weights and reactivity of 
the structural proteins with different antisera under the same 
experimental conditions. The techniques of SDS-PAGE and Western 
blotting were therefore used in conjunction with polyclonal and 
monoclonal antibodies against BCV to study its molecular biology.
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MATERIALS AND METHODS
Viruses:
The 5 BCV strains and the HCV-0C43 strain were grown in HRT 18 
cells. In addition, BCV/S3 was also used in some experiments. Virus 
pellets of each of these viruses and a control HRT 18 cell pellet were 
obtained by ultracentrifugation.
Antisera:
Rabbit polyclonal antisera to these viruses (except BCV/S3) and 2 
monoclonal antibodies to BCV/S2 were used. Sequential serum samples 
from the gnotobiotic calf experiment (Chapter IV) were also used in 
order to assess the immunogenicity of different BCV proteins.
Buffers and Solutions:
All reagents were purchased from Sigma. The buffers and solutions 
required for the gel electrophoresis and Western blotting techniques 
were made up as described in Appendix A.
SDS-PAGE:
The polyacrylamide gel electrophoresis technique utilising sodium 
dodecyl sulphate that was first developed by Laemmli (1970) was used 
throughout.
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The Bio-Rad Minigel apparatus was cleaned with methanol and 
assembled according to the manufacturer's instructions. Five ml of 10% 
polyacrylamide gel solution was introduced into the vertical plate
assembly taking care not to introduce air bubbles. One ml of the 3%
stackig gel solution was then immediately and gently layered on top. An 
appropriate comb was placed in the 3% stack and the plates were left on 
a flat surface until polymerization was complete. The comb was then 
removed and the plate assembly filled with Laemmli electrode buffer. 
Each virus pellet or the molecular weight markers were mixed with an 
equal volume of X2 sample buffer and boiled for 90 seconds. This 
mixture was loaded onto the gels. In multi-well gels 15ul was loaded 
onto each well, and in the single well gels 140ul was loaded onto the 
gel. In each case 200V was applied across each gel for 35 mins, and
the gels were then either stained with coomassie blue solution
overnight at RT and destained with several changes of destain solution 
or were electo-blotted onto nitrocellulose.
Western Blot Analysis:
The Western blotting technique of electrophoretic transfer of 
proteins from polyacrylamide gels onto nitrocellulose sheets was used 
(Towbin et al, 1979; Burnette, 1981).
A nitrocellulose sheet and 2 sheets of filter paper, slightly larger 
than the dimensions of the gel, were soaked in blotting buffer. The 
nitrocellulose paper was placed onto one of the filter papers and the 
polyacrylamide gel was placed onto the wetted nitrocellulose, taking 
care to exclude air bubbles. The second filter paper was placed on top 
of the gel. This stack was held together in an electrode assembly with 
the nitrocellulose sheet on the anodic side of the tank, which
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contained blotting buffer. A current of 0.2 A was applied overnight at 
.RT. This current allowed the molecular-weight dependent transfer of 
the separated proteins from the gel to the nitrocellulose, with the low 
molecular weight proteins transferring first. A small pump circulated
the blotting buffer around the tank. On removal from the tank, the
polyacrylamide gel (which had shrunk slightly) was stained with 
coomassie blue.
The nitrocellulose was washed three times for 5 mins with PBS
containing 0.5% Tween 20 (PBS/T). The Tween 20 acted as a blocker of
non-specific attachment sites on the nitrocellulose but allowed
subsequent immunoreactions to occur (Batteiger et al, 1982). The
proteins on the nitrocellulose were reacted with the appropriate
antiserum for lh at 37°C. The rabbit antisera and the gnotobiotic calf
antisera were used at a dilution of 1/50, and the monoclonal
antibodies at 1/400, in PBS/T. After the primary antibody reaction, the
nitrocellulose was washed three times for 5 mins in PBS/T and reacted
with a secondary iodinated probe. For mouse and rabbit immunoglobulins,
125a protein A probe conjugated to I was used. For bovine
immunoglobulins, a rabbit anti-sheep iodinated probe was used. The 
iodination of these probes was performed by Mr N. Inglis at the MRI.
The probe was diluted in PBS/T to an activity of 168KBq and was 
allowed to react with the nitrocellulose for 1 h at RT. The 
nitrocellulose was washed three more times for 5 mins in PBS/T and 
allowed to dry. The protein bands which reacted with the primary 
antibody were visualised by autoradiography using Kodak X-ray film and 
an intensifying screen at -70°C. Following autoradiography, the
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nitrocellulose was post-stained with coomassie blue in order to show 
all the protein bands and for acurate alignment of the molecular weight 
markers, the protein bands and the autoradiograph.
Dot Blot Analysis:
The seven virus pellets and the control HRT 18 cell pellet were
dotted onto nitrocelluolse in 5ul volumes. These were probed with
125MAB/S2/1 and MAB/S2/2 and visualised using I-protein A as described 
above.
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RESULTS
Molecular Weight Standards:
A curve was plotted from the molecular weight standards (figure 28), 
and was used to calculate the molecular weights of viral proteins from 
their relative mobilities.
Virus Controls:
The pellets of the BCV strains M, PQ, CK, SI and S2 contained 
approximately the same amount of virus as shown by the HA titres, but 
the pellets of BCV/S3 and HCV-0C43 contained a much lower concentration 
of virus (table 28). The protein concentration of the virus pellets 
ranged between 0.97 and 2.09mgml \
Immunogenicitv of the Different BCV Proteins:
Sequential serum samples from a gnotobiotic calf inoculated orally 
and intranasally with BCV/S1 at days 0 and 24 were reacted with 
nitrocellulose strips bearing the separated proteins of BCV/S1 (figure 
29) . The first detected reaction was with the H protein in the serum 
sample of day 14 followed by reaction with the M protein and a lower 
molecular weight protein on day 24. Reaction with the peplomer protein 
was only detected on day 34 and beyond. The control reaction of the day 
48 serum with a nitrocellulose strip containing HRT 18 cell pellet 
produced no visible bands.
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Figure 28:
Graph of the molecular weight standards.
M
o
l
e
c
u
l
a
r
 
Ul
ei
gh
t
/
K
D
200
160
120
80
40
0 0.2 0.4 0.6 0.8 1
Relative Mobility
151
Table 28:
The antigens used in the molecular studies.
Virus HA titre of pellet Protein concentration/mgml
M 20,480 1.53
PQ 40,960 1.80
CK 40,960 1.62
SI 10,240 1.66
S2 20,480 1.71
S3 160 2.09
0C43 2,560 0.97
HRT (Cell control) <10 1.31
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Figure 29:
The reaction of sequential serum samples from 
gnotobiotic calf L965 with the proteins of BCV/S1 
on nitrocellulose strips.
The number below each strip represents the day 
(post inoculum) on which the serum sample was 
taken.
: HRT 18 control strip of nitrocellulose 
reacted with the serum sample of day 48.
★  : Top of gel.
• : Dye front.
P : 190KD peplomer protein.
H : 58KD haemagglutinin.
M : 28KD matrix protein
(followed by a 20KD protein).
M-#..
m f w
8 8  75 48 4 1 34 28 17 10 3 ^
105 81 51 4 4 37 31 24 14 7 0
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Western Blotting of the SI Strain with Polyclonal Antisera:
The proteins of BCV/S1 and HRT 18 cell control pellets were 
separated by SDS-PAGE, Western blotted and reacted with convalescent 
and hyperimmune bovine antiserum to BCV. Many protein bands were 
detected in the nitrocellulose strips that were post-stained with 
coomassie blue (figure 30). On reaction of the Western blots with 
convalescent antiserum, only the proteins at 190KD, 62KD and 32KD in 
the lanes containing BCV/S1 were detected (confirming the results 
obtained in figure 29) and no bands were visible in the HRT 18 control 
lanes (figure 31). The hyperimmune antiserum detected 5 proteins: 
190KD peplomer; 62KD haemagglutinin subunit; 50KD nucleocapsid; 32KD 
and 22KD matrix proteins probably reflecting different degrees of 
glycosilation.
Dot Blot Analysis:
Using MAB/S2/1 and MAB/S2/2 on dot blots of whole virus pellets 
showed that both monoclonal antibodies reacted with the pellets of M, 
CK, PQ, SI and S2 but not with HCV-OC43 or HRT 18 cells (figure 32). No 
reaction with BCV/S3 was detected but this was presumed to have been 
due to the low virus concentration.
Western Blotting with Monoclonal Antibodies:
MAB/S2/1 reacted with a 58-62KD protein of M, CK, PQ, SI and S2 
corresponding to the H protein. No reaction was detected with S3, 
HCV-0C43 or HRT 18 cells (figure 33). This was confirmation that 
MAB/S2/1 was directed against an epitope on the haemagglutinin shared 
by the BCV strains but absent in HCV-OC43. Again BCV/S3 was presumed to 
have been present at too low a concentration.
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Figure 30:
Molecular weight markers (lane 1) and 
nitrocellulose sheets bearing the proteins of 
BCV/S1 (lanes 2, 4, and 5) and HRT 18 cells (lane 
3) post-stained with coomassie blue after reaction 
in a Western blot. Many bands appear in both cell 
control and BCV lanes.
★  : Top of gel.
• : Dye front.
Figure 31:
A) Western blot of BCV/S1 (lanes 1 and 3) and 
HRT 18 cell control (lane 2) reacted with
convalescent antiserum to BCV/S1. The P, H, and M
proteins are seen in BCV lanes but no bands are
visible in the control lane.
B) Western blot of BCV/S1 reacted with
hyperimmune antiserum to BCV/S1. The P, H, N, and 
M proteins are visible.
*  : Top of gel.
• : Dye front.
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Figure 32:
Dot blot analysis of whole virus pellets 
reacted with MAB/S2/1 (A) and MAB/S2/2 (B). Dots 
1 to 8 contained the pellets of BCV/M, CK, PQ, SI, 
S2, S3, HCV/OC43, and HRT 18 control respectively.
A 1 2 3 4
I • • •
5 6 7 8
• o o o
5 6 7 8o o o
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Figure 33:
Reaction of the fractionated viruses with 
MAB/S2/1. The nitrocellulose strips 1 to 8
contained BCV/M, CK, PQ, SI, S2, S3, HCV/0C43 and
HRT 18 control respectively. These strips were not 
aligned.
★  : Top of gel.
• : Dye front.
1 2 3 4 5 6 7 8

157
Figure 34:
Reaction of the fractionated viruses with 
MAB/S2/2. The nitrocellulose strips 1 to 8
contained BCV/M, CK, PQ, SI, S2, S3, HCV/OC43 and
HRT 18 control respectively. These strips were not 
aligned.
★  : Top of gel.
• : Dye front.
1 2 3 4 5 6 7 8
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MAB/S2/2 reacted with a 58-63KD protein on SI, S2 and HCV-OC43 
(figure 34). Although the quality of this autoradiograph was poor, no 
other bands were detected. It seemed therefore that MAB/S2/2 was also 
directed against the haemagglutinin but to a distinct neutralizing but 
non-haemagglutinating epitope. This monoclonal antibody did not react 
with any other viral proteins or with the cell culture control.
Molecular Comparisons of the BCV and HCV-0G43 Strains:
The BCV strains M, PQ, CK, SI, S2, S3, the HCV-0C43 and HRT 18 cell 
control pellets were separated on SDS-PAGE and Western blotted onto 
nitrocellulose paper. A strip of nitrocellulose containing the proteins 
of each virus was reacted with rabbit antiserum to each of the strains. 
Figures 35 to 42 represent the autoradiographs obtained with M, PQ, CK, 
SI, S2, S3, HCV-0C43 and HRT 18 cells respectively. Each figure 
contained 6 strips of nitrocellulose each of which was reacted with 
rabbit antiserum to SI, S2, CK, M, PQ or 0C43.
All the rabbit antisera reacted with a 68KD protein in the HRT 18 
cell control pellet (figure 42). The 0C43 antiserum also reacted with 
a 65KD protein in this cell control. Some other very faint bands were 
also observed with the antisera to S2 and PQ.
After close analysis of figures 35 to 42, tables 29 and 30 were 
compiled. The peplomer protein was detected in both the whole and 
reduced forms while the haemagglutinin was only detected in the reduced 
form. Slight variation was detected between the molecular weights of 
the structural proteins of the strains tested. Each antiserum reacted 
with the proteins of the viruses and the cell control in a slightly 
different manner but all BCV antisera detected 4 structural proteins
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Figures 35-42:
In the following 8 figures, the nitrocellulose 
strips 1 to 6 were each reacted with one rabbit 
polyclonal antiserum to BCV/M, PQ, CK, SI, S2 or 
HCV/OC43 respectively.
: Top of gel P : peplomer protein
• : Dye front P': reduced peplomer protein
H : haemagglutinin N : nucleocapsid
M : matrix protein.
Figures 35:
The proteins of BCV/M reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
Figures 36:
The proteins of BCV/PQ reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
1 53456• i d
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Figures 37:
The proteins of BCV/CK reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
Figures 38:
The proteins of BCV/S1 reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
1 2 3
•M
161
Figures 39:
The proteins of BCV/S2 reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
Figures 40:
The proteins of BCV/S3 reacted with polyclonal 
antisera to the 6 viruses in Western blotting.
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Figures 41:
The proteins of HCV/0C43 reacted with 
polyclonal antisera to the 6 viruses in Western 
blotting.
Figures 42:
The proteins of HRT 18 cells reacted with 
polyclonal antisera to the 6 viruses in Western 
blotting.
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Table 29:
The variation in molecular weight of different 
coronavirus strains.
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Table 30:
Cross reactions of the rabbit antisera with 
each of the proteins of the coronaviruses in 
Western blotting. The homologous reactions are 
boxed.
Virus Protein ______________________Antiserum_______________
M PQ CK SI S2 0C43
M P
H
M
N
NR
+
+
+
+
+
+
+
+
+
+
+
PQ P
H
M
N
NR
+
NR
+
NR
+
+
+
+
+
NR
+
CK P
H
M
N
NR
+
NR
+
NR
+
+
+
NR
+
+
+
NR
+
NR
+
SI P
H
M
N
+
+
+
+
S2 P
H
M
N
+
+
NR
+
+
+
NR
+
0C43 P NR NR NR NR NR NR
H + + + + + +
M NR NR NR NR NR NR
N NR NR NR NR NR NR
P: peplomer, H: haemagglutinin, M: matrix, N: nucleocapsid, 
NR: no reaction, +: reaction
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of homologous virus. All the rabbit sera, including the homologous 
antiserum, reacted with only the haemagglutinin protein of HCV-OC43 
(figure 41), probably due to insufficient virus being present as 
indicated by the low HA titre of this virus pellet. The most consistent 
antibody reactions were obtained using BCV/S1 (figure 38). The six 
antisera reacted with all the major proteins of this virus.
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DISCUSSION
Differences between BCV strains at the molecular level have not been 
fully investigated.
On analysis of sequential serum samples from a gnotobiotic calf 
experimentally infected with BCV/S1, it was noted that antibody was 
produced sequentially to H, M, and P, but no antibody production 
against the nucleocapsid protein was observed. These results implied 
that the haemagglutinin was the most immunogenic protein, and the P 
protein had a relatively low immunogenicity. This may explain why the 
peplomer preparation used to inoculate the gnotobiotic calf in Chapter 
IV failed to raise the serum neutralizing antibody titre. No 
immunogenicity was detected for the N protein.
The monoclonal antibodies against BCV/S2 reacted in dot blots with 
the whole virus pellets of BCV/M, PQ, CK, SI and S2 but not with 
HCV-OC43 or HRT 18 cells. This confirmed the results obtained with the 
IF test in Chapter V. When these viruses were fractionated and then 
reacted with these monoclonal antibodies, MAB/S2/1 reacted with the H 
protein of M, PQ, CK, SI and S2. This monoclonal antibody therefore 
reacted in Western blotting with all 5 BCV strains but not 0C43. It 
also inhibited HA activity in all BCV strains so was directed against a 
common group haemagglutinating and neutralizing epitope on the H 
protein of BCV. This monoclonal antibody neutralized 3 strains of BCV. 
MAB/S2/2 was also directed against the H protein, but only reacted with 
SI, S2 and 0C43 in Western blots. This monoclonal antibody did 
neutralize all BCV strains but not HCV-0C43 and did not inhibit HA
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activity, so was directed against a neutralizing epitope on the H 
protein. This discrepancy may have been due to the Western blotting 
technique not being fully optimised. The lack of reactivity of this 
monoclonal antibody with fractionated M, PQ and CK as compared to the 
whole virus dot blots may have been an indication that some 
antigenicity was lost by the use of SDS-PAGE.
On comparison of the structural proteins of the various strains, the 
detected pattern was similar to published data (Chapter I, table 2). 
Variation in the quoted molecular weights of each protein may reflect 
sequence differences but is more likely to be due to differing degrees 
of glycosilation in the case of the peplomer, haemagglutinin and matrix 
proteins. Minor experimental variations such as temperature and current 
may also play a role in this low level of diversity of molecular 
weights. The technique of co-electrophoresis would be expected to 
distinguish proteins of different but closely related molecular 
weights. Unfortunately the proteins of BCV have a tendency to 
co-migrate and are not likely to be distinguished by such a technique 
(Sturman and Holmes, 1983). Proteins of the same molecular weight 
however may still be antigenically very different.
The "other proteins" that were detected in virus preparations may 
have been breakdown products or aggregates of structural proteins, or 
may be cell culture products since some proteins of similar molecular 
weights were detected in the cell culture controls.
168
The BCV/S3 strain was used in some experiments but since this strain 
could not be maintained in cell culture it was excluded from further 
analysis.
When the rabbit antisera to each of the strains were used in the 
Western blots there was extensive antigenic cross reaction between each 
viral protein and each antiserum but occasional proteins were missed. 
The significance of these one-way differences however was difficult to 
interpret. There was no evidence of any consistent 2-way strain 
variation. These tests were only performed once, and the systems were 
not fully optimised. So the only conclusion from this very brief study 
was that all BCV proteins cross reacted with heterologous strains in 
Western blotting and that 0C43 H protein also cross reacted with the 
BCV strains. No conclusion was possible on 0C43 P, M or N proteins. In 
order to assess the nature and significance of the minor differences, 
a more detailed analysis such as the sequencing of the genomes of the 
different strains is required.
One consistent finding however was that using polyclonal antisera, 
no differences between the haemagglutinin of the various strains was 
detected by this Western blotting technique. This protein was also 
found to be the most immunogenic. This technique could not detect any 
differences between the haemagglutinin of the SI and PQ or CK strains 
which were shown to be serologically distinct by the HAI test. The use 
of Western blotting however does have its limitations. The 
antigenicity of the proteins may be altered in the presence of SDS or 
2-mercaptoethanol to such an extent as to not reflect their true state 
in the virion. Some differences therefore may not be detected when the 
tertiary structure of the proteins is lost.
CHAPTER VTI
EPIDEMIOLOGICAL
SURVEY
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INTRODUCTION
A prospective survey was carried out on a dairy farm during the 
calving season in order to investigate the prevalence of enteric and 
respiratory pathogens affecting young calves, with particular emphasis 
on BCV. The farm which was located some 70 miles south west of 
Edinburgh was chosen since Rotavec K99 vaccine against rotavirus and 
E. coli (K99) had been administered to all pregnant cows, because BCV 
had previously been frequently detected on this farm and because of the 
willing co-operation of the farmer and his practising veterinary 
surgeon.
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MATERIALS AND METHODS
The work of sampling animals was divided among researchers of three 
departments at the MRI. Faeces and nasal swabs were collected from 18 
calves every alternate day from birth until they were 14 to 42 days of 
age. Any respiratory (cough or nasal discharge) or enteric symptoms 
(diarrhoea) at the time of sampling were recorded on a numerical scale. 
Faecal samples were examined for rotavirus using PAGE, for
Cryptosporidium using Ziehl-Nielsen staining and for BCV by ELISA 
(Chapter III). The nasal swabs were used to detect BCV in the
respiratory tract by the immunofluorescence test (Chapter IV). Blood 
samples were collected at the beginning and end of the survey period 
and were used to detect initial and final levels of anti-coronavirus 
antibodies by the serum neutralization test (Chapter III).
The Chi-square test in 2X2 contingency tables was performed on a
computer in order to obtain "P" values. The assumption of individual 
results being unrelated to each other was made. There was considered to 
be an association between a pathogen and any clinical signs only when 
the detection of that pathogen fell within 2 days of the manifestation 
of clinical symptoms.
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RESULTS
Clinical and Diagnostic Findings:
The clinical signs and the pathogens detected in the 18 calves on 
the survey are represented in table 31.
A total of 193 faecal samples and 193 nasal swabs were collected 
from the 18 calves. All 18 calves developed diarrhoea at some time 
during the survey period. Twelve calves exhibited respiratory 
symptoms, either cough or nasal discharge. A total of 17 calves 
excreted Cryptosporidium. 9 calves excreted rotavirus and 9 calves 
excreted coronavirus. Coronavirus was detected in the respiratory tract 
of 5 calves, in the enteric tract of 1 calf and in both the enteric and 
respiratory tracts of three calves. Of the 18 animals, 14 scoured in 
association with Cryptosporidium. 1 in association with Cryptosporidium 
and rotavirus, 1 in association with coronavirus, 2 in association 
with rotavirus and coronavirus and 1 in association with all 3 
pathogens.
Coronavirus was detected in nasal swabs in 11 samples associated 
with respiratory symptoms and in 5 samples from animals not showing any 
respiratory symptoms. A total of 154 samples did not contain any virus 
and were not associated with respiratory symptoms while 23 nasal swabs 
from animals showing respiratory symptoms also did not contain BCV.
These results were represented in a contingency table:
Respiratory symptoms No respiratory symptoms 
BCV in nasal swabs 11 5
No BCV 23 154
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Table 31:
The clinical signs and pathogens detected in 
the 18 calves during the survey.
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A significant association of BCV in the respiratory tract and
respiratory disease was therefore found (P<0.001).
Similarly the contingency table for the detection of BCV in either 
the enteric or respiratory tracts and diarrhoea was as follows:
Diarrhoea No diarrhoea
BCV in respiratory or 15 9
enteric tracts
No BCV 43 126
Here again there was significant association between the detection of
BCV and diarrhoea (P<0.001).
There was no significant relationship between the detection of
rotavirus in faeces and diarrhoea (P=0.13) as shown in the following 
contingency table:
Diarrheoa No diarrhoea
Rotavirus 8 8
No rotavirus 50 127
For Cryptosporidium in faeces the following contingency table
applied:
Diarrheoa No diarrhoea
Cryptosporidium 50 8
No Cryptosporidium 19 116
In this case, there was a very significant relationship between the 
detection of Cryptosporidium and enteric disease (P«0.001).
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The assumption for this statistical test however may not hold 
entirely true, as each set of results from one animal could be 
considered related to each other. Using the Chi-square test on
unrelated individual animals rather than individual samples, then 
Cryptosporidium was still closely associated with diarrhoea (P<0.05) 
but no definite conclusions could be made about diarrhoea and either 
coronavirus or rotavirus since there were very few animals shedding 
only one pathogen when diarrheic. A larger number of animals was needed 
in order to obtain a group of animals shedding only one organism. This
was not the case for BCV in the respiratory tract, as Cryptosporidium
and rotavirus are known not to infect the respiratory tract.
Respiratory symptoms were detected in 8 of 9 calves that were BCV 
positive and in only 4 of 9 calves that were BCV negative. There was 
therefore a statistically significant association between BCV and 
respiratory symptoms (P<0.05) using the exact probability test.
A more valid statistical analysis however would use the exact 
relative risk "Re” (Schwabe et al, 1977). This measures the ratio:
R e ------------
V W
where P^ to P^ are the proportion of observations in each of the 
following categories:
Disease
Present Absent
Present P1 P2
Organism
Absent P3 P4
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and P-+Po+Po+P.=1.0 1 2  3 4
The 95% confidence interval is used to assess the statistical
association without the need to make assumptions that may not be
justified. For the detection of rotavirus in faeces, the Re value was
-41.77 and the 95% confidence interval was between 8.4x10 and 3,751. 
The value 1.0 lies well within these confidence limits indicating no 
relationship between diarrhoea and the detection of rotavirus. For the 
detection of coronavirus the Re value was 2.5 and the 95% confidence 
interval was between 0.9 and 17.4. In this case the value 1.0 just
falls within these limits. One must therefore conclude that there was 
no significant association between diarrhoea and BCV, but such an 
association might have been detected if a larger number of calves had 
been sampled.
Serology:
The virus neutralizing titres to the M strain are represented in 
table 32. The initial and final neutralization titres varied between 40 
and 640 and seroconversion was demonstrated only in calf number 7.
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Table 32:
Serology results of the field survey.
Calf number BCV/M neutralization titre in serum taken at age
2 days 14 days 28 days
1 80
2 640
3 640
4 80
5 320
6 320 160 80
7 40 <40 640
8 160
9 160
10 40
11 40 <40 40
12 160 40 80
13 <40
14 160 80 40
15 80
16 160
17 40
18 640 320 320
blank: no sample; reciprocal titres quoted
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DISCUSSION
The predominant problem on this farm seemed to be cryptosporidiosis 
as this organism was detected in 17 out of the 18 calves surveyed and 
.was closely associated with diarrhoea. This fits with previous reports 
of Cryptosporidium as a significant enteric pathogen in calves 
(Angus, 1983). Coronavirus was also isolated from both the enteric 
and respiratory tracts, and a significant association was obtained 
between BCV in the respiratory tract and respiratory symptoms but a 
statistically significant association could not be obtained between 
coronavirus and diarrhoea. This was mainly due to the complex 
interactions between several agents which made statistical analysis 
very difficult with the numbers involved. There was circumstancial 
evidence for the involvement of BCV in diarrhoea which has previously 
been shown statistically (Reynolds et al, 1985). The subclinical 
rotavirus infections in the calves were presumably due to effective 
passive immunisation (Snodgrass, 1986).
The blood samples that were collected from 18 calves at the start of 
the survey had anti coronavirus antibody titres that ranged between 40 
and 640 indicating absorption of colostral antibodies from cows 
endemically infected with BCV. Due to some animals being removed from 
the farm during the survey period, only 6 final blood samples could be 
collected. The final antibody titres against BCV again ranged between 
40 and 640 with one calf demonstrating seroconversion (a greater than 4 
fold increase in antibody titre over 2 weeks) . This was confirmation 
that at least one calf was actively infected with coronavirus. This 
calf was diarrheic and excreted detectable levels of coronavirus in its 
faeces.
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On a time course basis, the farm was visited between 2/11/87 and 
18/12/87. Cryptosporidium was mainly detected between 8/11/87 and 
30/11/87. This wave of Cryptosporidium infection was followed by a 
wave of coronavirus infection. Coronavirus was first detected on 
26/11/87 and quickly spread to other calves and was not detected beyond 
6/12/87. Within this ten day period, there were 10 calves on the survey 
and 9 of these calves were infected with coronavirus. It seemed 
therefore that BCV arrived suddenly on the farm, infected most of the 
animals that were present and disappeared soon afterwards. Rotavirus 
was detected sporadically between 10/11/87 and 4/12/87. These phases 
may have important epidemiological significance but were not 
age-related since calves were added to the survey as they were born 
throughout the period 2/11/87 to 22/11/87.
This survey reflected the importance of diarrhoea as a disease of 
neonatal calves and showed the significance of BCV in the respiratory 
tract in addition to its well established role as a cause of diarrhoea.
CHAPTF.R VTTT
GENERAL DISCUSSION
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GENERAL DISCUSSION
Several workers have noted that the progress in research on enteric 
coronaviruses in domestic animals has been slow (Siddell et al, 1983; 
Tzipori, 1985). This may be attributed to the slow recognition of 
their aetiological role in diarrhoea, due partly to the difficulty of 
adapting BCV to grow in cell culture (Storz et al, 1981; Tektoff et al, 
1983). The discovery that HRT 18 cells were permissive to the 
replication of some BCV strains (De Leeuw and Guinee, 1981) was a major 
breakthrough. However, many strains could not be adapted to replicate 
in HRT 18 cells. Bovine fetal TOC provided an alternative culture 
method, but the supply of these was inconsistent. In this study only 2 
of 25 faecal samples containing BCV could be adapted to HRT 18 cell 
culture. A larger number of strains might have been adapted to cell 
culture if more TOC had been available, or if very thorough attempts 
had been made to adapt a sample from each TOC fluid to each of the 
different cell types. For the purposes of this study the isolation of 
the two strains SI and S2 was sufficient to allow strain comparisons to 
be initiated.
Three other strains of BCV (M, PQ and CK) and a HCV-0C43 strain were 
obtained from other laboratories and were also adapted to HRT 18 cell 
culture. None of these viruses caused any cytopathic changes to the 
cell culture. The M strain caused CPE in BEK-1 cells (Inaba et al, 
1976) but no CPE was detected in HRT 18, Vero or MDBK cells infected 
with the F15 isolate (Tektoff et al, 1983). Cytopathic changes are 
therefore uncommon, and may depend on the individual strain, the cell 
type and the degree of adaptation.
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The optimum growth conditions, including the trypsin treatment and 
the growth kinetics were worked out for the M strain. A similar 
investigation utilising all the available strains may provide useful 
information about biological differences between the strains.
The production of HA activity by virus infected cells was found to 
be independent from the production of infectious virus. This was an 
indication of the production of non-infectious particles. Other workers 
have reported a ratio of infectious to non-infectious virus particles 
of between 1 in 100 to 400 (Shockley et al, 1987).
The lack of specificity and sensitivity of BCV diagnostic tests 
(Bridger et al, 1978a) has lead to an under-estimation of the spread 
and extent of coronavirus enteritis. The immunogold EM technique 
should help to alleviate this problem while the ELISA test is 
appropriate for use on large numbers of samples. The sensitivity of 
this ELISA may be improved with the use of monoclonal antibodies. The 
immunofluorescence test on nasal epithelial cells should also prove a 
valuable addition to the range of diagnostic tests since BCV also 
infects the upper respiratory tract and this test may detect virus when 
none is detectable in the faeces.
A neutralization test was developed and optimised for quantifying 
anti-BCV antibody titres. The mean specific antibody titre in the 
colostrum of a group of normal cows was found to be around 1/1,000 and 
rapidly declined to 1/80 in the day 3 milk samples. A coronavirus 
vaccine which was administered to the pregnant dams was found not to 
significantly alter these antibody levels. The live rotavirus- 
coronavirus vaccine "Calf-Guard" was also found not to increase the
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antibody level in vaccinated cows (Rodak et al, 1982). Different 
strategies therefore need to be considered for controlling BCV 
enteritis as several vaccines have been shown to be ineffective.
The experimental use of animals should always be minimised and is 
only warranted when the benefits of such work outweigh the moral 
objections. In the study of an infectious agent and its control, animal 
experiments have to be performed. The gnotobiotic calf experiment 
confirmed the pathogenicity of BCV which was detected in both the 
enteric and respiratory tracts. On a subsequent challenge with BCV, 
the calf did not develop diarrhoea or any other symptoms but excreted 
virus from the respiratory tract. This had important epidemiological 
significance since the detection of BCV in the respiratory tract should 
also be considered as potential virus in the enteric tract. The nasal 
mucous and epithelial cells are continuously shed and transported into 
the gastrointestinal tract.
On hyperimmunization of this gnotobiotic calf with a peplomer 
protein preparation, no substantial increase in antibody level was 
detected. The low immunogenicity of the peplomer protein was shown by 
the Western blotting experiment utilising sequential serum samples and 
may have played a role in the lack of reactivity obtained here. 
However, no confirmation of the extraction procedure was performed and 
the absence of a boost in the antibody titre may have been due to the 
peplomer preparation lacking the peplomer protein. Such confirmation 
could have been obtained by Western blotting analysis of the extract 
but was not performed due to lack of material.
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The colostrum fed calves were not symptomatically infected with BCV 
but did excrete the virus in the faeces. In the field such 
asymptomatic shedding may play an important role as a source of 
infection to other susceptible calves.
The gnotobiotic lamb experiments had only limited success. The cell 
culture CK strain caused virus excretion but no symptoms in 1 of 2 
lambs. This strain could not be further passaged in more gnotobiotic 
lambs but CVLPs were detected. A more detailed study of these CVLPs 
may provide information regarding the source and nature of these 
particles and their relationship to BCV.
A small animal model of BCV infection would contribute immensely 
towards the study of this agent and towards reducing the number of 
large animals used for experimentation. Preliminary results showed that 
faecal and cell culture BCV could cause diarrhoea in newborn mice. A 
more detailed investigation however into the histopathology and 
serology of infected mice is required before one can be confident of 
this model.
In the serological comparisons of the BCV strains and with HCV-0C43, 
no differences were detectable by the IF test using polyclonal 
antisera. Using monoclonal antibodies in this test, the human virus 
was distinguishable from the bovine viruses. Using the HAI test, both 
the polyclonal and monoclonal antibodies could differentiate between 
the human and bovine viruses. Additionally the HAI test serologically 
distinguished between the SI strain and the PQ or CK strains. In the 
neutralization test, the polyclonal antisera showed the 5 BCV strains 
to belong to one serotype and the HCV-OC43 to another. However the SI
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and S2 strains were found to be more closely related to HCV-OC43 than 
the M, PQ or CK strains. The monoclonal antibody MAB/S2/1 neutralized 
the M, PQ and S2 strains equally but failed to neutralize the CK, SI or 
the 0C43 strains. This may aid in the sub-grouping of bovine 
coronaviruses. A more detailed investigation into the differences 
between the BCV strains should be performed using a larger panel of 
monoclonal antibodies against many different epitopes and against 
different strains. Epitope mapping by competitive binding assays and 
the detection of hypervariable epitopes would assist in the more 
detailed sub-grouping of these viruses and in planning a means of 
controlling them.
The molecular comparisons of the coronavirus strains have shown them 
to possess structural proteins of similar molecular weights and 
antigenic reactivity. The haemagglutinin protein of all the strains 
cross reacted with all the polyclonal antisera . However, many one-way 
reactions were detected between the polyclonal antisera and the 
fractionated proteins, the significance of which was unknown. 
Cross-reactivity between the structural proteins of BCV/M and OC43 has 
previously been reported (Hogue et al, 1984) using antisera to the 
structural proteins of BCV/M. A fuller molecular investigation such as 
genome sequencing and comparison of the different strains would provide 
valuable information about the exact nature of any differences. Such 
studies are currently underway in different parts of the world (Lapps 
et al, 1987; Cruciere and Laporte, 1988).
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The two monoclonal antibodies that were used were shown to be 
directed against different epitopes on the H protein. MAB/S2/1 reacted 
with the H protein of the 5 BCV strains but not with that of OC43. 
MAB/S2/2 however reacted with SI, S2 and 0C43 confirming the 
relationship between these 3 viruses which was first shown 
serologically. The use of more monoclonal antibodies in such molecular 
studies and in radio-immunoprecipitation experiments is also likely to 
yield more helpful data.
When a prospective epidemiological survey was carried out, diarrhoea 
was shown to affect all of the 18 newborn calves on the survey. This 
diarrhoea could be associated with Cryptosporidium but not with BCV or 
rotavirus. BCV could be associated with enteric symptoms if the 
Chi-square test was used but this could not be statistically validated 
using the relative risk test due to the low numbers of animals used and 
due to the appearance of other enteric pathogens. BCV infections were 
confined to a short time period during which most animals on the survey 
shed the virus. The detection of BCV however was not age related. Due 
to the complex nature of the interactions of pathogens and the low 
number of animals on the survey, a full statistical analysis could not 
be carried out. This survey reflected the importance of diarrhoea as a 
disease of young calves and although no deaths were reported, a loss in 
weight and a reduced growth rate may have occurred in some of the 
calves. All the calves on this survey received colostrum soon after 
birth and this may have protected them from a more severe diarrhoea.
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Only mild respiratory symptoms were detected during the survey period 
but these symptoms were significantly associated with the presence of 
BCV in the respiratory tract. More detailed surveys incorporating a 
larger number of animals and concentrating on the interactions of 
different pathogens and on environmental conditions would provide 
useful information towards the control of neonatal calf diarrhoea.
The role of BCV in winter dysentery was not investigated in this 
study but this is another area requiring further research.
Many of the aims of this project have been fulfilled but many more 
questions have been posed and warrant more research. Some improvements 
have been made in the culture and diagnosis of BCV infections as well 
as in the epidemiology and molecular biology of this virus. 
Serological and antigenic differences between the various strains have 
been shown. Many more benefits could still be obtained from more 
detailed investigation into genome sequencing, comparison of the 
strains using more monoclonal antibodies and attempts at perfecting the 
mouse model.
Since the haemagglutinin protein of BCV was found to be the most 
immunogenic of the structural proteins and bears epitopes that are 
conserved among the strains, it may prove fruitful to utilise this 
protein in a control strategy.
APPENDIX A
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APPENDIX A
Stacking gel buffer:
Trisma base 3.03g
Sodium dodecyl sulphate 0.2 g
Distilled water (DW) to 100 ml
The pH was adjusted to 6.8 with concentrated HC1.
Laemmli gel buffer:
Trisma base 18.16g
Sodium dodecyl sulphate 0.4 g
DW to 100 ml
The pH was adjusted to 8.8 with concentrated HC1.
X4 sample buffer:
Stacking gel buffer 5.0 g
Sucrose 4.0 g
DW 2.48g
Bromophenol blue 8 mg
X2 sample buffer:
X4 sample buffer 1 ml
10% sodium dodecyl sulphate 400 ul
2-mercaptoethanol 80 ul
DW 520 ul
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Laemmli eletrode buffer:
Tris 7-9 15.14g
Glycine 72.09g
Sodium dodecyl sulphate 5.0 g
DW to 500 ml
The pH of this buffer should be 8.3
Blotting buffer:
Tris 7-9 
Glycine 
Methanol 
DW
12 g 
57.65g 
1000 ml 
to 5000 ml
The pH of this buffer should be 8.3.
Coomassie blue solution for gels:
Coomassie blue (R) 0.2 g
100% trichloroacetic acid 5 ml
Glacial acetic acid 37 ml
Methanol 250 ml
DW to 500 ml
Coomassie blue destain solution for gels:
Glacial acetic acid 70 ml
Ethanol 230 ml
DW to 1000 ml
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Coomassie blue destain solution for nitrocellulose:
Glacial acetic acid 
Methanol 
DW
This solution was not allowed to react with the nitrocellulose for 
longer than 5 minutes.
Coomassie blue solution for nitrocellulose:
Coomassie blue solution for gels 
Coomassie blue destain for nitrocellulose
30% acrvlamide stock solution:
Acrylamide 250 g
N,N'bis-methylene acrylamide 6.72g
DW to 833 ml
This solution was filtered through a Whatmann filter in order to 
remove particles in suspension.
10% nolvacrvlamide gel solution:
30% acrylamide stock solution 6.5 ml
Laemmli gel buffer 5 ml
Sucrose 1 g
DW 8.03 ml
This solution was degased under vacuum and polymerization initiated 
by adding lOul of tetra-methyl-ethylene-diamine (TEMED) and 50ul of 10% 
ammonium persulphate.
4 ml 
96 ml
5 ml 
30 ml 
to 100 ml
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3% polyacrylamide stacking gel solution:
30% acrylamide stock solution 1 ml
Stacking gel buffer 5 ml
DW 4 ml
This solution was also degased and polymerization initiated by 
adding lOul of TEMED and 50ul of 10% ammonium persulphate.
Molecular weight markers:
The following molecular weight markers were used:
 Protein  Molecular weight / KD
a-Lactalbumin 14.2
Carbonic anhydrase 29
Ovalbumin 45
Bovine serum albumin 66
B-phosphorylase 97.4
B-galactosidase 116
Myosin 205
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Summary
A solid phase colloidal gold immunoelectron microscopy (IGEM) technique for 
detecting bovine coronavirus (BCV) was developed and shown to be specific. This 
test was compared with three other diagnostic tests using fifteen faecal samples. 
Bovine coronavirus was detected in 2 samples by direct electron microscopy 
(DEM), in 3 samples by immunosorbent electron microscopy, in 5 samples by 
haemadsorption-elution-haemagglutination and in 6 samples by IGEM. Ninety four 
faecal samples were tested by DEM and IGEM. Of 26 samples found to contain 
BCV by IGEM only 14 were positive by DEM. The IGEM technique is simple, 
efficient and less susceptible than others to non-specific reactions.
Bovine coronavirus; Immunogold; Electron microscopy, Diagnosis
Introduction
Neonatal calf diarrhoea is a syndrome of complex aetiology in which several in­
fectious agents interact with environmental influences to determine the health of 
the young calf. Bovine coronavirus (BCV) is an endemic virus known to be in­
volved in calf diarrhoea (Bridger et al., 1978; Mebus et al., 1973; Patel et al., 1982; 
Reynolds et al., 1986; Saif et al., 1986; Snodgrass et al., 1986; Stair et al., 1972), 
and has been isolated also from the respiratory tract (McNulty et al., 1984; Saif et 
al., 1986). In two recent studies BCV was detected in 4% of 302 diarrhoeic calves 
in Scotland and the north of England (Snodgrass et al., 1986) and 14% of 490 diar­
rhoeic calves in the south of England and Wales (Reynolds et al., 1986).
Correspondence to: D .R. Snodgrass, Moredun Research Institute, 408 Gilmerton Road, Edinburgh, 
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Several methods have been used to detect BCV in faeces. With direct electron 
microscopy (DEM) (Reynolds et al., 1984) it is often difficult to differentiate pleo­
morphic coronavirus particles from membranous material or other fringed bodies. 
The characteristic morphology of the core virion surrounded by a fringe of pe- 
plomers is not always apparent (Dea et al., 1981; Crouch and Acres, 1984).
An alternative method, the haemadsorption-elution-haemagglutination assay 
(HEHA) (Van Balken et al., 1978/79) relies on the virus’ selective adsorption to 
and elution from rat red blood cells at different temperatures. The HEHA occa­
sionally suffers from non-specific reactions due to the complex nature of faeces 
(Viscidi et al., 1984).
Additionally, several enzyme linked immunosorbent assays (ELISA) (Reynolds 
et al., 1984; Crouch et al., 1984) have been reported for detecting BCV but re­
quire highly specific antisera.
The detection of coronavirus antigen in cells of the infected gut using a fluores­
cent antibody technique has been described by Woode et al. (1978), but is de­
pendent on tissue being removed very shortly after death and most antigen is pres­
ent early in the course of disease. Coronavirus isolation in cell or organ cultures 
has been attempted but is also of limited value as many coronavirus strains do not 
grow readily in vitro (Bridger et al., 1978; Mebus et al., 1973).
In this paper an immunogold electron microscopy (IGEM) technique is de­
scribed which was developed in an attempt to provide a rapid sensitive test that 
would be less susceptible to non-specific reactions. Immunogold labelling has al­
ready been shown to improve the detection of faecal viruses by increasing speci­
ficity and sensitivity (Kjeldsberg, 1985; 1986).
Materials and Methods
Virus preparation
Faeces from gnotobiotic calves experimentally and separately infected with BCV 
or rotavirus were used as positive and negative control samples respectively. Fae­
cal samples were diluted 1 in 4 in phosphate buffer (PB), pH 7.2, mixed and ground 
with carborundum powder, centrifuged at 10000 x g for 3 min and the clarified 
supernatant fluid was examined for the presence of BCV.
Bovine coronavirus was also grown in vitro on fetal tracheal organ culture as 
described by Stott et al. (1976); and in human rectal tumour (HRT 18) cells as 
described by Laporte et al. (1979). Culture fluid was clarified by centrifugation at 
10000 x g for 1 min and the supernate examined.
Antisera
Antiserum was produced in a gnotobiotic calf which had been infected orally with 
BCV at 4 days of age and given an intramuscular injection of BCV in Freund’s 
complete adjuvant 4 wk later. Serum was collected 2 wk later and IgG extracted 
by affinity chromatography (Hudson and Hay, 1980). In addition, IgG from an anti- 
BCV serum produced in a gnotobiotic piglet was extracted by ion exchange chro­
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matography (Hudson and Hay, 1980). The bovine and porcine sera had neutral­
ising antibody titres of 1/1280 and 1/3840 respectively and were used at a dilution 
of 1/100 in all immunosorbent electron microscopy (ISEM) and IGEM tests.
Direct electron microscopy 
Formvar carbon-coated 400 mesh copper EM grids were used throughout. A  3.5 
|xl drop of poly L-lysine was added to each grid and excess fluid was blotted with 
filter paper. A 3.5 |xl drop of fluid to be examined was placed on each grid as ap­
propriate and the excess removed with filter paper. The grids were negatively 
stained using phosphotungstic acid and ammonium molybdate (2:1).
A  set pattern of examining EM grids was adhered to in order to standardise the 
counting of virus particles and facilitate comparison between different prepara­
tions. Virus particles were counted around the 4 edges of a grid square and across 
one diagonal. A  total of ten grid squares from different areas of 2 duplicate grids 
was examined. The grids were coded and examined at a magnification of 20000 
on a Siemens Elmiskop 1A electron microscope.
Immunosorbent electron microscopy
Copper EM grids were floated on a 10 (j l I drop of bovine anti-BCV IgG on a 
block of dental wax and incubated. The grids were then washed twice in PB and 
refloated on a 10 |xl drop of antigen. After a second incubation the grids were neg­
atively stained as previously described for DEM.
All incubations were performed in a moist chamber at 37°C for 1 h.
Immunogold labelling and the IGEM test
A copper EM grid was coated with the porcine antibody by floating the grid on 
a drop of the pig anti-BCV IgG and was incubated for 1 h. The grid was washed 
twice with PB and reacted with a drop of antigen. After incubation for 1 h the grid 
was washed as described earlier and then floated on a drop of bovine anti-BCV 
IgG, reincubated for a further 30 min and washed as described previously. The 
grid was then placed on a drop of pig anti-bovine IgG which was conjugated to 5 
nm colloidal gold. The conjugation was performed following the technique de­
scribed by De Mey (1984). This conjugate was stored at 4°C and was diluted 1/5 
in PB immediately before use. Any aggregates which may have formed on storage 
were removed by centrifugation of the diluted conjugate at 10000 x g for 2 min. 
After incubation with the gold conjugate for 1 h excess fluid on the grid was re­
moved by blotting the side with filter paper and the grids negatively stained as de­
scribed.
All incubations were performed in a moist chamber at 37°C, and a standard drop 
of 10 jXl was used throughout.
During examination only virus particles with more than 20 gold particles at­
tached to them were counted as positive to reduce the possibility of confusing light 
background staining with specific labelling.
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Sucrose gradient fractionation o f BCV
A  volume of 60 ml of BCV grown in HRT18 cells was clarified by centrifugation 
at 3000 x g for 20 min to remove gross debris. Virus in the supernate was pelleted 
through a 10% (w/w) sucrose cushion by ultracentrifugation at 100000 x g for 45 
min at 4°C in a Beckman L5 Ultracentrifuge using an SW28 rotor. The pellet was 
resuspended in 0.3 ml TNE buffer (0.01M tris-hydrochloride (pH 7.5) -  0.1 M 
NaCl-1.0 mM EDTA), layered onto a 20-55% (w/w) sucrose gradient and cen­
trifuged at 52000 x g in an SW40 Ti rotor overnight at 4°C. The gradients were 
fractionated on an ISCO Density Gradient Fractionator and 0.5 ml fractions col­
lected. Each fraction was examined by IGEM and the haemagglutination (HA) titre 
measured by the method described by Sato et al. (1977), using rat red blood cells.
Comparison o f diagnostic tests 
Fifteen bovine faecal samples were examined for BCV by DEM, ISEM, HEHA  
and IGEM. The HEHA test was performed as described by Van Balken et al. 
(1978/79). A further 94 faecal samples were compared by DEM and IGEM.
Results
Direct electron microscopy 
It was often difficult to visualise intact virions and differentiate these from other 
fringed bodies by DEM. The low numbers of virus particles in addition to the 
presence of faecal debris compounded these difficulties and made unequivocal di­
agnosis of the presence of coronavirus difficult. Fig. 1A illustrates a coronavirus 
particle in a bovine faecal sample and highlights the problem of differentiating co- 
ronavirus-like particles.
Immunosorbent EM
The virus was concentrated approximately one thousand-fold using ISEM. The 
faecal background debris was markedly reduced but fringed bodies and virus-like 
particles were still detected in around 30% of samples, sometimes making inter­
pretation difficult. The concentration effect of ISEM is illustrated in Fig. IB.
Immunogold EM
Using IGEM BCV particles were both concentrated and specifically labelled. As 
illustrated by Fig. 1C, most of the gold particles were closely associated with the 
virus particles, with minimal gold background staining.
Fig. ID illustrates a negative sample in which relatively low gold background 
staining was observed and debris or other particles which may have been mistaken 
for coronavirus were not labelled. Compared to DEM the background debris was 
also substantially reduced.
Control experiments utilised cultured and faecal BCV, and a faecal rotavirus 
preparation (Table 1). These control experiments showed that all the virus parti­
cles in the test (Table 1, column 1), were specifically labelled. In the coating an-
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Fig. 1. (A ) A  particle considered  to be BC V  (large arrow ) and a coronavirus-like particle (sm all a r ­
row) observed  by D E M . T he po ten tia l for misdiagnosis is clear. (B) BCV  particles detected  by ISE M . 
The p leom orphic coronavirus particles (large arrow ) are concen tra ted  on to  the antibody coated  grid. 
In add ition , m any in tact peplom ers (small arrow ) are obvious. (C) A n IG E M  p repara tion  o f a bovine 
faecal sam ple contain ing  BCV. T he 5 nm colloidal gold particles are mainly bound  to the co ronav irus 
particles (arrow ed). (D ) A  bovine faecal sam ple, negative for B C V , as observed by IG EM . F ringed 
coronavirus-like particles are not labelled. Bars rep resen t 100 nm.
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TABLE 1
Number of coronavirus and coronavirus-like particles in 10 grid squares observed in IGEM and control 
preparations.
Sample Technique
IGEM IGEM performed without
1st Ab 2nd Ab 1st and 2nd Ab
Cultured BCV 3,556/0 0/1 0/2,943 nt
Faecal BCV 6,225/0 6/3 0/1,344 0/0
Faecal rotavirus 0/0 0/4 0/1 0/4
Ab : antibody, nt : not tested. - / -  : no. of labelled particles / no. of unlabelled particles
tibody control, the results were similar to DEM examination, with no concentra­
tion of particles (column 2). Where the second antibody was omitted (column 3), 
results similar to ISEM were obtained, with concentration of the sample but no 
specific labelling. Finally by omitting both antisera (column 4), no concentration 
and no specific labelling were observed. These results demonstrate.the specificity 
of the IGEM test.
Sucrose gradient
The number of labelled virus particles in sequential fractions of a sucrose gra­
dient and the HA activity of each fraction are given in Fig. 2. The fractions con­
taining the highest numbers of virus particles coincided with the peak of HA ac-
DENSITY 
g/m l 
. 1.20
. 1.18
. 1.16
. 1.14
. 1.12
. 1.10
. 1.08
FRACTION NUMBER
RECIPROCAL HA TITRE
NUMBER/10 GRID SQUARE A-
2 0  4 8 0
2 5 6 0
3 2 0
4 0
5 10 15 20 25
Fig. 2. H A and IGEM results on a 20-55% (w/w) sucrose gradient BCV preparation.
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tivity. The density of this region was 1.18 g ml 1 which corresponds with that of 
BCV in sucrose (Siddell et al., 1983).
Comparison of diagnostic tests 
Of 15 samples examined, coronavirus was detected in 2 samples by DEM, in 3 
samples by ISEM, in 5 samples by HEHA and in 6 samples by IGEM (Table 2).
In the comparison of 94 faecal samples, 68 samples were found to be negative 
for BCV by both DEM and IGEM. Of the remaining 26 only 14 were positive when 
examined by DEM, whereas all were found;to be positive in the IGEM test (Table 
3). '
Discussion
It has been noted that BCV peplomers are fragile and easily sheared from the 
outer envelope leaving a much less distinctive particle (Stair et al., 1972). Our re­
sults confirmed that when faecal samples containing BCV were examined by DEM  
coronavirus particles were usually observed to be widely spaced and the back­
ground heavily contaminated with debris. Equivocal results were compounded by 
the presence in faeces of other fringed particles which could be mistaken for co­
ronavirus (Dea et al., 1981).
In this study a higher sensitivity and specificity were observed in ISEM prepa-
TABLE 2
Comparison of four tests for diagnosis of BCV in faeces.
Faecal sample Detection of BCV by
DEM ISEM HEHA IGEM
1 + + + +
2 + + + +
3 - + + +
4 - - + +
5 - - + + .
6 - ■ ' - +
7-15 - -
Total + 2 3 5 6
TABLE 3
Comparison between DEM and IGEM in the diagnosis of BCV in 94 faecal samples.
Results No. of samples
DEM  +  IGEM + 14
DEM  + IGEM - 0
DEM  -  IGEM + 12
DEM  -  IGEM - 68
222
rations. However around 30% of faecal samples still contained virus-like particles 
which could not be unequivocally determined to be BCV.
An attempt was made to further increase the sensitivity and specificity of BCV 
diagnosis by combining the concentrating effect of ISEM with the specific labelling 
of antibody conjugated to colloidal gold in an IGEM test. This was successfully 
achieved, with the IGEM allowing coronavirus-like particles to be diagnosed ac­
curately as BCV or debris. The results of the coronavirus purification on a sucrose 
gradient gave further confirmation of specificity. The peplomers of coronavirus 
particles were rarely seen in IGEM preparations as the antibody coating seemed 
to obscure these projections. The main disadvantages of IGEM are the expense of 
reagents and equipment and the limited throughput of samples. IGEM should de­
tect different BCV strains as all isolates examined so far have been serologically 
similar (Dea et al., 1982).
The principle of this immunogold detection technique can be applied to other 
antigens which are not morphologically distinct and need to be labelled or local­
ised. The technique therefore has widespread applications (Horisberger, 1981; 
Ducatelle et al., 1984) and has been used to label rotaviruses and adenoviruses 
(Kjeldsberg, 1985) in human faeces by an indirect labelling test where the viruses 
were directly adsorbed onto EM grids. Caliciviruses (Kjeldsberg, 1986) in human 
faeces have been labelled in suspension and the complexes adsorbed onto EM grids.
This novel technique should prove useful in the epidemiological study of disease 
associated with BCV infection, and as a standard against which to evaluate the de­
velopment of other diagnostic techniques, such as the new dot-blot hybridization 
assay to detect viral RNA using a cDNA probe (Shockley et al., 1987).
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A STATISTICAL ASSOCIATION BETWEEN BOVINE CORONAVIRUS 
AND RESPIRATORY TRACT INFECTIONS OF CALVES
A.A. El-Ghorr, D. Blewett, J.C. Cuthbertson and D.R. Snodgrass
Moredun Research Institute, 408 Gilmerton Road,
Edinburgh EH17 7JH, Scotland, U.K.
SUMMARY:
A prospective survey to investigate the prevalence of enteric and 
respiratory pathogens affecting young calves, with particular emphasis 
on BCV was carried out on a dairy farm during the calving season. This 
survey showed that the detection of bovine coronavirus (BCV) in the 
respiratory tract was associated significantly with respiratory 
symptoms. In the enteric tract, Cryptosporidium but not rotavirus nor 
BCV was shown to be statistically associated with diarrhoea in the 18 
calves on the survey.
INTRODUCTION
Rotavirus, Cryptosporidium and coronavirus are well established as 
enteric pathogens of young calves (Estes and others, 1983; Angus, 1983; 
Mebus and others, 1973). Additionally bovine coronavirus (BCV) has been 
detected in the respiratory tract of calves (McNulty and others, 1984)
but its role in respiratory disease is unclear. The interaction and 
prevalence of these enteric pathogens, and the significance of BCV 
infections of the respiratory tract were studied on a farm 
approximately 70 miles south west of Edinburgh. This farm was selected 
because Rotavec K99 vaccine against rotavirus and E. coli (K99) had 
been administered to all pregnant cows and because BCV previously had 
been detected on this farm.
MATERIALS AND METHODS
Animals:
All calves born on the farm between 30 October and 19 November 1987 
and which remained on the farm for at least twelve days were included 
in the survey.
With a few exceptions all calves were housed in a large ridge-roofed 
shed. Individual calf management was not standard. Thirteen were 
accommodated initially in individual pens and bucket fed. After six 
days approximately most of these calves were moved to multiple pens 
with either a suckler cow or a nursette type system. The remaining 
five calves were accommodated immediately in multiple pens.
Clinical and Diagnostic:
Occurring respiratory symptoms of cough and nasal discharge and all 
incidents of diarrhoea at the time of sampling were recorded.
Faeces and nasal swabs were collected from each of 18 calves on 
alternate days from birth until a maximum of 42 days of age. Faecal 
samples were examined for:
1. Rotavirus (RV) using a polyacrylamide gel electrophoresis 
technique (PAGE) for the detection of RV double-stranded RNA (Herring 
and others, 1982).
2. Cryptosporidium using a modified Ziehl-Nielsen staining method 
(Henriksen and Pohlenz, 1981).
3. BCV by an indirect antibody sandwich blocking ELISA test, based 
on the technique developed by Engvall and Perlmann (1972). Dynatech 
M129A micro ELISA plates containing lOOul per well were used
throughout. PBS/T^q was used as diluent, each incubation step was for
lh at 37 C (except where otherwise stated) and the plates were washed 3 
times in PBS/T^q between each step. The plates were coated with ovine 
anti-BCV IgG in carbonate/bicarbonate buffer (pH 9.6) and incubated at 
4 C overnight. Antigen was added to each of 6 wells and incubated for 
3h at 37 C. An ovine anti-BCV serum and an ovine anti- rotavirus serum 
were then used at a dilution of 1/20 in duplicate wells for the 
blocking step. The other 2 wells per sample received only PBS/T2 Q. 
Rabbit anti-BCV IgG was added to all wells. Goat anti-rabbit serum 
conjugated to horseradish peroxidase was purchased from Wellcome and 
used at an optimum dilution of 1/6,000. After incubation the substrate 
o-phenylenediamine (OPD) in 0.1M citric acid - 0.2M disodium phosphate 
buffer was added and left at RT in the dark for 10 min. The colour
reaction was stopped by the addition of 50ul per well of 2M sulphuric 
acid and the plates read in a Titertek Multiskan spectrophotometer
using a 492nm filter. The blank wells only received the substrate and 
sulphuric acid. Samples which gave optical density (OD) readings above
0.2 and were blocked specifically only by the anti-BCV serum, with 
>50% reduction in OD, were considered positive. The lower limit of the 
sensitivity of this test was fixed at 0.2 by the mean OD of 18 negative 
faecal samples plus 2 standard deviations. BCV positive samples were 
confirmed to contain BCV by an immunogold EM technique (El-Ghorr and 
others, 1988).
Nasal swabs were collected using sterile cotton swabs, placed in 
virus transport medium and stored on ice for up to 24 hours. The 
epithelial cells from the nasal swabs were centrifuged onto glass 
slides in Cytospin apparatus (Shandon Southern), and fixed in cold 
acetone for 5 min. A standard indirect IF test was then performed using 
a rabbit anti-BCV serum at 1/320 in PBS, for 30min at 37°C followed by 
the addition of a goat anti-rabbit FITC conjugate (Wellcome) at 1/60, 
for 30min at 37°C.
Statistics:
There was considered to be an association between a pathogen and any 
clinical signs only when the detection of that pathogen fell within 2 
days of the onset of clinical symptoms. The Chi-square and exact 
probability tests were used for statistical analysis of the results. 
The exact relative risk "Re" (Schwabe and others, 1977) was also used 
for statistical analysis. This test measured the ratio:
Re = ¥ W
v w
where P^ to P^ were the proportion of observations in each of the 
following categories:
Disease 
Present Absent
Present P^ P^
Organism
Absent P„ P,
3 4
and P^+Pg+Pg+P^-l.0
A 95% confidence interval was used to assess the significance of 
each statistical association.
Serology:
Blood samples were collected at the beginning and end of the survey 
period and antibodies to BCV in sera were estimated using a serum 
neutralization test. Nunc tissue culture grade 96-well fl^t bottome<jl 
microtitre plates were seeded out with lOOul/well of 2x10 cells ml 
HRT 18 cells in RPMI medium containing 20% FBS, and incubated at 37°C 
for 2 days or until confluent. The medium was replaced by 200ul/well 
of 2% FBS RPMI medium. Each serum sample was heat inactivated at 56 C 
for 30 min and then double diluted jn duplicate in 25ul volumes of 2% 
FBS RPMI medium containing lOugml trypsin, in microtitre transfer 
plates (Flow Laboratories). Cell culture grown BCV/M strain was then 
added (25ul/well) to the antibody samples at a previously determined 
dilution which provided 20 to 200 fluorescing cells per field in the UV 
microscope at a magnification of xl25. Virus and antibody were allowed 
to interact at 37 C for lh. This 50ul mixture was then inoculated onto 
the HRT 18 cells, using the transfer plate as a template which 
simultaneously transferred 50ul to each of the 96 wells of the 
microtitre plate. The microtitre plates were sealed and incubated at 
37 C for 2 days after which time the cells were washed, fixed in 
acetone and the infected cells visualised by IF using a gnotobiotic 
calf anti-BCV serum and a pig anti-sheep FITC conjugate. The recorded 
titre of serum samples was the highest dilution to cause a 90% 
reduction in the number of fluorescing cells compared to the mean of 
the virus control wells.
RESULTS
Clinical and Diagnostic Findings:
A total of 193 faecal samples and 193 nasal swabs were collected 
from the 18 calves. All 18 calves developed diarrhoea at some time 
during the survey period. Twelve calves exhibited respiratory 
symptoms, either cough or nasal discharge.
A total of 17 calves excreted Cryptosporidium. 9 calves excreted 
rotavirus and 9 calves excreted coronavirus. Coronavirus was detected 
in the respiratory tract of 5 calves, in the enteric tract of 1 calf 
and in both the enteric and respiratory tracts of three calves (Table 
1) . Of the 18 animals, 14 scoured in association with Cryptosporidium. 
1 in association with Cryptosporidium and rotavirus, 1 in association 
with coronavirus, 2 in association with rotavirus and coronavirus and 
1 in association with all 3 pathogens.
Statistics:
The Chi-square test could not be used to analyse individual results 
in this survey since the assumption for this statistical test of each 
result being unrelated to another may not hold entirely true. Each set 
of results from one animal could be considered related to each other. 
Using the Chi-square test on unrelated individual animals rather than 
individual samples, then Cryptosporidium was found to be closely 
associated with diarrhoea (X =4.0 and P<0.05) but no definite 
conclusions could be made about diarrhoea and either coronavirus or 
rotavirus since there were very few animals shedding only one pathogen 
when diarrheic. A larger number of animals was needed in order to 
obtain a group of animals shedding only one organism. This was not the 
case for BCV in the respiratory tract, because Cryptosporidium and 
rotavirus are known not to infect the respiratory tract. Respiratory
symptoms were detected in 8 of 9 calves that were BCV positive and in 
only 4 of 9 calves that were BCV negative. There was therefore a 
statistically significant association between BCV and respiratory 
symptoms (P<0.05) using the exact probability test. For the detection 
of rotavirus in faeces, the calculate^ Re value ^as 1.77 and the 95% 
confidence interval was between 8.4x10 and 3.8x10 . The value 1.0 lay 
well within these confidence limits indicating no relationship between 
diarrhoea and the detection of rotavirus. For the detection of 
coronavirus the Re value was 2.5 and the 95% confidence interval was 
between 0.9 and 17.4. In this case the value 1.0 just fell within 
these limits. One must therefore conclude that there was no 
significant association between diarrhoea and BCV, but such an 
association might have been detected if a larger number of calves had 
been sampled.
Serology:
The virus neutralizing titres to BCV/M strain are represented in 
table 2. The initial and final neutralization titres varied between 40 
and 640 and seroconversion was demonstrated only in calf number 7.
Ta
bl
e 
1:
 
Cl
in
ic
al
 
si
gn
s 
an
d 
pa
th
og
en
s 
de
te
ct
ed
 
in 
th
e 
18 
ca
lv
es
 
du
ri
ng
 
th
e 
su
rv
ey
.
<r
Csl
o
oo
co
voco
co
CM
co
O
CO
oo
CM
VO
CM
CM
CM
CM
O
CM
00
VO
CM
O
a
o
Q
Pi
CQ
PiO
CQ
CQ
U
Q O
U
O
Q
Pi
O
u
u
o
o
Pi
Q
Pi Pi
PiPi CQQ Q PQ
oCQ Q
O O PiQ CQ Q <
PiO CQ
< Pi <O PQ Q Q Pi
OCQ CQ
<! O CQO Q Q o
O <Q O U o
oio Pi o oo Q O o o Q
o Pi o oQ o Q Q
OPi PiPi u o Uo Q Q Q O Pi
o O
Q O o
o o u
a O Q
PiU
Q
Pi
o
Pi
DR
Pi DC
pi u
CR u
o CB
CR
o
VO o
o u
CM
r-I CM 00
O
OV r—I
CO in vo
r—I rH
I''. 00 
\— I i— I
Q  6*
di
ar
rh
oe
a,
 
R:
 
re
sp
ir
at
or
y 
sy
mp
to
ms
, 
0:
 
ro
ta
vi
ru
s 
in 
fa
ec
es
, 
A:
 
co
ro
na
vi
ru
s 
in 
fa
ec
es
, 
B:
 
co
ro
na
vi
ru
s 
in 
na
sa
l 
sw
ab
s 
Cr
yp
to
sp
or
id
iu
m 
in 
fa
ec
es
, 
un
de
rl
in
in
g:
 
sa
mp
le
 
av
ai
la
bl
e
Table 2: Serology results of the field survey.
Calf number BCV/M neutralization titre in serum taken at aee
2 days 14 days 28 days
1 80
2 640
3 640
4 80
5 320
6 320 160 80
7 40 <40 640
8 160
9 160
10 40
11 40 <40 40
12 160 40 80
13 <40
14 160 80 40
15 80
16 160
17 40
18 640 320 320
blank: no sample ; reciprocal neutralization titres are quoted.
DISCUSSION
The predominant problem on this farm seemed to be cryptosporidiosis 
as this organism was detected in 17 out of the 18 calves and was 
closely associated with diarrhoea. This fits with previous reports of 
Cryptosporidium as a significant enteric pathogen in calves (Angus, 
1983).
Coronavirus was isolated from both the enteric and respiratory 
tracts, and a significant association was obtained between BCV in the 
respiratory tract and respiratory symptoms. BCV has previously been 
detected in the respiratory tract (McNulty and others, 1984; Reynolds 
and others, 1985) but no statistical association with respiratory 
symptoms has been reported (Thomas and others, 1982).
A statistically significant association could not be obtained 
between coronavirus and diarrhoea. This was mainly due to the complex 
interactions between several agents which made statistical analysis
very difficult with the numbers involved. However there was
circumstantial evidence for the involvement of BCV in diarrhoea which 
has previously been shown statistically (Reynolds and others, 1985). 
Subclinical rotavirus infections in the calves were presumably 
attributable to effective passive immunisation (Snodgrass, 1986).
The blood samples that were collected from 18 calves at the start of 
the survey had coronavirus antibody titres that ranged between 40 and 
640 indicating absorption of colostral antibodies from cows endemically 
infected with BCV. Because of some animals being removed from the farm 
during the survey period, only 6 final blood samples could be
collected. The final antibody titres against BCV again ranged between 
40 and 640 with one calf demonstrating seroconversion (a greater than 4 
fold increase in antibody titre over 2 weeks). This indicated that at 
least one calf was actively infected with coronavirus. This calf was 
diarrheic and excreted detectable levels of coronavirus in faeces.
On a time course basis, the farm was visited between 2/11/87 and 
18/12/87. Cryptosporidium was mainly detected between 8/11/87 and 
30/11/87. This wave of Cryptosporidium infection was followed by a 
wave of coronavirus infection. Coronavirus was first detected on 
26/11/87 and quickly spread to other calves and was not detected beyond 
6/12/87. Within this ten day period, there were 10 calves on the survey 
and 9 of these calves were infected with coronavirus. It seemed 
therefore that BCV arrived suddenly on the farm, infected most of the 
animals that were present and disappeared soon afterwards. 
Alternatively BCV may have been present endemically on the farm and was 
excreted when colostral antibodies declined. Rotavirus was detected 
sporadically between 10/11/87 and 4/12/87. These phases may have 
important epidemiological significance but were not age-related because 
calves were added to the survey as they were born throughout the period 
2/11/87 to 22/11/87.
This survey reflected the importance of diarrhoea as a disease of 
neonatal calves and showed the significance of BCV in the respiratory 
tract in addition to its well established role as a cause of diarrhoea.
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EVIDENCE FOR SEROLOGICAL VARIATION AMONG 
BOVINE CORONAVIRUSES
A.A. El-Ghorr, D.R. Snodgrass, F.M.M. Scott and I. Campbell
Moredun Research Institute, 408 Gilmerton Road, 
Edinburgh EH17 7JH, Scotland, U.K.
Summary:
Two field samples of bovine diarrheic faeces containing bovine 
coronavirus (BCV) were adapted to grow in HRT 18 cells following 
initial isolation in bovine fetal tracheal organ culture. These, and 
three other strains of BCV and a human coronavirus (HCV) strain 
obtained from other laboratories, were compared in immunofluorescence 
(IF), haemagglutination inhibition (HAI) and neutralization tests. 
Polyclonal antisera against these 6 viruses were raised in rabbits. No 
significant differences between viruses were detected by IF 
incorporating homologous and heterologous antisera but HCV could be 
distinguished from the bovine coronaviruses in a cross neutralization 
test. In this test all BCV isolates were determined to be of one 
serotype. In the HAI test however, the HCV strain was distinguishable 
from the 5 BCV strains and serological differences between the BCV 
strains were shown. Two monoclonal antibodies prepared against one of 
the BCV strains distinguished the HCV from the BCV strains in all three 
tests. These monoclonal antibodies did not distinguish between the 5 
BCV strains in the IF or HAI test but did so in the neutralization 
test.
INTRODUCTION
Members of the Coronaviridae family are assigned to a small number 
of groups based on serological characteristics. Transmissible 
gastroenteritis virus (TGEV), feline infectious peritonitis virus 
(FIPV), canine coronavirus (CCV) and human coronavirus (HCV-229E) form 
one group (here named group A). Mouse hepatitis virus (MHV), rat 
coronavirus (RCV) and rat sialodacryoadenitis virus (SDAV) form another 
group (Bl) which is related to the group containing human coronavirus 
(HCV-OC43), haemagglutinating encephalomyelitis virus (HEV) and bovine 
coronavirus (BCV) (group B2). Infectious bronchitis virus (IBV), foal 
enteritis coronavirus (FECV), porcine epidemic diarrhoea virus (CV777) 
and turkey coronavirus (TCV) were found to be unrelated to any of the
above groups and to each other (2, 11, 13, 16, 17, 21).
There has been no extensive serological comparison of different 
strains of BCV or investigations into the extent of their relationship 
with other members of group B2. There have been a few limited 
comparisons between selected isolates. The strains M and PQ were found 
to possess similar physicochemical and biological properties (3), but 
differed antigenically by counterimmuno- electrophoresis and 
immunodiffusion techniques (4). Four British isolates, 1 from the 
enteric tract and 3 from the respiratory tract, were compared by a 
neutralization test using antisera to three of these isolates raised in 
pigs. There was complete virus neutralization in tests with homologous 
sera and significant cross-reactions with the other isolates (18) 
indicating one serotype. At the molecular level, slight variation in
the molecular weights of the structural proteins of different BCV
strains has been reported (5, 7, 12, 14) and this may reflect
serological differences.
A comprehensive serological comparison of 5 different BCV and a 
HCV-OC43 strain was undertaken using polyclonal and monoclonal 
antibodies in order to investigate possible variation.
MATERIALS AND METHODS
Viruses:
Three reference BCV strains already adapted to cell culture were 
obtained from other laboratories. The American M strain of BCV was 
kindly supplied by Dr S. McNulty, Veterinary Research Laboratory, 
Belfast (15); the Canadian PQ strain by Dr L. Babiuk, University of 
Saskatchewan, Canada (3); and the British CK strain by Dr Janice 
Bridger at the Institute for Animal Health, Compton (18). Two Scottish 
field isolates of BCV (designated SI and S2) were adapted to grow in 
HRT 18 cells following initial isolation in bovine fetal tracheal organ 
culture as described elsewhere (8). These five BCV strains were 
biologically cloned by three terminal dilutions and grown in roller 
cultures in HRT 18 cells as described previously (20). The Qvirus 
inoculum was pre-treated with lOugml trypsin for 1 hour at 37 C and 
lugml trypsin was incorporated in the maintenance medium.
Human coronavirus OC43 was kindly supplied by Mr G Winters of the 
City Hospital, Edinburgh. This virus had been passaged in newborn mice 
by intracerebral inoculation. A 1/100 mouse brain homogenate in PBS 
was treated with lOugml trypsin for 1 hour at 37 C and inoculated 
onto HRT 18 cells. This virus was adapted to this cell line by 5 
passages; and was detected in cells by immunofluorescence (IF) using 
ovine anti-BCV/Sl serum.
Rabbit Polyclonal Antisera:
Each of the six virus strains was pelleted by ultracentrifugation 
(8). Antiserum to each was raised in a rabbit by intramuscular 
inoculation of virus pellet emulsified in Complete Freunds Adjuvant 
(CFA). After 4 weeks, each rabbit received an intramuscular boost of 
the same virus pellet in Incomplete Freunds Adjuvant (IFA), and was 
bled out under anaesthesia 2 weeks later.
Mouse Monoclonal Antibodies:
Mouse monoclonal antibodies to the BCV/S2 strain were raised and 
ascites produced using a standard technique (7). Hybridoma containing 
wells were screened by IF, haemagglutination inhibition (HAI) and 
neutralization test (NT) for anti-BCV activity. Positive hybridomas 
were cloned by three terminal dilutions. In this study two monoclonal 
antibodies were used: MAB/S2/1 which had the characteristics IF+, HAI+ 
and NT+ and MAB/S2/2 which was IF+, HAI- and NT+.
Cross Immunofluorescence Test:
Microtitre plates containing confluent monolayers of HRT 18 cells 
were inoculated with 10 TCID50 per well of each virus strain, incubated 
at 37 C for 2 days, washed twice with PBS and fixed in acetone. 
Doubling dilutions of each serum sample were made in PBS and added in 
duplicate to the fixed cells. After 30 min incubation at 37 C, the 
plates were washed twice in PBS and the appropriate FITC conjugate 
(either goat anti-rabbit or swine anti-mouse; Wellcome) added and 
incubated at 37 C for a further 30 min. The plates were washed twice 
more in PBS and examined under incident UV light using a Leitz UV 
microscope. IF titres were recorded as the highest dilutions to provide 
clear fluorescing cells when compared to uninoculated controls.
Cross Haemagglutination Inhibition Test:
The HAI test was performed as previously described (19). Each serum 
sample was kaolin extracted, treated with rat erythrocytes and 
complement inactivated. Each virus was used at a standard dilution of 8 
HA units. Serum samples were double diluted in duplicate and reacted 
with the virus. The highest titres to completely inhibit the HA 
activity of 8 HA units of virus were recorded.
Cross Neutralization Test:
Each serum sample was titrated in duplicate against each of the 5 
BCV strains and the HCV-OC43 in a neutralization test (9). This test 
was repeated using all the sera and all the virus strains in order to 
provide a replicate set of results.
Comparison of Strains:
In the comparison studies replicate results were obtained in each 
case. Most of these replicate titres fell consistently within four-fold 
values. The geometric mean of 2 replicate results was calculated in 
each case and quoted in the results below. Strains were assumed to be 
serologically different on the basis of a 20 fold or greater difference 
between homologous and heterologous titres. The antigenic relationship 
(R) between the strains was calculated by a slight modification of the 
method of Archetti and Horsfall (1), using the formula:
where rl = heterologous titre (strain 2) / homologous titre (strain 1)
and r2 = heterologous titre (strain 1) / homologous titre (strain 2)
A high R value indicated a close degree of relatedness. A value of 
R<5% was assumed to show antigenic distinction between two strains, as 
this R value corresponded to a 20 fold reciprocal difference between
homologous and heterologous titres.
Virus Culture:
During this study it was noted that no CPE was detected in HRT 18 
cells at any stage with any of the strains and that the use of trypsin 
was essential for virus replication. Virus was detected in cell culture 
by IF and haemagglutination.
Immunofluorescence Test:
Using the IF test, the 5 BCV strains and the HCV-0C43 strain were 
shown not to be significantly distinct when reacted with polyclonal 
antisera (tables 1 and 2) . None of the R values fell below or equalled
Using monoclonal antibodies against BCV/S2 in this test however 
HCV-0C43 was clearly distinguished from the bovine strains (Table 1). 
Both monoclonal antibodies had >20-fold lower IF titres when tested 
against the M and SI strains than against the homologous strain. 
MAB/S2/2 in addition had a 32-fold lower IF titre against strain CK.
%
RESULTS
5%
Haemagglutination Inhibition Test:
The results of the HAI test are shown in tables 3 and 4. Using the 
polyclonal antisera, the HCV-OC43 was assigned to a different serotype 
(R<5%) from BCV/PQ, CK and S2 (Table 4). The R values of the HCV with 
the BCV/M and SI strains were 9 and 6% respectively. These low R 
values indicated a considerable serological difference between HCV-0C43 
and all BCV isolates. Within the BCV strains, distinct serological 
differences were detectable by the HAI test between the SI and the PQ 
and CK strains.
Using the HAI positive monoclonal antibody to the S2 strain, marked 
differences were detected between the human and bovine viruses. 
MAB/S2/1 reacted with all BCV strains. Its reaction with the BCV/S1 
however was 16 fold lower than with the homologous strain (Table 3).
Neutralization Test:
The neutralization results are shown in tables 5 and 6. Human 
coronavirus was clearly distinguished from the BCV/M, PQ and CK
strains using the polyclonal antisera to the BCV strains. The R values 
of HCV-OC43 with the SI and S2 strains were 7% and 11% respectively, 
which reflected considerable antigenic differences. Within the 5 
bovine strains, no significant or serotypic differences could be 
detected using the polyclonal antisera (Table 6).
With monoclonal antibodies however, differences were detected. The 
MAB/S2/1 clearly distinguished between M/PQ/S2 on the one hand and 
CK/S1 on the other, while MAB/S2/2 neutralized all 5 strains of BCV to 
a similar extent (Table 5). Additionally, both monoclonal antibodies 
clearly differentiated the HCV-OC43.
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Table 2: Mean IF titres with coronavirus isolates
+ R% using polyclonal antisera.
Coronavirus ______________ Anti serum to Coronavirus_______
M PQ CK SI S2 OC43
M 100
PQ 35 100
CK 21 100 100
SI 50 118 71 100
S2 21 100 59 59 100
0C43 15 84 30 30 50
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Table 4: Mean HAI titres with coronavirus isolates
+ R% using polyclonal antisera.
Coronavirus ______________ Antiserum to Coronavirus_______
M PQ CK SI S2 0C43
M 100
PQ 70 100
CK 21 18 100
51 15 5 5 100
52 18 30 84 21 100
0C43 9 5 4 6 4 100
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Table 6: Mean neutralisation titres with coronavirus isolates
+ R% using polyclonal antisera.
Coronavirus ______________ Antiserum to Coronavirus_______
M PQ CK SI S2 0C43
M 100
PQ 35 100
CK 50 59 100
SI 42 59 35 100
S2 30 35 35 42
OC43 0.8 0.5 0.2 7
DISCUSSION
Polyclonal antibodies are directed against many different epitopes 
on viral proteins and differences may be masked as only a proportion of 
these epitopes need remain constant for the antiserum to react with the 
virus. This can be highlighted in the case of BCV by the 
haemagglutinin and peplomer proteins, both of which elicit 
neutralizing activity (6). In a neutralization test, if the peplomer 
protein remained unchanged, differences in the haemagglutinin protein 
would not be detected using polyclonal antiserum. This also applies in 
the case of different epitopes on one protein.
Monoclonal antibodies however can often be too specific and minor 
antigenic differences may be detected by these antibodies but these 
differences may have no biological significance. Alternatively, 
monoclonal antibodies may be directed against a common antigen and may 
not detect important differences between strains.
For these reasons both monoclonal and polyclonal antibodies were 
used in a variety of serological tests to determine the extent of 
differences detween isolates. The antigenic relationship value of 5% 
for serotypic differences was severe in the light of 10-32% used in 
differentiating between types and subtypes of foot-and-mouth disease 
virus (10).
The one-way interactions which occurred in these comparative tests 
appear difficult to explain but variations between the individual 
animals used to produce the antisera may have played a role in 
determining the extent of such reactions. The use of R values for 
antigenic relationships helped in the interpretation of results while 
taking into account these interactions.
The immunofluorescence test using the polyclonal antisera could not 
distinguish between any of the bovine or human strains indicating that 
all these viruses possess at least one common or similar epitope 
recognisable by these polyclonal antibodies. Using the monoclonal 
antibodies in the IF test, the HCV-OC43 was easily distinguishable. It 
is likely that shared recognition sites were more common between BCV 
strains than between BCV and HCV. The MAB/S2/1 and MAB/S2/2 also 
detected some differences between M/CK/S1 and PQ/S2 in this test. The 
significance of these differences was unclear since no other monoclonal 
antibodies were available to perform reciprocal tests.
The HAI test provided information regarding the haemagglutinin of 
the different strains although stearic hindrance may have also played a 
role. The haemagglutination reactions of HCV-0C43 with polyclonal 
antisera differed considerably from those of the bovine strains. This 
was confirmed by MAB/S2/1. Clear differences between the PQ and CK 
strains and SI were also demonstrated suggesting that they may belong 
to different serotypes.
The neutralization test yielded more information regarding the 
grouping of these coronaviruses. With the aid of polyclonal antibodies 
the HCV-0C43 could be considered a different serotype to M, PQ and CK. 
The SI and S2 strains were found to be more closely related to the 
HCV-0C43 although the SI and S2 antisera clearly distinguished the 
human strain. No major serotypic differences could be detected between 
the 5 BCV strains while using polyclonal antisera. When MAB/S2/1 and 
MAB/S2/2 were used, the BCV/S2 strain could be clearly differentiated 
from 0C43 confirming the results obtained with the S2 polyclonal 
antiserum. The anti-S2 monoclonal antibody MAB/S2/2 could not 
differentiate between the 5 BCV strains indicating that they shared
this epitope. The anti-S2 haemagglutinin monoclonal antibody MAB/S2/1 
could not distinguish between the haemagglutinin proteins of M,PQ or S2 
but marked differences were detected in the. haemagglutinin of the CK 
and SI strains. This result confirmed the serotypic difference obtained 
with the PQ and SI strains in the HAI test using polyclonal antisera.
Using the IF and neutralization tests therefore, the five BCV 
strains were shown to be closely related and belong to one serotype 
since only minor
differences could be detected between them using polyclonal 
antisera. With the HAI test however the SI strain was found to belong 
to a different serotype to the PQ or CK strains. The highly specific 
monoclonal antibodies could not differentiate between the 
haemagglutinin of the M, PQ and S2 strains, but the CK and SI
haemagglutinin was different to that of the others. No difference in
the five BCV strains was detectable with the MAB/S2/2 monoclonal 
antibody other than by the IF test when the CK, SI and M strains
reacted more than 20 fold less effectively than with the S2 strain.
These monoclonal antibodies also differentiated the HCV-OC43 strain by 
all three tests while the polyclonal antisera could not differentiate 
0C43 by the IF test but could generally do so by HAI and NT. Some cross 
reaction occurred with the anti-0C43 antiserum and the SI and S2 BCV 
strains in the NT probably due to the polyclonal nature of the serum. 
The HCV-OC43 was confirmed to belong to a different serotype from M, PQ 
and CK but showed some similarities with the Si and S2 strains.
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